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ABSTRACT 
Chronic venous disease (CVD) of the lower limbs is a major problem in the western 
world with 1% of the adult population estimated to be affected at any one time. The 
clinical sequelae of CVD of the lower limbs range from oedema, haemosiderosis and 
pigmentation, to gross lipodermatosclerosis (LDS) and venous ulceration. The site most 
commonly affected is the gaiter area of the lower limb. The extent and severity of 
venous disease can be assessed by clinical and physiological methods which include 
duplex ultrasonography and plethysmography. Tissue oedema can be assessed by 
volumetric or circumferential measurements and venous ulcers may be quantified by 
area measurements and response to treatment in ulcer healing studies. In the vast 
majority of patients a spectrum of skin changes precedes venous ulceration. At present, 
there is no standardised objective method of assessing the degree of skin change in these 
patients, so that the response to treatment can be objectively monitored . 
I have developed a tissue tonometer and standardised the methodology for the objective 
assessment and quantification of the skin changes seen in patients. The tissue tonometer 
is a simple non-invasive instrument which uses a sensing device that detects the 
movements of a loaded plunger placed on the skin. The movement of the plunger is 
dependent on the mechanical properties of the skin and subcutaneous tissue. The 
instrument is positioned on the gaiter region of the leg with the subject in the supine 
position. The movement of the plunger into the tissues is recorded and analysed by a 
computer. The data obtained from the tonometer were analysed as distance and rate 
constant parameters. A simple mathematical model using spring and dashpot constants 
was also applied to see if it fitted the data. 
Skin compliance was investigated in normal control subjects and patients with varying 
severity of skin changes due to CVD, clinically classified according to the CEAP 
(Clinical, (A)Etiological, Anatomical and Pathophysiological) method. There was a 
significant reduction in skin compliance in patients with clinically severe LDS as 
compared to normal controls and patients with pigmentation alone or oedema without 
any clinical evidence of skin change. 
I further investigated the correlation between the recently introduced CEAP method of 
classification and scoring of chronic venous disease of the lower limbs with the tissue 
tonometry findings and parameters obtained with duplex ultrasonography, air 
plethysmography and photoplethysmography. 
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Tissue tonometry provides a standardised objective means of assessing the severity of 
skin change in CVD which may prove to be useful in evaluating response to a particular 
treatment and comparing data from different centres. The deterioration of the venous 
physiology shown by blood flow measuring techniques correlates poorly with the 
clinical sequelae of venous disease, whether assessed by a trained observer or measured 
by the tonometer. Patients show a wide range of sensitivity to venous valvular 
incompetence, suggesting that factors related to the tissue response to venous 
hypertension are crucial in determining which patients develop venous ulceration. 
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FOREWORD 
'Men you can measure what you are speaking about and express it in numbers, you 
know something about it, but when you cannot express it in numbers, your knowledge is 
of a meagre and unsatisfactory kind; it may be the beginning of knowledge, but you 
have scarcely, in your thoughts, advanced to the edge of science, whatever the matter 
may be'. 
Lord Kelvin, 1891 
(From: Thomson W: Popular lectures and addresses, ed 3. Vol. 1. Constitution of 
matter. London, 1891, Macmillan and Co. ). 
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Dedicated to the memories of auntie Farida and auntie Layah. 
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SECTION I 
Introduction 
iLf1th*. 
19 
1.1 Epidemiology of lower limb chronic venous disease. 
Lower limb chronic venous disease (CVD) has been recognised since ancient times. 
The clinical sequelae of lower limb CVD, which include oedema, liposclerotic skin 
changes and ulceration, occur in between 3% (Coon et al, 1973) and 11% of the 
population (Da Silva et al, 1974). It has also been estimated that the annual development 
of new symptoms is approximately 1% for oedema and 0.8% for skin changes (Widmer 
et al, 1992). The annual incidence of varicose veins in the female population averaged at 
2.6% and 1.9% in males (Brand et al, 1988). In the western world about 0.3% of the 
adult population have active venous ulcers (Callam et al, 1985; Cornwall et al, 1986; 
Nelzen et al, 1991; Coon et al, 1973) and the prevalence of active and healed ulcers 
combined is about 1% (Nelzen et al, 1991). The point prevalence estimates of ulcers 
present in the community varies from 0.11% in Australia (Baker et al, 1992), to 0.15% 
in Scotland (Callam et al, 1985), 0.18% in England (Cornwall et al, 1986) and 0.30% in 
Sweden (Nelzen et al, 199 1). From a population questionnaire sent to 549 elderly people 
in Scotland it was estimated that the overall prevalence of lower limb ulceration was 
3.6% among people older than 65 years. This corresponds to 1% of the adult population 
in Scotland (Dale et al, 1983). In the United States of America, the Tecumseh 
community health study, a longitudinal study of a population in Michigan, extrapolated 
their data to the United States 1970 consensus figures and estimated that in the USA, 24 
million people have significant varicose veins (prevalence 12.9%), while 6 to 7 million 
people have stasis changes in the skin of the legs (prevalence 3%) and that nearly half a 
million people have or have had a varicose ulcer (prevalence 0.1%) (Coon et al, 1973). 
Leg ulcers can have a variety of causes with the majority being as a result of chronic 
venous disease. In a cross-sectional population study in a health district in England, a 
random sample of 100 patients (193 limbs) with leg ulcers were examined with 
ultrasound and photoplethysmography to assess the venous and arterial circulation. It 
was found that 38% had deep venous incompetence, 43% had superficial venous 
incompetence, 22% was of mixed venous and arterial aetiology and 9% was of arterial 
aetiology alone. (Cornwall et al, 1986). Leg ulcers with liposclerotic skin changes were 
most commonly found in the gaiter area of the limb. One study showed that 88% of 
ulcers were located in the gaiter area of which 76% were on the medial side (Callam et 
al, 1992). 
It has been reported that patients of low social class have delayed ulcer healing (Franks 
et al, 1995). In general, the prognosis of leg ulcers is poor with only 50% healing at 4 
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months (Skene et al, 1992), 20% remain open at 2 years and 8% at five years (Callam et 
al, 1987). 
The effects of lower limb chronic venous disease can also have a huge impact on the 
national economy of the country. In one study, 12.5% of patients with ulcers took early 
retirement (DaSilva 1992) and it was estimated that in England and Wales, about 
500,000 working days are lost per year. In the USA, the figure is 2 million working days 
(Browse et al, 1978). In Brazil, the fourteenth most frequently quoted disease for 
absenteeism from work and the thirty second most frequent cause of permanent 
disability and financial aid is lower limb chronic venous disease (De Castro-Silva, 
1997). 
In France, the total annual cost of venous insufficiency to the health service in 1991 was 
estimated to be 14.7 billion French francs (Lafuma et al, 1994), representing 2.6% of the 
whole health expenditure. In the United Kingdom, it is estimated that the annual cost of 
venous ulcers is between 400-600 million pounds sterling (Callarn et al, 1992; Jantet et 
al, 1992) and in the United States of America, the figure is over 1 billion dollars (Hume 
et al, 1992). 
1.2 A brief historical review of lower limb venous disease. 
The problems of the treatment of lower limb venous disease is not a new one and has 
been recognised since ancient times. The Ebers Papvrus, named after the German 
professor Georg Ebers; (1837-1898), described possibly the first 'venous' publication 
from around 155OBC in which varicose veins were described as 'serpentine windings' in 
ancient Egypt. In the 4th Century BC in Athens, the oldest known illustration of a 
varicose vein, a stone plaque showing a man holding a leg with a varicosity of the long 
saphenous vein, was found at the foot of the acropolis in Athens in the shrine of a 
physician named Amynos. Between 460-377BC, Hippocrates in his work, De ulceribus, 
documented a connection between leg ulcers and varicose veins and that the leg ulcers 
contained blood and 'evil humours'. Hippocrates is also said to be the first to note an 
association between the two and recommended incision of the varices and compression, 
to squeeze out the 'humours'. 
During the middle ages, there was still a widespread belief that as a result of standing, 
'evil humours' would collect in the legs and cause ulcers. Avicenna in AD900 still 
supported the Hippocratic view that ulcers should not be allowed to heal because they 
were a site from which 'evil humours' could escape. If an ulcer did heal, he advised that 
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it should be deliberately broken down again. Some thought that it was dangerous to 
apply compression bandages which would prevent the 'humours' from escaping thus 
causing melancholy and madness. 
Throughout the Middle Ages, the dogmatic views of the Church with regards to access 
to post mortern human specimens, marked an enduring stagnation in the development of 
surgery in Europe. The relaxation of the Church's ban on human dissection paved the 
way for the anatomists with Leonardo da Vinci (AD1452-1519) producing over 779 
anatomical drawings many of which illustrated the venous system. The famous 
anatomist Vesalius (AD1514-1564) described the venous system in great detail but 
could not find the valves alluded to by Canano in AD 1546. However, in 1551, Amatus 
stated that veins contained valves possibly the first description of a venous valve. 
Hieronymus Fabricius of Aquapendente re-described the valves in his work entitled De 
venarum ostiolis after demonstrating them at public dissections in 1579. In 1585, 
Salmon Alberti published the first recorded drawing of a valve in a vein. He noticed that 
they stopped retrograde flow but thought that they participated in the control of the ebb 
and flow of blood described earlier by Galen (AD 130-200). 
The belief that 'humours' were responsible for causing ulcers was still around in 1620, 
when Faflopio stated that varicose veins caused ulcers because the 'varices carry 
jaeculent humours which cause ulceration'. 
In 1628, the greatest physiological revolution in the history of medicine which provided 
the foundation of our present understanding of the circulation, was published by 
William Harvey in the book Exercitatio anatomica de moty cordis et sanguini's in 
animalibus. Biohistorians agree that the landmark work done previously by Fabricius on 
venous valves led directly to William Harvey's discovery of the circulation. It can also 
be said that the background for Harvey's discoveries may have been laid as early as 
1550BC in the Ebers papyrus. Harvey demonstrated that the blood circulated and made 
the fundamental observation that the valves in the veins were there to ensure 
unidirectional flow of blood. After William Harvey's description of the physiology of 
the venous circulation and the function of the valves in the veins, the belief that 'evil 
humours' were responsible for ulcers were finally cast aside. 
The principles of modem day treatment of varicose veins and venous ulcers have not 
changed much since the time of Hippocrates with the use of compression treatment 
and/or varicose vein surgery being the recommended methods of healing ulcers, but the 
technology has improved. In the last three decades, there has been a large number of 
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publications on the treatment of venous disease and the improving of surgical 
techniques, surgical instruments, compression treatment techniques and materials. 
However, with better understanding of the microcirculation several authors have 
suggested new theories of the causes of venous ulcers. Amongst them are the fibrin cuff 
theory (Browse and Bumand, 1982) and more recently, the white cell trapping theory 
(Coleridge Smith et al, 1988). It is hoped that the latest investigations of the 
microcirculation will provide a better understanding of causes of venous ulcers and may 
one day provide a cure by pharmacological means. 
1.3 A brief historical review of the development of venous testing. 
There has been a gradual development of clinical tests of venous physiology since the 
latter part of the 17th century after the William Harvey publications which shed a new 
light on the venous circulation and the function of the venous valve. All of these were 
dependent upon careful clinical observation by an experienced physician interested in 
the physiological function of the superficial and communicating venous valves and the 
interplay of the muscle pump. Fabry in AD 1589 while examining a leg ulcer, described 
blood in the veins receding immediately towards the head when the leg was elevated and 
descending instantly when the leg was placed in a dependent position, thus describing 
what we now know as venous reflux or retrograde flow in the veins. Sir Benjamin 
Brodie, in 1846, formalised that observation by describing his test of venous valvular 
function where, after having emptied the veins of the leg, he demonstrated that reflux 
could be controlled by pressure on the vein above. Trendelenberg in the 1890s 
popularised this test and is still a standard clinical test. Perthes in 1895 was the first to 
describe a test to assess muscle pump function by asking the patient to walk after 
proximally constricting the superficial veins and noting that the superficial varicosities 
would disappear only if the valves of the deep venous system were competent. 
The tests mentioned above have been very important in the application of modern 
electronic equipment to assess venous pathology. Today, we use the powers of 
continuous-wave, pulse-wave and colour Doppler instruments to assess blood flow 
based on the powers of observations that had been made previously in the tests 
described above. 
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1.4 Recent advances in the non-invasive diagnostic techniques of venous testing. 
In the 1970s, several non-invasive methods for the study of peripheral vascular and 
cerebrovascular problems were developed. These include Doppler ultrasound, lower 
extremity pressures, pulse volumes, oculoplethysmography and carotid 
phonoangiography for carotid bifurcation studies and impedance mercury strain-gauge 
and air plethysmography for study of venous physiology. These measurements of 
velocity, pressure and volume, represented the foundation of methodology in the 
vascular laboratory. 
In the 1980s, the most important technical advances in instrumentation were the 
development of pulsed Doppler systems and their use in conjunction with B-mode 
imaging in the duplex scanner, which will be described in more details later in the 
chapter. 
By 1985, duplex scanning was the main direct test for disease of the carotid bifurcation 
and had replaced most of the indirect tests including bruit analysis, 
oculoplethysmography, and periorbital Doppler velocity studies, because duplex 
scanners provide anatomical and functional information about the critical carotid 
lesions. 
Since 1985, several new instruments have been developed. The most significant is real- 
time colour Doppler imaging (see section 1.4.3). Venous applications of the colour 
duplex ultrasound scanner, both for acute peripheral venous thrombosis, pre-operative 
mapping of veins and for identifying and quantifying chronic venous reflux, have 
defined a new era of non-invasive studies. 
It is now possible to derive precise functional information regarding the venous system 
from non-invasive tests using Doppler and plethysmographic techniques without the 
need of exposing the patients to ionising radiation, blood products or even skin 
puncture, all of which may subject the patient to risk. These non-invasive investigations 
are very well tolerated by patients and can be used in sequential studies for repeat 
measurements in clinical studies. 
1.4.1 Airplethysmography 
This is a pneumatic plethysmograph designed for measuring absolute volume changes in 
millilitres or millilitres per second in the lower and upper extremities by detecting 
volume changes which occur in response to postural changes and exercise. These 
detected volume changes are analysed to obtain parameters of venous function and 
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arterial perfusion. In the modem version a plastic sleeve is zipped around the patient's 
leg and filled with air to a pressure of 6-8mmHg known as the 'bias' pressure 
(Christopoulos et al, 1988). This is sufficient to ensure close conformity with the leg, 
but does not interfere with the venous physiology under study. It is now possible for the 
device to be calibrated so that absolute volume changes in the limb can be deduced (see 
section 2.2 for details). 
This technique has many advantages in that it is simple, non-invasive, quantitative, has 
multiple applications and can be calibrated during each examination while connected to 
the subject. This technique has been validated and shown to measure global reflux in 
n-A/second (Christopoulos et al, 1987; Katz et al, 1991). 
1.4.2 Photoplethysmography 
The photoelectric plethysmograph was first described in the 1930s and was intended for 
use in the assessment of the arterial system rather than the venous system where it was 
first applied in 1978 (Bames et al, 1978). It consists of a sensor combining a light 
emitting diode (LED) operating in the near infrared and a very sensitive phototransistor 
detector. Light emitted by the LED is reflected from blood moving in the area being 
investigated. Changes in the reflected signal are detected by the phototransistor and 
processed to display the waveform. Photoplethysmography provides a sensitive means 
of detecting blood flow in the microcirculation near the skin's surface by assessing the 
variation in the light absorption of the skin by haemoglobin in the dermal venous 
plexuses. When these are full during high venous pressure the haemoglobin in the red 
blood cells absorbs light. As venous pressure falls the venous plexuses become less full 
and light transmission increases. The light is derived from a light emitting diode which 
emits non-coherent light with an emission peak at about 805 nanometres. The transducer 
is designed so that when applied to the skin with double-sided adhesive tape, light must 
traverse the skin to reach the detector. A phototransistor is used which also amplifies 
current produced by light falling on the sensitive region. The transducer is connected to 
an amplifier which permits adjustment of the output voltage. The resulting trace may be 
recorded by a chart recorder or displayed on a computer. The methodology is described 
in details in section 2.3. 
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1.4.3 Measurement of bloodflow using the Doppler principle 
In a Doppler ultrasound system, the difference in frequency between transmitted and 
received signals contains the blood flow information. The Doppler principle, the 
Doppler equation and the instrumentation of spectral analysis and its basic principles are 
described below. 
Doppler principle and the Doppler equation 
The Austrian physicist Christian Johann Doppler (1803-1853) demonstrated 
mathematically that the frequency of sound emitted or reflected from a moving object 
varies with the velocity of the object (Nayman et al, 1974) and is shown in the Doppler 
equation below. The frequency appears to increase to an observer who is moving 
towards the source of the sound and appears to decrease to an observer moving away 
from the source. 
fD= 2f ycos 0 
C 
where fD is the change of the ultrasound frequency (the Doppler shift 
frequency), 
f is the frequency of the incident sound wave, 
v is the relative velocity between the transducer and the target, 
c is the speed of sound in tissues (1.54 mm. / gsec), 
and 0 is the angle of insonation between the direction of flow and ultrasound 
beam. 
In 1957, Satomura, first described a method of utilising this effect for detection of 
moving structures within the body (Satomura et al, 1957). The use of Doppler 
ultrasound as an indicator of blood flow was first suggested in the early sixties (Franklin 
et al, 1961). 
Spectral Analysis Instrumentation 
Sounds are created by the vibrations from objects, which travel through the air as 
sinusoidal. waves with different frequencies. Sound waves are categorised as, infrasonic 
(less than 2011z), audible (20Hz to 20kHz) and ultrasonic (greater than 20KHz). 
In blood flow measurements using ultrasound, reflections from red blood cells rely on 
Raleigh-Tyndall scattering and it is rare to have a sample volume containing red blood 
cells travelling at a single velocity. Usually the signal received by the transducer is a 
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combination of many varied Doppler shifted frequencies. The Doppler signal is 
summation of information from a large number of reflectors or red blood cells with 
different velocities within the sample volume as selected with the pulsed Doppler gate 
(figure 1.4.3.1). 
Probe beam 
Vein wall 
<I 
, Pulsed Doppler gate 
-p 
Incident angle to flow 
Figure 1.4.3.1 The pulsed Doppler gate should insonate the entire vessel wall with the 
incident angle to flow cursor parallel to the vessel walls and not exceeding 60 degrees. The 
slower velocity red blood cells are indicated by the smaller arrows with the fastest red cells 
indicated by a longer arrow in the middle of the vessel. 
Spectral analysis is the breaking up of the components of a complex wave or signal and 
spreading them out in frequency order. The human auditory system accomplishes this 
for sound. The ear and brain break down the complex sounds we receive into the 
component frequencies contained in the sounds. Thus, we can listen to a Doppler signal 
and recognise normal and abnormal flow sounds. If all the blood cells were moving at 
the same speed and in the same direction, then a single Doppler shift will result. 
However, this is not the case and the extent of the range of generated Doppler-shift 
frequencies is dependent on the character of the flow. The fast Fourier transform is the 
mathematical technique that the instrument uses to derive the Doppler spectrum from 
the returning echoes of various frequencies. It is an algorithm which in real time 
analyses short periods of the Doppler signal into a series of spectra. A spectrum is a 
graph showing the relative power or amplitude of each of the velocity or frequency 
components in the Doppler signal. It is an amplitude versus frequency plot and is in 
effect a 'snapshot' of all the velocities in the sample volume at any instant in time. 
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Ultrasound imaging 
Images are produced by examining the tissues with a scanning beam of ultrasonic sound 
which may be produced from a rotating transducer or a multielement phased array of 
transducers with no moving parts. The returning echoes carry information about the 
structure of the tissues and permit an ultrasound image to be reconstructed. Modem 
equipment allows this to be accomplished in real time, so that moving images of the 
structures beneath the transducer can be obtained as the examiner moves the transducer 
to examine different aspects of the tissues. Ultrasound is subject to Raleigh-Tyndall 
scattering which results in the absorption of energy by the tissues, as well as return of 
some of the transmitted sound. The scattering is proportional to the fourth power of the 
ultrasound frequency so that, as higher frequencies are used to improve resolution of 
structures within the tissues, greater difficulty is experienced in examining greater 
depths. Frequencies used to examine peripheral vessels are in the range 5-IOMHz. The 
structures can be identified and precise anatomy defined as demonstrated in the B-mode 
(brightness mode) image of a popliteal vein with the valve sinus and valve cusps clearly 
visible (Figure 1.4.3.2). Blood within veins often has a hyperechoic pattern, after a 
patient has been lying on the examination bed for a few minutes, which can be used to 
determine the direction of flow (Sigel et al, 1983; Machi et al, 1983). However, an 
imaging system alone cannot provide precise information regarding flow. 
Duplex ultrasound imaging system 
The limitation of having no flow data available has been overcome in duplex ultrasound 
systems by the inclusion of a pulsed Doppler facility (Taylor et al, 1987). In some 
systems this is provided by the addition of an extra transducer in the scanning head 
which provides Doppler information. In other systems phased array transducers are used 
to provide both image and Doppler information. The pulsed Doppler mode means that 
precisely defined areas can be studied to determine the velocity and direction of flow. 
This is invaluable in examination of the venous system. The presence of flow in major 
vessels can be established, and the location of venous reflux, for example, can be 
determined beyond doubt (Szendro et al, 1986). The lower limb vessels may be 
identified in turn, with the patient standing or lying on a tilted examination couch with 
the feet dependent. Forward flow can be produced in the calf by manual compression 
and the presence of forward flow and reflux assessed in each vein of the lower limb in 
turn. 
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Figurel. 4.3.2 Bi-i,, Iitiic,, siiiode(B-iiiodc)iiiia,, cot)týiiiicdtl-()IiizidLij)lcx Zý Cý 
scanner showing a popliteal vein with the dilated valve sinus and valve 
cusp easily identified. 
Figure 1.4.3.3 BrI1.7htness mode (B-mode) linazing combined with zr 
spectral Doppler analysis provides inforination of flow in the veins indi- 
cating antegrade flow (area below the baseline) and retrograde flow 
(reflux) (area above the baseline). 
Virtually all veins below the inguinal ligament can be imaged completely by this 
technique and the competence of individual valves may be assessed (Rollins et al, 
1987). 
This technique allows the assessment of anatomical structures as well as defining 
function. Figure 1.4.3.3 shows a B-mode image of the long saphenous vein combined 
with spectral Doppler analysis to demonstrate antegrade flow and reflux in the vein after 
calf compression with the patient in the standing position. 
Colourflow mapping 
Duplex ultrasound imaging permits the assessment of each vein in turn, and localised 
flow anomalies may be overlooked. Colour flow ultrasound machines (triplex scanning, 
angiodynography) assess the Doppler shift of each pixel of the ultrasound image in a 
(user-defined) area and convert the usual grey scale image to a colour of a different 
saturation depending on the velocity of flow (Merritt et al, 1987). Distinct colours are 
used for forward and reverse flow so that venous reflux assessment is simplified 
(Persson et al, 1986) as demonstrated in figures 1.4.3.4,1.4.3.5,1.4.3.6 and 1.4.3.7. 
Several vessels may be assessed at once for reflux with such a machine. The accuracy of 
colour flow-mapped ultrasound in defining venous function remains to be proved. 
Precise anatomical data are obtained, but little numerical information regarding overall 
venous function can be derived. The information is much more comprehensive, and 
presumably closer to real events, than that obtained in descending phlebography studies 
where contrast medium must be injected. The ultrasonic machines described above have 
the advantage that it is not unpleasant for the patient and can be repeated frequently if 
necessary since there seems to be no hazard to biological systems from ultrasound 
energy at the levels used in such machines. It avoids the use of ionising radiation and the 
expense of radiology suites permitting real-time screening. 
Transducers 
Colour flow images are produced most commonly by linear sequenced arrays and 
phased sector arrays although, less commonly, annular arrays are also utilised. 
A linear sequenced array is a line of rectangular transducer elements that are operated in 
groups (sequenced). Each group is energised by a voltage from the pulser in the 
instrument thus producing an ultrasound pulse that travels through the tissues generating 
a series of echoes that are presented as a scan line on the display. Subsequent pulses use 
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Figure 1.4.3.5 Colour duplex ultrasound irnage showing a normal coin- 
mon femoral vein (CFV) (blue pixels; antegrade flow), an 
incompetent sapheno-femoral junction (SFJ) and an incompetent long 
saphenous vein (LSV) depicted by red pixels indicating retrograde flow 
or rellux. 
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Figure 1.4.3.4 Colour duplex ultrasound image showing a normal colli- 
mon femoral vein (CFV), normal sapheno-fernoral junction (SFJ) and a 
normal long saphenous vein (LSV) depicted by blue pixels indicating nor- 
mal antegrade flow. 
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Figure 1.4.3.6 Colour duplex ultrasound image showing a normal I 
popliteal vein. normal sapheno-popliteal junction (SPJ) and a normal 
short saphenous vein (SSV) depicted by blue pixels indicating normal 
antegrade flow. 
Figure 1.4.3.7 C01OUr dLll)ICX uitrasound image showing a normal 
popliteal vein (blue pixels; antegrade flow), an incompetent sapheno- 
popliteal junction (SPJ) and an incompetent short saphenous vein (SSV) 
depicted by red pixels indicating retrograde flow or reflux. 
different groups of elements shifting across the array usually by one element for each 
subsequent pulse. In a traditional linear array, all pulses travel out in the same direction 
producing parallel scan lines on a rectangular display. 
A phased array is a small line of rectangular elements that are energised in such a way 
that the direction of the emitted pulse is determined by phasing or delays in the voltage 
applied to each element. With larger delays the pulses are steered further from the 
centre. With no delay the pulse travels out perpendicularly from the face of the array. 
Electronics in the instrument automatically adjust the delays so that each pulse travels 
out in a slightly different direction from the previous one. This results in an 
electronically steered sector image. 
The transducers described above are therefore used to acquire the grey-scale and colour 
flow information. The Doppler colour flow instruments are pulsed-Doppler instruments 
and are subject to the same limitations some of which are described in section 1.4.5. 
1.4.4 Cutaneous ultrasound - measurement of skin and subcutaneous layer 
thickness. 
The human skin is a large, complex multi-layered organ with an area of approximately 
1.75m2 and is the largest organ in the body (Perednia et al, 1995 book). Currently, the 
most practical modality for imaging the skin is ultrasound. Other methods include 
histology and electron microscopy. 
Ultrasound examination of the skin itself is best performed with 20-MHz transducers 
(Fornage et al, 1993). However there are limitations to this type of transducer which 
include the narrow field of view, less than 2cm in width, and inability to visualise the 
subcutaneous tissues beyond a depth of approximately 1.5cm. These limitations 
emphasise the need for lower frequencies (7.5 or 1OMHz) transducers to image 
structures that lie beyond the scope of the 20MHz transducers and also because of their 
low cost and wider availability. 
Linear-array transducers are preferred to mechanical sector probes of the same 
frequency because of their better near-field resolution and wider field of view. Also, the 
ultrasound beam of the linear-array transducers is perpendicular to the skin surface and 
most of the underlying interfaces in the subcutis. This is important because it minimises 
the scattering artefacts. The ACUSON 128 XP/10v (Acuson, Mountain view, 
California) 7.5MHz linear-array probe has a field of view of about 4 cm wide and 4 to 6 
cm deep. 
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Brightness mode or B-mode ultrasound can be applied to study the skin in different 
ways. The ultrasound collects the data and presents it as a digitised two-dimensional 
picture with bright pixels representing strong reflections and dark pixels depicting the 
absence of reflections. As the transducer is moved across the surface of the skin with 
coupling gel applied, ultrasound pulses are transmitted and echoes received from each 
transition zone where the acoustical properties of the tissues differ. The returning echoes 
are timed and the returning times multiplied by the speed of sound in the tissues to 
determine the distance travelled before reflection. The strength of the echo at each point 
is converted to a brightness value between 0 and 255, with the stronger echoes given a 
higher brightness. When all the individual readings are placed beside one another over 
the scan length of the transducer, a two-dimensional B scan image is formed. B-mode 
displays represent a pictorial cross-section of the skin and subcutaneous tissues in a 
visual way. 
Skin contains collagen which is an important source of echogenicity in any tissue. Cells 
and collagen fibres intertwined within the dermis produce a bright or 'echogenic' layer 
within the B-scan map. The subcutaneous fat is a homogeneous layer which contains 
little collagen with relatively few areas in which tissue structure and therefore sound 
impedance changes, resulting in dark or 'echolucent' structures on the B-scan image. 
In normal skin the interface between the dermis and the subcutaneous fat is far from 
smooth due to attachments of subcutaneous retinacula. The anatomical thickness of the 
subcutaneous fatty layer is even more variable. A precise distance measurement can 
never be attained due to the biology itself being so 'noisy' even if the ideal scanner 
existed. 
Normal Ultrasound Anatomy. 
Using a 7.5MHz linear-array probe, the skin appears as a thin, regular layer of tissue that 
is more echogenic and sharply demarcated from the underlying hypocchoic 
subcutaneous fat (Fornage et al, 1986; Miyauchi et al, 1983). 
The interface between the echogenic skin and the hypoechoic subcutis is clearly 
depicted in most areas of the body, allowing measurement of the skin thickness, 
although with less accuracy than at higher frequencies (Fornage et al, 1993; Fornage et 
al, 1986). 
The subcutaneous tissues are composed of hypoechoic fat with a few scattered 
echogenic strands of connective tissue. 
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Ultrasound has also been used to measure the thickness of subcutaneous fat at various 
sites in normal subjects (Maruyama et al, 199 1). 
Ultrasound is widely used to evaluate changes in the thickness of subcutaneous fat 
associated with various clinical conditions in humans (Gooding et al, 1986; Heckmatt et 
al, 1988). 
The use of 7.5- and 10-MHz transducers are ideal for use in the ultrasound imaging of 
the subcutaneous tissues with the added advantages of being low cost, versatile, quicker 
to perform and more widely available than any other cross-sectional imaging modality 
currently available. When recording B-scan images for analysis, one should consider 
that the received ultrasound signal is influenced by attenuation due to absorption and/or 
scattering and reflection. Attenuation is the decrease in amplitude and intensity as a 
wave travels through a medium. Reflection takes place mainly at the boundaries of 
tissue compartments. Absorption is high when the relative amounts of proteins and 
collagen in the tissue increases and low if the liquid content is elevated. As a result of 
attenuation, a signal coming from a given tissue structure varies not only to the acoustic 
tissue parameters but also to the distance between the structure and the transducer. This 
is why it is very important to keep the probe-to-skin distance constant by using a gel 
stand-off pad between the probe and the skin as this improves the examination of the 
skin and superficial subcutaneous tissues with the skin being closer to the focal zone 
(Fornage et al, 1984). 
While the ultrasound examination of the skin is possible at these frequencies it is best 
done with transducers of 20 MHz or more. However, the limited penetration of these 
very high frequency transducers does not allow adequate examination of the 
subcutaneous tissues (Fornage et al, 1995). 
1.4.5 Effect ofphysiologic and system hardware variables on the accuracy of 
quantitative volume bloodflow measurements using duplex ultrasound. 
Time averaged velocity 
Inaccuracies in estimating volume blood flow with ultrasound arises in the calculation 
of several values including the time averaged velocity (TAV), which is the average rate 
of flow through the vessel over a period of time. 
The TAV measurements are calculated by the ACUSON 128 system computer software. 
The introduction of errors during TAV measurements could arise from contamination 
due to background noise as a result of poor signal-to-noise ratio, tissue and wall motion 
and/or signals from vessels other than the target vessel. Solutions to errors arising 
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during TAV measurements which will improve the accuracy of volume flow 
calculations includes placing the baseline in the centre of the spectral Doppler display 
which will result in equal amounts of noise on both sides of the baseline with the mean 
of the positive and negative noise balances approaching zero. Strong Doppler signals 
should be obtained which will result in less impact from background noise. The relative 
amplitude of background noise is small compared to Doppler shifts from moving blood. 
Incorrect angle of insonation 
Incorrect angle of insonation can also contribute to the possibility of incorrect 
estimation of volume flow at the point of spectral sampling. 
As in all Doppler examinations using velocity information, the angle of the blood flow 
within the vessel relative to the Doppler beam must be computed. Errors of several 
degrees can lead to large changes in the cosine value used in the Doppler formula, with 
resultant miscalculation of the TAV values. If the probe beam is placed perpendicular to 
the blood flow with a scanning angle of 90 degrees, it would yield no Doppler shift, and 
it would indicate that there is occlusion or no flow in the vessel under investigation even 
though the vessel is actually patent. The probe beam should be oriented to make a 30 
degree to 60 degree scanning angle with the vessel lumen and angles greater than 60 
degrees should be avoided. According to the Doppler equation, the angle between blood 
flow and the Doppler beam is a critical factor because of the cos 0 term. An important 
point to remember is that what the transducer measures is the v cos 0 component of 
blood flow. Slight inaccuracies in estimating an angle less than 60 degrees results in 
small or insignificant errors in actual flow measurement while the same inaccuracy at an 
angle greater than 60 degrees will provide extremely large errors. 
Aliasing 
Aliasing is an artefact that can be noted on the Doppler spectrum. The information 
contained by the higher frequency shifts is displayed at a lower frequency. The 
electronics of the ultrasound machine can process the information from the ultrasound 
echoes at a maximal rate defined by the pulse repetition frequency (PRF). If the PRF 
increases, higher frequency shifts can be displayed and aliasing is less likely. If the PRF 
decreases, there is a greater chance of aliasing occurring. 
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Inaccurate cross-sectional area measurements 
Inaccurate cross-sectional area measurements is another important factor in the incorrect 
estimation of volume flow at the point of spectral sampling. The area of the vessel 
should be measured at the same point in the vessel that the Doppler sample volume was 
acquired. Because Doppler samples must be taken using longitudinal views of the vessel 
to assure quantification accuracy, the only way to use the same image is to measure the 
diameter of the vessel to calculate the radius and then use that value to calculate the area 
(A= 7cr2 or ic D2/4). 
Vessels not imaged at 90 degrees can also result in inaccurate measurement of the cross- 
sectional area. It is easy to be at a slight angle to the vessel rather than perpendicular 
even with careful technique. An ultrasound slice that is not perpendicular to a vessel 
will create an elliptical structure. The area of an ellipse is larger than a circle, and will 
result in an overestimation of cross-sectional area. When using a diameter measurement 
from a longitudinal view, the beam may not cut through the vessel at exact points on 
opposite sides of the vessel. The diameter will be less than the true value, introducing 
error into the value for radius. This error will be further magnified when the radius is 
squared to calculate area. 
37 
1.5 Tissue tonometry 
At present, there is no standardised objective method of assessing the degree of skin 
changes seen in patients with lower limb chronic venous disease. A tissue tonometer has 
been developed in our laboratory for the objective assessment and quantification of the 
skin changes seen in these patients. 
1.5.1 Previous models 
An instrument which measured the compression of tissues by a mass was developed in 
the seventies to objectively determine the pitting in lymphoedema (Clodius et al, 1976). 
This instrument, known as the Clodius tonometer, consisted of a plunger connected to 
an analogue scale. Weights were added to the plunger and the distance travelled by the 
plunger was measured. Several studies using this instrument to quantify the pitting in 
oedema have been published (Piller and Clodius, 1976; Chen et al, 1988; Kar et al, 
1992). However, the Clodius instrument had two major drawbacks. Firstly, the 
instrument was top heavy making it unstable and secondly, the instrument measured 
only the depth of compression and gave no indication of the rate of compression and the 
depth of pitting measured was time dependent. The problem of stability was addressed 
by Chen et al in 1988 to fix the instrument with a moveable grip. 
A durometer has been used to determine the degree of induration in LDS by Romanelli 
and Falanga (Romanelli et al, 1995) based on previous work done on the assessment of 
skin hardness in patients with systemic sclerosis (scleroderma) by Falanga and Bucalo 
(Falanga et al, 1993). The durometer is the international standard for measurement of 
hardness of plastic, rubber and other non-metallic materials, and it has a calibrated 
gauge that linearly registers the relative degree of hardness. This instrument senses 
hardness with a spring loaded indentor (plunger) and assesses the distance travelled by 
the plunger into the material under test. The durometer judges only one aspect of the 
material or tissue to which it is applied, that is, its elasticity. The skin and subcutaneous 
tissues is a complex structure and we suspected that it would be useful to assess a 
number of other mechanical properties of this to provide a complete picture of the 
changes produced by venous disease. 
An instrument to objectively record the depth and rate of pitting in lymphoedernatous 
arms was developed by Bates et al in London (Bates et al, 1994) based on the Clodius 
tonometer. It consisted of a plunger attached to a lever which deflected a strain gauge 
transducer. The deflection caused a change in voltage output of the transducer, which 
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was amplified and recorded on a chart recorder. The pitting curves obtained were 
analysed in terms of distance and rate constant parameters. A mathematical model (see 
section 1.5.3), the Kelvin-Hooke model was proposed to analyse the pitting curves 
obtained from the instrument and to determine the spring and dashpots constants. 
1.5.2 The Middlesex Hospital Vascular Laboratory tissue tonometer 
A computerised tissue tonometer was developed at our laboratory (The Middlesex 
Hospital Vascular laboratory, 1995) and is based on a model designed by Bates et al 
described above. It is a simple, non-invasive device which consists of a plunger which 
may be loaded with different weights (figures 1.5.1,1.5.3,1.5.4.1.5.5 and 1.5.6). The 
plunger is attached to a cantilever bar which is on a pivot and connected to a linear 
variable differential transformer (LVDT) position detector, a sensing device, that detects 
the movements of the plunger which is positioned on the skin. The plunger can be 
released by a cable release mechanism and is allowed to sink into the tissues under 
gravitational force. The signals obtained by the LVDT in the tonometer are converted by 
an analogue to digital (A/D) converter in the computer into the traces displayed on the 
computer screen. Though our model is based on the Bates's tonometer, I have modified 
certain aspects of my tonometer to suit our measurements. I have installed an electronic 
sensor within the tonometer connected to an analogue to digital converter in an IBM 
compatible computer to analyse the traces electronically on a computer screen. During 
measurements, I used a weight of 30g and a plunger size of 4mm. diameter in all the 
studies so as to standardise the measurements. The weighted plunger was allowed to 
sink into the tissues following release. 
Typical traces obtained from the computer consisted of an initial fast indentation phase 
followed by a subsequent slower indentation phase or creep phase (figure 1.5.2). 
The traces obtained were analysed using specially written computer software (by 
PDCS) to calculate the distance and rate constant parameters. The traces were divided 
into three phases: phase I, phase II and phase III. 
Phase I occurs within the first second to reflect the initial rapid indentation phase. The 
start cursor is placed at the site indicating where the plunger is released unto the tissues 
and the end cursor is placed at the end of the straight line just before the start of the 
creep phase as shown in figure 1.5.2. The distance between the start and end cursors will 
give the distance travelled in mm during phase 1. 
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Figure 1.5.1 Schematic diagram of the tissue tonometer showing the plunger 
with weights which is attached to a cantilever bar on a pivot that is 
connected to a sensing device that detects the movements of the 
plunger on the skin and sends signals to a computer via an 
analogue to digital converter to convert the signals into traces. 
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Figure 1.5.2 Typical traces obtained from displacement versus time curves 
using a tissue tonometer. The arrow indicates the time the plunger 
is allowed to sink into the tissues. The initial fast indentation 
phase, phase 1, which occurs within I second, is indicated by the 
black crosses and is followed by the subsequent slower indentation 
phase which has been divided into phase 11 (1-10 seconds) and 
phase 111 (10 - 300 seconds). 
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Figure 1.5.3 The tissue tonometer showing the fixed and moveable ends 
with the plunger and added weights attached to a cantilever bar which is 
connected to a linear variable differential transformer (LVDT) position 
detector that sends signals to an analogue/digital converter present in a 
computer. The spirit level is used to ensure that the cantilever bar is 
parallel to the surface of the table during calibration. 
Figure 1.5.4 After calibration, the tonometer is placed on the subject's 
limb with the plunger positioned over the area of interest, the gaiter area, 
of patients with lower limb chronic venous disease. 
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Figure 1.5.5 The plunger with the selected weight is positioned just 
above the area of interest without causing indentation. 
contoured around the calf (red-end) and resting on velcro material to pre- 
vent slipping. The other moveable end can be moved along the bar to any 
desired site to ensure maximum stability. 
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Figure 1.5.6 The tonometer is placed on the subject's limb with one end 
I thought it was necessary to subdivide the subsequent slower indentation phase or creep 
phase into phases H and III with the former lasting from I to 10 seconds and the latter 
lasting from 10 to 300 seconds because a mono-exponential regression line did not fit 
the whole of this part of the trace and it was better to use two exponential regression 
lines. For phase H, the start cursor is placed at the beginning of the creep phase and the 
end cursor is placed at the 10 second mark which is shown on the computer screen. The 
specially written software then plots a mono-exponential regression line to provide the 
distance parameter in mm. and the rate constant parameter (-I/tau in seconds-') which is 
the slope of the line. For phase III, the distance and rate constant parameters are 
calculated from a mono-exponential regression line after the start and end cursors are 
placed at the 10 second mark and 300 second mark respectively. 
The tissue tonometer had been adapted to cope with the change in speed between the 
initial fast indentation phase and the subsequent slower indentation phase with the 
recording mode in the first ten seconds of indentation, the rapid indentation phase, set at 
40 samples per second which automatically switched to a slower speed of 4 samples per 
second to record the relatively slower subsequent indentation phase in the last 290 
seconds. 
Five minutes of recording following release of the plunger was selected for all 
measurements using the tissue tonometer after it was observed in preliminary 
measurements that the trace levelled off before 5 minutes had elapsed and that five 
minutes recording was reasonable before patient fatigue and/or restlessness sets in 
which may introduce 'noise' into the data. 
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1.5.3 Analysis of displacement versus tiaw curves obtained with tissue tonoinetry 
Me Kelvin-Hooke model 
The displacements versus time curves obtained from the tissue tonometer both in vitro 
(compression of glycerol soaked sponges) and in vivo (normal control subjects and 
subjects with evidence of lower limb chronic venous disease), showed an initial rapid 
indentation phase followed by a subsequent slower indentation phase or creep phase. 
In this thesis, I have applied a simple mathematical model, the Kelvin-Hooke model, to 
explain the tonometry curves obtained for all in vitro and in vivo studies in measuring 
the mechanical properties of the skin in lower limb chronic venous disease. This model 
was previously used by Bates et al in 1994 and was shown to fit his tonometry results in 
post-mastectomy lymphoedematous arms. Since the skin and glycerol soaked sponges 
show visco-elastic properties, this simple mechanical model generates curves of the type 
described above and would be used to explain the curves obtained with the tissue 
tonometer. It is a simple mathematical spring and dashpot visco-elastic model, which 
has a Kelvin and a Hooke element in series (Viidik et al, 1973) and is explained in 
details below. 
A force is required to alter a specimen of material by mechanical means. Rheology is 
the study of the properties of a material which are time-dependent. Macrorheology is the 
part of rheology that is confined to the study of the external property changes due to 
external forces as in the deformation of the specimen. Many of the changes that occur in 
a material can be described by certain basic elements that can be combined to provide 
rheological models. These models will help to visualise the mechanical properties and 
to facilitate their mathematical description but will not necessarily correspond to the 
physical events within real materials. 
Elasticity is symbolised by a perfect spring which is extensible without limits and with a 
constant spring rate (c) and is also known as the Hooke element which is represented by 
a spring attached to a wall (figure 1.5.7) and obeys the equation 
F= cX, 
Where X is the deformation and F is the load. 
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Figure 1.5.7 The Hooke element of an ideal spring attached at the left 
to a fixed point and at the right, the load (F) is applied and the deformation (X) 
is measured. 
All loadings, independent of speed, follow the same curve (i. e. a straight line) and are 
completely reversible along the same curve (Figure 1.5.8) This means that no energy is 
dissipated and there is no time dependence with all responses being instant. 
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Figure 1.5.8 The load-deformation curve for the Hooke element of ideal 
or linear elasticity. 
Viscosity, represented by the Newton element is visualised by a viscous damper or 
dashpot (Figure 1.5.9). The dashpot functions as a syringe with a small gauge needle 
i. e., the more fluid to be injected per unit time, the more pressure needed on the syringe 
plunger (note that in the mathematical model the flow is between the cylinder wall and 
the piston whereas in the syringe it is through the needle). On the other hand, the more 
tviscous' is the fluid, the more pressure is required on the plunger to inject the same 
amount of fluid per unit time. This is expressed mathematically 
F=kX 
Where k is the damping constant and X is the velocity or time derivative of deformation 
which can also be written as dX/dt. Therefore the above equation becomes 
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F=k. dX/dt 
If the load and velocity are constant, the time-deformation relationship is a straight line 
as shown in figure 1.5.10. This means that if the velocity and/or coeff icient of viscosity 
is very low, and X -= 
0, then almost no counterforce is created in the dashpot. 
On the other hand, if a sudden load is applied, this will result in the 'speed' becoming 
very high and X -> oD, the dashpot would become locked and behave initially like a rigid 
body with very little fluid flowing through the space between the piston and the cylinder 
with the pressure in the fluid becoming very high. 
Figure 1.5.9 The dashpot, k, symbolising the Newton element of linear viscosity. 
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Figure 1.5.10 The deformation-time relation for the Newton element of linear 
viscosity when the constant load of Fo is applied to it. 
The most simple combinations of the idealised elements are those containing an elastic 
and a viscous element in series or parallel. When the elements are coupled in parallel, 
the system is known as the Kelvin element shown below in figure 1.5.11 
46 
, ýý I., Iý, 11-0 
F 
0--* 
Figure 1.5.11 The Kelvin element is the Hooke and Newton elements coupled in 
parallel. 
In this system, both elements are always subjected to equal deformation while the total 
load is distributed between the two, thus, 
Xc ý-- Xk 2-- X 
Fk =F, 
which gives the equation for the system 
F= cX+ kX 
And if the load FO is applied at time t=0 and X=0, a gradually increasing deformation 
occurs 
X= Fo[ 1 -exp (-ct/k)] /c 
The above equation suggests that initially most of the counterload is generated in the 
dashpot and with increasing deformation the counterload is gradually transferred to the 
spring as the system is elongated. The load in the dashpot is exhausted asymptotically 
and at t= oo, Fo / c, all load is on the spring. This is shown graphically below in figures 
1.5.12 and 1.5.13 where the effects of sudden load removal at t= tj is also shown. 
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Figure 1.5.12 The deformation-time relationship for the Kelvin element at time 
t=0, when the load of Fo is applied and at t= tj when the load is removed. 
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Figure 1.5.13 The load-time relationship for the Kelvin element at time 
t=0, when the load of Fo is applied and at t= tj when the load is removed. 
In biological contexts, the model for an ideally viscoelastic material giving both an 
instant elastic response to loading and lacking plastic properties has been proposed to 
describe the skin. It is a combination of a Kelvin element in series with an elastic 
element (Hooke element) and is described diagrammatically below (Figure 1.5.14): 
F 
x 
Figure 1.5.14 A model for an ideally viscoelastic material with a Kelvin 
and a Hooke element in series. 
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The above model is a simple biological model which does not take into account the 
plasticity exhibited by most biological materials and obeys equation 1 which is an 
integration of the expressions for the Kelvin-Hooke array giving the expression for 
deformation X as a function of time, 
Xt= a+b(1- e't"r) .................... equation 1 
where, 
Xt = distance moved at time t, 
a=F C2 i. e. Force divided by spring constant of the series Hooke element 
b=FC, i. e. Force divided by spring constant of the series Kelvin element 
,r (tau) = is the ratio of dashpot constant to spring constant in the Kelvin element, 
,r=k/ C1. 
After releasing the plunger with the 30g weight, the distance travelled at t=O ( X0 ) is: 
Xo=a=F/C2 ............................... equation 2 
X0 can be read from the initial drop (i. e. phase 1, the initial rapid indentation phase) and 
F is known, therefore, C2. the spring constant of the series Hooke element, can be 
calculated. 
At t=infinity, the distance X, is equal to a+b. 
X, =a+b=Xo+F/Cl ................ equation 3 
Substituting equations 2 and 3 into I gives the relation between distance from final 
equilibrium ( X, - Xt) and time, 
t Pr Xi - Xt = (Xi - Xo) e............... equation 4 
Equation I can be illustrated graphically as in figure 1.5.15 below with four theoretical 
curves shown with various spring and dashpot values (Bates PhD thesis 1993). 
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Figure 1.5.15 Theoretical tonometer curves as described by equation I with the values 
of Xo, XI, tau, CI. C2and k given. 
Once t >0 seconds, the initial elastic deformation phase or phase I (initial rapid 
indentation phase) which is 10mm in all cases shown, has no effect on the shape of the 
curve. An increase in the final value that the plunger reaches (XI) is a result of a decrease 
in the Kelvin elastic component, C1. An increase in the rate at which the final value is 
approached results from a decrease in the rate constant. 
The dashpot constant (k) is equal to the product of -c and C, and is proportional to the 
resistance to flow. An increase in the dashpot constant will therefore cause an increase in 
the time the plunger takes to level off. 
If the final distance reached also increases, however, (decreasing CI) then the dashpot 
constant may be the same (see black curve and green curve above). The dashpot constant 
will be greatest when both T and C2 are maximum, i. e. very slow pitting and to a very 
small depth as in the blue curve above. The dashpot constant will be lowest in very 
oedematous legs (red curve). 
If X, can be determined, then C 1, the spring constant of the series Kelvin element, can be 
calculated and thence, k the dashpot constant, can also be calculated. 
50 
From equation 4, a linear expression is obtained by taking the natural logarithm: 
In (XI - Xt) = In (XI - Xo) - t/T ............................ equation 5 
By plotting In (Xi - Xt ) against time, a straight line should result, if the model is valid, 
with an intercept of In (XI - X0 ), and a gradient of - I/T called the rate constant. Because 
,r= k/Cl, the dashpot constant, k, can be calculated once C, is known. X, cannot be 
measured directly but can be estimated by an iterative procedure. The final recorded Xt 
was taken as an initial estimate of Xj. If this value was too small or too large, the semi- 
log plot was non-linear and correlation coefficient was low. X, was then iteratively 
increased or decreased until an optimum correlation coefficient, closest to 1, was found 
and this was taken as the best estimate of X, and used in the estimation of 'T, CI and k. A 
simple computer curve fitting programme was designed to iteratively find the best 
estimate of X, (PDCS, 1996). 
Interpretation of the Kelvin-Hooke model 
The biological components equivalent to the two elastic and one viscous components in 
the above model are not specified but by analogy with other biomechanical work 
investigating fluid flow through cartilage (Mow et al, 1984; Armstrong et al, 1984), the 
initial fast indentation phase was analogous to the rapid elastic deformation of a 
compressible matrix and the subsequent slower indentation phase was analogous to the 
viscous creep of fluid through that matrix until it approaches elastic equilibrium. 
Two elastic spring constants (C2 and CI) and the viscous dashpot constant (k) are 
provided by the Kelvin-Hooke model. The initial rapid deformation of a visco-elastic 
material, as explained by the above model, depends on its elastic component or Hooke 
element (spring 2), C2 . which is in series with a parallel dashpot-spring system (Kelvin 
element). The Kelvin element comprises a dashpot, k, and spring I (CI) in parallel and 
this gives rise to the exponentially decaying creep until an elastic equilibrium is reached. 
C2 represents the initial ability of the interstitial matrix to undergo elastic deformation 
without flow. The size of the subsequent deformation X, - X0 for a given load reflects 
the strength of the in-parallel component, C1. The rate at which the final value is 
reached depends on C, and the resistance of the dashpot constant, k. The assumption is 
that k would depend on the mobility of interstitial fluid and on the interstitial hydraulic 
resistance which is widely accepted to be reduced in oedema. From the Kelvin-Hooke 
analogy, the following features would be expected: 
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(i) C2 (or Xo) (g/mm) should depend only on the initial elastic compressibility and 
should not depend on the viscosity of the fluid in the matrix through which it is being 
forced. 
(ii) The total depth of pitting (X, )(mm) should depend on C, (g/mm) and not on the 
viscosity of the fluid in the matrix. 
(iii) The rate constant, -I/Tau (seconds-), depends on the dashpot constant, k 
(g/(mm/sec), and hence on the resistance to flow as well as C1, so k should increase with 
viscosity. 
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1.6 Methods of classification and grading of lower limb chronic venous disease. 
1.6.1 Previous classification methods 
Previous methods of classification of lower limb venous disease include that of Widmer 
(Widmer et al, 1978) which categorised limbs based on their clinical appearance. More 
recently, he recognised that chronic venous insufficiency must include both superficial 
and deep lesions regardless of their cause or their clinical presentation and suggested a 
five-stage chronic venous insufficiency classification (Griton and Widmer; 1992). 
Hach in Germany (Hach et al, 1980) classified reflux in the long saphenous veins into 
four stages ranging from reflux in the proximal thigh as stage 1 to ankle reflux as stage 
4. He also correlated increased superficial vein diameter, elongation and tortuosity with 
the progressive stages of reflux Again though this classification was popular in some 
countries it never achieved world-wide acceptance. 
In Russia in 1985, a more detailed method based on haemodynamic and phlebographic 
data was described by Sytchev but this was not widely publicised outside Russia and 
hence never gained universal acceptance. 
In the late eighties, methods of classification included the addition of an anatomic 
category, a clinical severity scale and recommendations for objective measurement of 
venous haemodynamics to document the presence of chronic venous insufficiency by 
the joint council of the Society for Vascular Surgery/North American Chapter, 
International Society for Cardiovascular Surgery (SVS/ISCVS) in their first edition of 
the reporting standards in venous disease 
In the early nineties, another classification method from Argentina (Enrici et al, 1992) 
was based on the clinical presentation of the patient using anatomical regions, clinical 
severity, physical examination and functional assessment. This classification method 
was similar to the Ad Hoc Committee of the SVS/ISCVS method of classification. 
More recently, Comu-Thenard of France, described a classification system which was 
exclusively for varicose veins and made no attempt to classify more severe venous 
disorders (Cornu-Thenard et al, 199 1). 
Attempts to use the SVS/NA-ISCVS clinical classification described above have been 
disappointing as some investigators found it necessary to group stages I and 2, the 
earlier stages of the clinical manifestation of venous disease, together in order to 
differentiate them from the more advanced stages 2 and 3. 
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1.6.2 CEAP method of classification and scoring of lower limb chronic venous 
disease. 
In 1994, an international consensus report under the auspices of the American Venous 
Forum presented the latest method of classification and grading of lower limb chronic 
venous disease which was as a result of significant progress made in the non-invasive 
field of investigations of venous pathology with the use of electronic and computer- 
aided technology. This system requirement were similar to those for diagnosing 
peripheral arterial disease which had long been in use. 
The CEAP method classifies lower limb chronic venous disease according to the clinical 
signs and symptoms (C), the (a)etiology (E), the anatomic distribution of the pathology 
(A) and the pathophysiologic dysfunction (P) resulting in a multi-axial system (Beebe et 
al, 1995). The clinical classification differentiates telangiectases from truncal varicose 
veins, and healed ulcers from open ulcers, in a seven stage description. In addition to the 
classification of disease, the CEAP method also allows you to score the disease. 
The CEAP method of classification is summarised in Table 1.6.1: 
C for Clinical signs (grade 0-6), supplemented by (A) for asymptomatic and (S) 
for symptomatic presentation. 
E for Etiologic classification (Congenital (Ec), Primary (E, ), Secondary (Es)). 
A for Anatomic distribution (Superficial (As), Deep (AD), or Perforator (Ap), 
alone or in combination). 
P for Pathophysiologic dysfunction (Reflux (P, or Obstruction (PO), alone or in 
combination). 
Table 1.6.1 CEAP classification of lower limb chronic venous disease. 
Clinical classification (C o. 6) 
C is for clinical signs (grade 0-6) graded in increasing order of severity according to the 
objective clinical signs of disease listed in Table 1.6.2 below. Limbs with more severe 
signs of chronic venous disease will be placed in the higher categories and may have 
some or all of the findings defining a less severe clinical category. Each limb will be 
further characterised as symptomatic and supplemented by (S) or supplemented by (A) 
for asymptomatic. 
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Therapy may alter the clinical category of a limb therefore it was recommended that 
limbs should be reclassified after any form of medical or surgical intervention at least 6 
months after. 
Class 0: No visible or palpable signs of venous disease. 
Class 1: Telangiectases or reticular veins. 
Class 2: Varicose veins. 
Class 3: Oedema. 
Class 4: Skin changes ascribed to venous disease (e. g. pigmentation, 
lipodermatosclerosis, venous eczema). 
Class 5: Skin changes as in class 4 with healed ulceration. 
Class 6: Skin changes as in class 4 with active ulceration. 
Table 1.6.2 Clinical classification of lower limb chronic venous disease. 
Etiologic classification (EC, Ep, or ES) 
E is for etiologic classification, that is, whether the venous dysfunction may be 
congenital, primary or secondary (table 1.6.3). 
Congenital (EC) 
Primary (Ep) - with undetermined cause 
Secondary (ES) - with known cause 
Post-thrombotic 
Post-traumatic 
Other 
Table 1.6.3 Etiologic classification of lower limb chronic venous disease. 
Anatomic classification (As, D, p) 
A is for anatomic distribution, that is, whether the vein(s) affected by venous disease is 
in the superficial, deep or perforator systems. One, two or three systems may be 
involved in any combination. Table 1.6.4. below lists the anatomic segments in the 
superficial, deep and perforator systems that may be involved. 
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Segment # Superficial Veins (AS 1-5): 
I Telangiectases / reticular veins 
Long Saphenous Vein 
2 Above Knee 
3 Below Knee 
4 Short Saphenous Vein 
5 Non-Saphenous Vein 
Deep Veins (AD6-16): 
6 Inferior Vena Cava 
Iliac 
7 Common 
8 Internal 
9 External 
10 Pelvic - Gonadal, broad ligament, other 
Femoral 
II Common 
12 Deep 
13 Superficial 
14 Popliteal 
15 Crural - anterior tibial, posterior tibial, peroneal (all paired) 
16 Muscular - Gastrocnernial, soleal, other 
Perforating veins (Ap17,18): 
17 Thigh 
18 Calf 
Table 1.6.4 Anatomic classification of lower limb chronic venous disease. 
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Pathophysiologic classification (Pp 
P is for pathophysiologic dysfunction which may result from reflux (P"), obstruction 
(PO) or both (P.,, O) as shown in table 1.6.5 below. 
It is now recommended that in the investigation of patients with chronic venous disease, 
sufficient objective measurements of venous haernodynamics and anatomy by either 
invasive or non-invasive means must be carried out to adequately document the 
individual pathophysiologic changes, reflux, and/or obstruction accompanying chronic 
venous disease. Phlebographic or vascular laboratory investigations can objectively 
assess the presence of venous outflow obstruction (PO) as well as the presence of venous 
reflux (P. J in the superficial, deep and perforating systems. 
The anatomic segments that are involved with either reflux or obstruction are reported 
using the venous segments outlined in table 4 above, as the severity of venous 
dysfunction is influenced by the anatomic location and extent of the reflux and/or 
obstruction present (Gooley et al, 1988; Hanrahan et al, 1991). 
Reflux (PR) 
Obstruction (PO) 
Reflux and Obstruction (PR, O) 
Table 1.6.5 Pathophysiologic classification of lower limb chronic venous disease. 
Scoring of venous dysfunction 
Another feature of the CEAP method of classification of lower limb chronic venous 
disease is the scoring system of chronic venous dysfunction that is incorporated within 
the system. This provides a numerical base for the scientific comparison of limb 
condition and evaluation of results of treatment. The scoring system is based on three 
elements: 
" the number of anatomic segments affected (anatomic score) 
" grading of symptoms and signs (clinical score) 
" disability (disability score). 
This method of scoring and grading is thought to be more accurate as the grading of 
signs is objective whereas the grading of symptoms is subjective. 
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Clinical Score 
The clinical score is the sum of the values assigned to the signs and symptoms listed in 
table 1.6.6 below: 
Signs and Symptoms Clinical Score 
Pain (0= none; 1= moderate, not requiring analgesics; 
Oedema, 
Venous Claudication 
Pigmentation 
Lipodermatosclerosis 
Ulcer - Size (largest ulcer) 
Ulcer - Duration 
Ulcer - Recurrence 
Ulcer - Number 
2= severe, requiring analgesics ) 
0= none; I= n-ffld/moderate; 2= severe 
0= none; 1= mild/moderate; 2= severe 
0= none; I= localised; 2= extensive 
0= none; I= localised; 2= extensive 
0= none; 1= <2cm dia; 2= >2cm dia 
0= none; 1= <3months; 2= >3months 
0= none; I= once; 2= more than once 
0= none; I= single; 2= multiple ) 
Table 1.6.6 Clinical scoring of the signs and symptoms of lower limb venous disease. 
Anatomical score 
The anatomical score is the sum of the anatomical segments affected by either reflux, 
obstruction or both, each scored as one point, as listed in Table 1.6.4. 
Disability score 
The disability score is the sum of the values assigned to the signs and symptoms listed 
below in Table 1.6.7. 
Score Level of disability 
0- Asymptomatic 
I- Symptomatic, can function without support device 
2- Can work 8-hour day ONLY with support device 
3- Unable to work even with support device. 
Table 1.6.7 Disability Score. 
58 
1.6.3 Previous applications of the CEAP method 
This method has been published in 19 different journals and books in 5 languages 
around the world. 
This classification has been used in the subfascial endoscopic perforator study (SEPS) in 
which they classified data of patients from 17 medical centres (Gloviczki et al, 1997). 
They found the disability scoring method very valuable, as calculated preoperatively and 
postoperatively, in giving a clear indication of the results of the intervention. 
In a crossover study investigating the controversy of non-operative versus operative 
therapy for the treatment of the complications of venous hypertension it was found that 
the clinical severity scoring was very useful in comparing the results pre- and post- 
operatively (DePalma et al, 1996). 
59 
1.7 Normal anatomy of the lower limb venous system 
Venous blood flow is influenced by physical factors such as pressure and resistance and 
is also dependent upon gravity, cardiac cycle, respiratory cycle, blood volume and the 
presence of the calf muscle pump which is often referred to as a 'peripheral heart'. 
1.7.1 Structure of the vein 
The veins consists of three layers: the intimal, medial and adventitial layers. The walls 
of the veins are on average much thinner than those of arteries. The intima is composed 
of a monolayer of endothelial cells with an underlying basement membrane and elastic 
lamina. The media consist of three layers of smooth muscle with interspersed elastic and 
connective tissue. The adventitia is histologically, the thickest layer of the vein wall. It 
is composed of interlacing fibres of collagen and contains the venous vasa vasora and 
the peri-venous adrenergic nerve fibres. 
The capacitance function of the venous system is primarily due to the thin, collapsible 
vein walls. The optimal function of the calf muscle pump is dependent on high venous 
capacitance. Duplex ultrasound B-mode scanning can clearly demonstrate the resulting 
elliptical configuration of a collapsed vein when subjected to external pressure. This 
pattern of collapse and re-expansion in response to external compression contributes to 
the high capacitance of the lower extremity venous system. Most of the veins in the 
lower extremity lie within the muscular compartments of the leg and are subject to 
external compression during calf muscle contraction. When veins fill and expand, they 
change from an elliptical to a circular configuration which results in an increase in 
venous volume without an increase in circumference of the vein. As the vein wall is not 
stretched, there is no resulting increase in pressure or energy expended to fill the vein. 
Once the vein reaches a circular shape further increases in venous volume require 
increased intra-luminal pressure to increase the venous circumference and venous 
volume. Because of the thinness of the vein walls, minimal pressure increases are 
needed to overcome the inherent stiffness of the adventitial layer. The venous volume is 
increased by over 250% as a result of an increase in the venous transmural pressure 
from 0 to 15 mmHg (Moreno et al, 1970). Using Duplex ultrasound B-mode scanning to 
observe the large axial veins that are not subject to muscular compression, it was found 
that they collapsed in a circular rather than elliptical configuration is response to a 
decrease in venous volume (Moneta et al, 1988). These veins are supported on all sides 
by connective tissue and/or fat and are subject to equal external pressure vectors at all 
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points on the vein wall and expand or collapse in response to changes in venous volume 
through changes in circular diameter rather than change in the shape of the vein 
resulting from external compression. 
1.7.2 The venous valves 
Valves are present in lower extremity veins and are bicuspid with a fine connective 
tissue skeleton and are extremely strong even though they are just a thin layer of 
collagen fibres covered with endothelium (Ackroyd et al, 1985). The valve cusps are 
stronger and more elastic than the vein wall. The valve sinus is always wider than the 
vein above and below the cusps (Cotton et al, 1961). The calf muscle pump (described 
in the next section) in combination with functioning venous valves provides the force 
necessary to overcome venous compliance and hydrostatic pressure and promote venous 
return in the upright position. There are more valves in the distal leg veins and they 
decrease in numbers proximally. The inferior vena cava and common iliac veins have no 
valves and 75% of external iliac veins have no valves, but only 25% of common femoral 
veins are valveless (Powell et al, 1951). Valves in the internal iliac systems are less 
frequent, occurring in about 7% of the population (Basmajian et al, 1952). It has been 
suggested that the lack of valves in the iliac and common femoral veins is the starting 
point for the development of a progressive descending valvular incompetence that 
causes varicose veins (Ludbrook et al, 1962). The valves in the axial veins ensure that 
blood flows from caudal to cephalad and from superficial to deep in the communicating 
veins of the calf with the exception of foot communicating veins where venous flow is 
from the deep veins in the muscles of the sole of the foot to the superficial veins on the 
dorsum (Gardner et al, 1983), (Pegum et al, 1967). The valves close in response to 
cephalad to caudal blood flow and a reverse flow velocity of at least 30 cm/s appears to 
be required for venous valve closure (van Bernmelen et al, 1990). 
1.7.3 Superficial venous system 
The lower extremity veins can be divided into three types: superficial, deep and 
perforating veins (see figure 1.7.1). The superficial venous system lies above the 
investing fascial layer of the leg and thigh and consists of the long and short saphenous 
veins and their tributaries. These veins are not compressed by the muscle contraction. 
The long saphenous vein (LSV) and short saphenous vein (SSV) referred to throughout 
in this thesis are also known as the greater saphenous vein (GSV) and the lesser 
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saphenous vein (LSV) respectively in American textbooks (please note to avoid 
confusion). The venules which are the smallest veins are present in all tissues. These 
join to form medium sized veins, which empty into the main trunks of the long and short 
saphenous veins. 
The long saphenous vein 
The long saphenous vein (LSV) is the longest vein in the body and it begins in the 
dorsum of the foot arising from the medial aspect of the dorsal pedal venous arch and 
ascends cephalad anterior to the medial malleolus. From the ankle, it follows a course 
immediately superficial to the anteromedial aspect of the tibia and at the level of the 
knee it lies about 8-10 cm dorsal to the medial edge of the patella. The saphenous nerve 
accompanies the vein anteriorly from the dorsum of the foot to the subsartorial canal in 
mid-thigh. The LSV remains superficial in the mid-thigh and moves deep to Scarpa's 
fascia in the upper thigh to enter the fossa ovalis, about 4 cm inferior and lateral to the 
pubic tubercle. Normally, the diameter of this vein is 2mm to 3mm in the calf and 6mm 
in the thigh, as seen on the venogram. The LSV contains between 10-13 valves and is 
duplicated in the thigh in an estimated 8% of patients with the duplicated segments 
reuniting at variable points distally in the thigh (Thompson et al, 1979). 
Tributaries of the long saphenous vein 
Important tributaries of the LSV include the posterior arch vein which arises from 
calcaneal branches posterior to the medial malleolus and courses cephalad in the 
posterior medial calf and unites with the LSV in the proximal calf. 
In the proximal third of the thigh, the LSV has major anterolateral and posterolateral 
tributaries joining it. These tributaries may be significantly varicose without clinically 
evident changes in the LSV. At the level of the fossa ovalis, the LSV has constant 
tributaries present which include the superficial circumflex iliac, the superficial 
epigastric, and the superficial external pudendal veins. These tributaries have variable 
courses and anatomical orientation to the LSV and are best identified at the level of the 
saphenofemoral junction. These tributaries may become varicose and can contribute to 
venous reflux. 
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Communicating orperforating veins associated with the long saphenous vein 
There are multiple communicating or perforating veins present between the posterior 
arch vein and the posterior tibial vein and are known as Cockett's perforators. 
Boyd's perforator connects the LSV to the deep veins approximately 10cm below the 
knee. The LSV lies immediately superficial to the tibia distally and so it does not 
directly communicate with the deep venous system in the distal leg but is indirectly 
connected to the deep system via perforating veins linking the posterior arch and 
posterior tibial veins. 
Connections exist between the LSV and the deep venous system in the thigh. The Dodd 
and Hunterian perforating veins connects the LSV and the superficial femoral vein 
approximately 15cm and 30cm proximal to the knee. Incompetence of this vein may be 
the aetiology of medial thigh varicosities in the presence of a competent saphenofemoral 
junction and a competent proximal LSV. There are also smaller communicating veins 
that may connect the LSV to the deep femoral vein, also known as the profunda femoris 
vein, in the middle third of the thigh. Many other communicating veins may exist in the 
LSV system and some may pass through muscle during their course. 
Short saphenous vein 
The short saphenous vein (SSV) originates laterally from the dorsal venous arch, 
travelling cephalad subcutaneously in the mid-posterior calf between the medial and 
lateral heads of the gastrocnemius muscle where it penetrates the deep fascia, usually in 
the upper third of the calf, to enter the popliteal fossa. Venographically, the diameter of 
the short saphenous vein normally measures up to 7mm and contains between 7-13 
valves and are more closely spaced than those in the LSV. The sural nerve lies 
immediately lateral to the SSV. The termination of the SSV is highly variable. It can 
enter the popliteal vein distally to the knee joint and it may do so proximally and on 
occasion continues subcutaneously and joins the LSV in the thigh. The intersaphenous 
vein links the SSV and LSV and it courses cephalad and medial to join the LSV directly, 
or indirectly, by way of the posterior arch vein. 
Tributaries of the short saphenous vein 
The main tributary of the SSV is the lateral arch vein which courses cephalad along the 
lateral calf and joins the SSV just distal to the popliteal fossa. Perforating veins typically 
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connect the lateral arch vein to the peroneal vein of the deep venous system. This is 
analogous to the posterior arch vein and its relationship to the LSV 
1.7.4 Deep venous system 
The deep veins lie beneath the fascial covering and are subject to compressive forces 
when the muscles of the limb are used. Venous return from the lower extremities is 
primarily through the deep veins. 
Venae comitantes 
There are three sets of paired venae comitantes paralleling the course of the three named 
arteries beginning in the distal. calf. They are the peroneal, posterior tibial and anterior 
tibial veins. The paired veins are connected by venous bridges along the course of each 
artery with the paired veins joining at the mid-calf level. From this level, the peroneal, 
anterior and posterior tibial veins continue cephalad with their respective arteries. The 
anterior tibial vein drains the anterior compartment, the posterior tibial vein drains the 
posterior compartment, and the peroneal veins drains the lateral compartment of the leg. 
They join to form the popliteal vein in the inferior aspect of the popliteal fossa. 
Popliteal vein 
The popliteal vein lies I to 2cm from the posterior surface of the distal femur. The close 
relationship of the popliteal vein to the femoral condyles has been implicated as a cause 
of the pseudo-obstruction of the popliteal vein seen on venography. The normal 
diameter of the popliteal vein is 9 to 15mm. when measured on anteroposterior 
radiographs at a point 8cm above the knee joint. In the popliteal vein, up to 2 valves 
may be present. Distally, the popliteal vein proceeds medial to the popliteal artery and 
proximally it courses lateral to the artery at the adductor opening and becomes the 
superficial femoral vein. The popliteal vein may be single, double with two femoral 
veins or triple. 
Superficialfemoral vein 
The superficial femoral vein lies initially lateral in the distal thigh and then medial to the 
superficial femoral artery in the proximal thigh. It measures 0.9 to 1.0cm in diameter 
and usually contains two to five valves. Four variations of the superficial femoral vein 
consist of a normal single vein, duplication of the lower segment, sequentially uniting 
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to form one single vein in the mid thigh, multiple veins and duplication of the entire 
superficial femoral vein. 
Deepfemoral vein 
The deep femoral vein, also known as the profunda femoris vein, drains the thigh 
muscles and it joins the superficial femoral vein laterally in the proximal femoral 
triangle to form the common femoral vein which lies medial to the common femoral 
artery. The long saphenous vein joins the common femoral vein about 3 cm distal to the 
inguinal ligament to form the sapheno-femoral junction. At the inguinal ligament, the 
common femoral vein becomes the external iliac vein and it receives tributaries from the 
deep epigastric and deep circumflex iliac veins. In the deep venous system, there are 
many hundreds of valves present with the greater number of valves present in the more 
distal vessels. 
1.7.5 Intramuscular venous channels 
The soleus and gastrocnernius are the two muscle plexus veins that can be seen on 
venography. The intramuscular venous channels are very important to the function of 
the calf muscle pump (see section 1.8.5). The numbers of venous sinuses present within 
the substance of the soleus muscle vary between 1-18. The soleal sinuses are valveless 
but are linked by valved small venous channels that prevent reflux. The soleal sinuses 
empty into the posterior tibial vein in the proximal calf. The soleus plexus veins are 
seen as saccular venous structures in the posterior calf region when viewed on the lateral 
venographic projection. There is also within the substance of the gastrocnernius muscles 
an interlacing valved venous network which coalesce to form a pair of venous channels, 
the gastrocnernius veins, that drains the blood from the gastrocnernius muscle and empty 
into the popliteal vein. These are seen as saccular venous structures in the medial calf 
region when viewed on the anteroposterior venographic projection. 
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1.8 Normal venous physiology of the lower limbs. 
There are many factors that influence the return of blood from the lower extremities to 
the heart and the relative importance of each factor varies with body position and 
activity. 
1.8.1 In the supine position 
When the subject is in the supine position, the respiratory cycle plays an important part 
in the venous return from the lower extremities. The foot vein pressure in the supine 
position is approximately 15 mmHg. The right atrial pressure is normally between 0 and 
2 mmHg so the venous return to the heart in the supine position is generated by a 
pressure gradient of 13-15 mmHg (Browse and Burnand, In: Diseases of the veins, 1988 
p 53). During inspiration, the volume of the veins of the thorax increases and the 
pressure decreases in response to reduced intrathoracic pressure (Moreno et al, 1967; 
Moreno et al, 1969). Expiration leads to the opposite effect, with decreased venous 
volume and increased pressure. The venous response to respiration is reversed in the 
abdomen, where the pressure increases during inspiration because of the descent of the 
diaphragm, and decreases during expiration as the diaphragm ascends. Increased 
abdominal pressure during inspiration decreases pressure gradients between peripheral 
veins in the lower extremities and the abdomen, thus reducing flow in the peripheral 
vessels (Duomarco et al, 1954). During expiration, when intra-abdominal pressure is 
reduced, the pressure gradient from the lower limbs to the abdomen is increased and the 
flow in the peripheral veins rises correspondingly. The respiratory effects are usually 
associated with clear phasic changes in venous flow in the extremities. These can be 
detected by various instruments, including many forms of plethysmography and Doppler 
flow detectors. The respiratory changes in venous velocity may be exaggerated by 
respiratory manoeuvres, such as the Valsalva manoeuvre, which increases intra-thoracic 
and abdominal pressures and decreases, abolishes, or even reverses flow in some 
peripheral veins. 
1.8.2 From the supine to the uprightposition 
When the subject moves from the supine position to the upright position, the influence 
of the respiratory cycle changes and the effect on the venous blood flow patterns has 
been demonstrated in the common femoral vein using a duplex ultrasound scanner with 
simultaneously recordings of the cardiac and respiratory cycles using an 
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electrocardiogram (ECG) monitor and a respiratory monitor (Moneta et al, 1988). The 
subject was placed in the supine position and non-weightbearing on a tilt table and 
gradually moved until fully upright. At minus 10 degrees head down, the weight of the 
abdominal viscera presses on the diaphragm and this is sufficient to counteract the 
descent of the diaphragm during inspiration. In this position, the outward movement of 
the chest wall generates the negative intra-thoracic pressure that is required for 
inspiration with little change in the intraabdominal pressure. The venous blood flow 
patterns were shown to be primarily dependent upon the cardiac cycle but virtually 
independent of the respiratory cycle. Blood leaving the legs essentially flows downhill 
into the passively dilating right atrium until it is stopped by the onset of the cardiac 
contraction. As the subject becomes more upright, the influence of the cardiac cycle on 
the venous return rapidly diminishes as the respiratory cycle becomes more important. It 
has been shown in the study above that with the subject in the non-weightbearing and 30 
degree head-up position on a tilt table, the respiratory monitor indicated presence of 
flow in the common femoral vein during expiration and ceases with normal inspiratory 
effort. 
1.8.3 In thefully uprightposition 
In the upright position, the column of blood between the level of the manubrium sterni, 
the point used as the zero reference for the pressure measurement, and the foot exerts a 
gravitational force known as the hydrostatic pressure. The pressure in the foot vein then 
becomes 15 mmHg plus the hydrostatic pressure. In this position, the expiratory 
promotion of venous flow is not enough to overcome the gravitational hydrostatic forces 
and promote adequate venous return. The contraction of the calf muscles is required to 
overcome this gravitational forces (see section 1.8.5) and promote venous return. The 
diagram below (figure 1.8.1) shows the arterial and venous blood pressure in a 6ft man 
in the standing position. 
1.8.4 The return of blood to the heart 
Blood returning from the lower extremity must flow against the forces of gravity to 
return to the right atrium. The foot vein pressure in the supine position is about 100 
mmHg, so in order for blood to return from the foot, it has to reach this pressure to 
ensure adequate return. Since the vascular system is a closed series of tubes, the return 
pressure on the venous side is balanced by an equal hydrostatic arterial pressure 
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Figure 1.8.1 The arterial blood pressures (in red) and venous blood pressures 
(in blue) in a 6ft (180 cm) tall standing man. The pressure at any point in the 
circulation is the sum of the dynamic pressure, which comes from the heart, and 
the hydrostatic pressure, which is exerted by the column of blood between the 
site of measurement and the zero reference point. The heart is used as the zero 
point when measuring the pressures. 
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supplying the limb. The pumping force of the heart results in the blood leaving the 
capillary system having a small residual pressure of 15-20 mmHg, the 'vis a tergo'. This 
is sufficient to ensure venous return whether in the supine or erect position. In the 
supine position, the venous return takes place at the expense of a high venous pressure 
in the extremity. A highly specialised pumping mechanism has been evolved to actively 
pump venous blood back to the heart from the lower limb. It is thought that the principal 
participants in the pumping mechanism are the calf veins, gastrocnernius and soleus, 
within the calf muscles. This mechanism will be described later on in the chapter. 
Failure of this system results in symptoms ranging from varicose veins to severe 
ulceration of the lower limb. 
1.8.5 The calf musclepump 
It is thought that the principal participants in the pumping mechanism are the veins of 
the calf within the calf muscles, gastrocnernius and soleus. These contain as much as 
250ml of blood (Ludbrook et al, 1964). Additional muscle pumps are also recognised in 
the thigh and foot (Gardner et al, 1983) (Gardner et al, 1989 book). The latter has a 
much smaller capacity (about 25ml), but assists in the return of blood from the foot. It 
may have a 'pump-priming' effect on the calf muscle pump. The calf pump is often 
referred to as the peripheral heart. Venous flow is also dependent upon the contractile 
force of the heart, static filling pressure and gravity. During calf contraction, the 
pressure in and around all the structures contained within the deep fascia becomes raised 
resulting in all the intra-muscular veins becoming completely compressed resulting in 
the blood that is present in these veins being emptied by the calf muscle pump into the 
outflow tract which is the popliteal vein. The large veins within the gastrocnemius and 
soleus muscles form the main chamber of the pump but all the other deep veins 
participate. Distal deep venous valves prevent axial reflux and valves in the 
communicating veins prevent reflux from the deep venous system to the superficial 
venous system (Almen et al, 1962). The average volume of the calf varies between 1500 
- 2000 ml and the calf blood volume is between 60 - 70 ml (Whitehead et al, 1983). 
With continuous exercise, the calf blood volume is reduced by 1.5 - 2.0 ml/100ml 
mainly as a result of the compression of the veins in the pump chamber and the average 
expelled volume is approximately 30 - 40 ml, that is, about 50% of all the blood within 
the pump. The pump will normally expel this volume in four or five contractions though 
one single sustained contraction can expel as much. The popliteal vein is a large bore 
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vein which offers virtually no resistance to outflow. As the gradient of 10 - 15 mmHg 
between the small veins and the heart is sufficient to ensure venous blood flow in the 
supine position, the increase in gradient produced by the calf muscle pump during 
contraction is more than enough to ensure an adequate rapid venous return to the heart 
during vigorous erect muscle exercise. 
As the calf muscles relax, valves cephalad to the muscle pump close and prevent reflux 
of blood from more proximally in the axial veins. The valves in the communicating 
veins open and allow normal blood flow from the superficial to the deep venous system. 
In addition, arterial inflow from the lower extremity capillary beds re-primes the calf 
muscle pump for a subsequent contraction. At the moment when the calf muscles relax 
their contained veins are empty, at low pressure and as yet unfilled by arterial inflow. As 
the veins are collapsed, they are unaffected by hydrostatic pressure. On the other hand, 
the superficial veins are full and subjected to hydrostatic pressure plus the remnant of 
cardiac generated pressure, the 'vis a tergo'. The pressure gradient between the two. 
compartment becomes 100 - 110 mmHg resulting in blood immediately flowing from 
the superficial to the deep compartment through the many communicating veins 
(Bjordal et al, 1970). This empties the superficial compartment and reduces its pressure 
(Pollack et al, 1949). Therefore the function of the calf muscle pump is vital in ensuring 
venous return from the lower limbs during exercise and the reduction of the superficial 
venous pressure thus removing the damaging effects of the hydrostatic pressure ever 
present as a result of man's upright posture. 
The effectiveness of the calf muscle pump can be investigated by air plethysmography 
and ambulatory venous pressure measurement technique which measures deep venous 
pressure directly by placing a needle in a dorsal foot vein and connecting it to a standard 
pressure transducer and a recording device during rest and exercise. 
1.9 Lower limb venous pathophysiology 
The pathophysiology of chronic venous disease is influenced by changes in the 
cutaneous microcirculatory physiology as well as macrocirculatory changes. These 
changes play an important role in the venous ulcerative process with the skin and 
subcutaneous tissues in the distal third of the lower limb, mainly in the gaiter area, 
acting as the final target organs of chronic venous insufficiency. The hydrostatic and 
ambulatory venous pressures are highest in this area as a direct result of venous 
hypertension due to valvular reflux, with the high venous pressures being transmitted 
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from the macrocirculation to the microcirculation which may ultimately result in 
oedema, skin changes and venous ulceration. 
1.9.1 VaIvular reflux or retrogradeflow 
This is the return of blood flow in the opposite direction from physiological flow which 
is centripetal. This reflux may be natural, physiological or pathological. The duration of 
the reflux flow depends on the physiological or pathological state of the valvular 
apparatus. There have been studies (van Bernmelen et al, 1989) to show that the 
duration of reflux in the deep venous trunks in normal subjects was less than 0.5 
seconds in 95% of subjects scanned. Other studies (Neglen et al, 1992; Neglen et al, 
1993) have also shown that reflux is significant if the duration of the retrograde flow 
within the veins exceeds 0.5 seconds. Although it is not necessarily correlated to the 
development of varicose disease, this minimum duration of 0.5 seconds does seem to 
be universally recognised as corresponding to pathological reflux (Sarin et al, 1992; 
Moulton et al, 1993; Coleridge Smith et al, 1993). Kistner proposed a classification of 
deep vein reflux according to the level of descent of radiological contrast medium, 
during descending venography (Kistner et al, 1978; In: Venous problems). He defined 
four classes in increasing order of severity, with class I corresponding to reflux 
descending to mid-thigh, class 2 corresponding to reflux descending to the knee, class 3 
corresponding to reflux descending to the mid-calf and class 4 corresponding to reflux 
descending to the ankle. 
There are several ways of eliciting reflux flow in the lower limb venous system and the 
most effective ones includes manual compression of the calf or by means of a cuff. 
Compression with the cuff placed on the calf and inflated to 120 mmHg and then rapidly 
deflated thus mobilising the blood from the superficial and deep veins is the method that 
is easy to reproduce systematically since automatic cuffs which can inflate and deflate 
rapidly are available. A rapid cuff inflator and cuff deflator device was built by the 
author (see section 2.7) to standardise all cuff compression studies to elicit antegrade 
flow in reflux quantification studies performed in this thesis and has been reported by 
others (van Bernmelen et al, 1989; Vasdekis et al, 1989). 
The accurate quantification of venous reflux in individual veins has not yet been fully 
established. Recently, there have been several methods of quantifying venous reflux in 
individual veins using duplex scanning. These include measurements such as valve 
closure time (Welch et al, 1992), venous reflux index or the Doppler efficiency index 
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(EId) (Beckwith et al, 1993), velocity at peak reflux and quantitative volume flow 
measurements by calculating the cross-sectional area of the vessel and the time-averaged 
velocity (Vasdekis et al, 1989). Experience with these methods are still limited (Araki et 
al, 1993). 
The haemodynamic studies, using the duplex scanner, are essentially that of reflux and 
will depend on several factors which can be standardised to provide useful information. 
However, this method can only measure one venous segment at a time. 
Several methods have been developed to assess venous reflux but ambulatory venous 
pressure measurements, though invasive, is still considered the 'gold standard' (Raju et 
al, 1990). However, duplex scanning is the non-invasive method of choice used for 
testing individual veins of the superficial, deep and perforating systems (van Bernmelen 
et al, 1989; Neglen et al, 1992; Welch et al, 1992; Szendro et al, 1986; Vasdekis et al, 
1989). Duplex scanning of patients in the upright position in combination with proximal 
deflation of a venous-occluding blood pressure cuff to augment flow in the veins is the 
best documented non-invasive method of quantifying reflux by measuring reflux 
duration in specific axial superficial or deep venous segments (Masser et al, 1995). In 
addition, duplex scanning can detect the presence of incompetent perforating veins 
(Hanrahan et al, 199 1; Hanrahan et al, 199 1). It can also determine the anatomy of veins 
in the popliteal fossa (Hobbs et al, 1986; Vasdekis et al, 1989; Engel et al, 1991). In the 
presence of deep venous disease, duplex scanning will determine whether the problem is 
due to anatomic obstruction, reflux or both, and the anatomic extent of the pathology. 
Quantifying the duration of reflux on duplex scanning provides a valid method for 
giving indications but is dependent on the endoluminal diameter and on the manoeuvre 
performed. The manoeuvre can be standardised by using standardised calf compression 
to elicit antegrade flow with an automatic cuff inflator and deflator using the 
methodology described by van Bernmelen (van Bernmelen et al, 1989). 
1.9.2 Oedema 
Starlingforces and how oedema isfOnned 
Oedema is described as a perceptible expansion of the interstitial fluid volume. While 
the clinical importance of oedema is usually that of its underlying cause, the 
accumulation of oedema fluid and elevation of tissue pressure may directly interfere 
with various physiologic activities. 
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Most of the fluid that enters the tissue space by ultrafiltration from the arterial end of the 
capillary bed is absorbed back into the circulation at the venous end of that network. 
Ernest Starling, in 1896, described interstitial fluid formation and absorption in terms of 
the pressure gradients acting across the capillary endothelium, the surface area available 
for fluid transfer and the permeability of the capillary membrane to protein. The direct 
and immediate causes of oedema are alterations in the Starling forces that lead to an 
increase in the capillary-absorption ratio and a decrease in lymphatic drainage. 
Oedema 4 observed in a wide variety of diseases in which one or more of the Starling 
forces are modified by the disease process. In most cases, there is a complex interaction 
among the factors that control transcapillary fluid exchange and interstitial volume. A 
simple example of oedema is the orthostatic oedema that occurs in the dependent parts 
of the body. In this case, gravity acts to impair venous return resulting in increased 
capillary filtration rate as a result of increased capillary volume and capillary pressure. 
The single affected element of the system is the capillary pressure. Any procedure that 
will facilitate venous return such as muscle activity or compression stockings will 
alleviate the condition. 
In lower limb chronic venous insufficiency, oedema may occur as a result of increased 
capillary pressure secondary to an elevation in venous pressure due to venous 
obstruction or increased venous hypertension due to valvular incompetence. Other 
causes of clinical oedema include pregnancy, congestive heart failure, renal or hepatic 
insufficiency. 
Interstitial glycosaminoglycan (GAG) concentration and viscosity. 
Normal interstitium consists of fluid within a GAG and collagen matrix. The presence 
of quasi-fixed very large GAG molecules in the interstitium contributes significantly to 
the resistance to flow of fluid through the interstitium (Levick et al, 1987). 
In oedema, pools of freely mobile interstitial fluid (oedema fluid) exist in contact with 
the neighbouring interstitial matrix (Guyton et al, 197 1). Leaching of GAGs into the free 
interstitial fluid pools might increase the viscosity of the oedema fluid and may make it 
more difficult for fluid to be removed from the tissue spaces. 
Interstitial protein concentration in lymphoedematous tissues is considered higher than 
other oedematous states. Therefore, lymphoedema is a high protein oedema. 
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In venous oedema of the lower limb, the interstitial fluid protein concentration was 
found to be 7.3g/I and in a lymphoedernatous upper or lower limb as a result of surgery 
it is between 21-36g/I (Crockett et al, 1956). 
Schematic representation of skin 
An anatomical model of skin has been previously described (Guyton et al, 1971) to 
characterise the rate of flow on compression as a function of two viscosities: that of the 
free fluid and that of the gel-like fluid (see figure 1.9.1). 
Fibres 
Free fluid 
Gel-like 
fluid 
Figure 1.9.1 Schematic representation of the anatomical model of skin. 
It has been previously demonstrated that the mobility of fluid flow in the subcutaneous 
tissue increases substantially with oedema (Guyton et al, 197 1). The fluid flow through 
the tissue spaces is normally restricted by solid elements and by the high viscosity of the 
gel-like matrix embedded in a network of collagen fibres (Brace and Guyton, 1979). As 
oedema develops, the tissue spaces become greatly enlarged and fluid replaces the gel in 
the tissue spaces. The mobility of the interstitial fluid should indicate the degree of 
oedema. 
1.9.3 Skin changes and venous ulceration 
Haemosiderosis 
Venular dilatation occurs after prolonged venous hypertension resulting in extrusion of 
red blood cells through the interendothelial pores in post-capillary venules. The red 
blood cells containing haemoglobin are broken down, leaving haemosiderin as a brown 
pigment which stains the skin mainly on the lower medial third of the lower limb. This 
staining may slowly spread around the leg to cover the entire 'gaiter' area. The 
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pigmentation may get darker and eventually look almost black (Browse and Burnand, 
1988). 
Lipodennatosclerosis 
Lipodermatosclerosis (LDS) has been described as the progressive fibrosis of the skin 
and subcutaneous tissues induced by chronic venous hypertension resulting in skin 
pigmentation and thickening and hardening of the skin and fat (Browse et al, 1983). 
LDS is characterised by skin induration and hyperpigmentation of the legs that often 
occurs in patients with chronic venous insufficiency. One study showed that 88% of 
ulcers and liposclerotic skin changes were located in the gaiter area of which 76% were 
on the medial side (Callam et al, 1992). Although it has not been demonstrated that all 
patients with LDS have venous insufficiency, most authors agree that LDS appears to be 
highly associated with or restricted to the legs of patients with chronic venous 
insufficiency. LDS is thought to consist of an acute inflammatory stage followed by a 
chronic stage characterised by extensive fibrosis or sclerosis. The acute phase of LDS 
has the clinical features of pain and discomfort in the leg above the medial malleolus. 
The area is erythematous, scaling, tender and warm. At this stage, some induration is 
already present though the sharp demarcation of hardness noted in chronic LDS is 
usually absent (Kirsner et al, 1993). 
In chronic LDS, the skin is stiff and shiny and fixed to the hard indurated contracting 
subcutaneous tissues with a palpable edge and the skin appears brown and shiny. The 
leg appears to look like an inverted 'champagne bottle' due to the oedema of the calf 
above and the progressive contraction of the skin and subcutaneous tissues which results 
in shrinkage of the gaiter area. 
1.9.4 Pathophysiology of venous ulceration 
The physiologic abnormalities accompanying the microcirculatory changes in chronic 
venous insufficiency are not well defined. There are three prominent theories that have 
been put forward to explain the steps that are involved in the development of a venous 
ulcer and are described below. 
Arteriovenousfistulas 
This is the oldest microcirculatory theory of venous ulceration which suggests that small 
arteriovenous fistulas transn-ýt arterial pressure to the venous circulation with resulting 
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increases in vascular permeability that ultimately lead to abnormalities of oxygen and 
nutrient delivery to the skin. 
However, studies using radio-labelled albumin to measure shunt volumes in lower 
extremities of patients with primary varicose veins versus controls showed no detectable 
differences between the two groups (Lindemayer et al, 1972). 
Currently, modem data do not support this theory as a cause of venous ulceration. 
Fibrin cuff theory 
It was proposed that the increased pericapillary fibrin cuffs that surround perimalleolar 
cutaneous capillaries in chronic venous insufficiency patients prevent adequate diffusion 
of oxygen and other nutrients into the surrounding tissues. This is the fibrin cuff theory 
of venous ulcer pathogenesis proposed by Browse and Burnand (Browse et al, 1982). 
They speculated that venous hypertension led to widening of endothelial gap junctions 
with subsequent extravasation of fibrinogen leading to the development of fibrin cuffs 
which then act as a barrier to oxygen diffusion and nutrient blood flow and cause 
epidermal cell death. 
White cell trapping theory 
This is the most recent theory concerning the pathogenesis of venous ulceration and it 
focuses on the adverse effects of white blood cells trapped within the skin 
microcirculation. Subsequent observations of decreased circulating leukocytes in blood 
samples obtained from the long saphenous veins in patients with chronic venous 
insufficiency led Coleridge Smith et al to propose the white cell trapping theory 
(Coleridge Smith et al, 1988). This theory states that circulating neutrophils are trapped 
in the venous microcirculation secondary to venous hypertension. The subsequent 
sluggish capillary blood flow leads to neutrophil activation. Neutrophil activation leads 
to degranulation of toxic metabolites with subsequent endothelial cell and skin damage. 
There are now proposed treatment strategies based on presumed activation of proteolytic 
enzymes released by entrapped white cells. 
1.10 Summary 
Chronic venous disease of the lower limbs has been shown to be a major problem in the 
western world with severe economic consequences. Its clinical sequelae range from 
oedema, haemosiderosis and pigmentation, to gross lipodermatosclerosis and venous 
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A biomechanical hypothesis 
In the early 1970s, Chant et al carried out a series of experiments in which the clearance 
of subcutaneously injected sodium-24 was measured. It was found that there was an 
almost perfect inverse relation between sodium-24 clearance and changes in venous 
pressure with posture. 
Tanner et al in 1989 investigated the hyperaemic response following 3 minutes of 
ischaernia in the microcirculation in patients with venous leg ulcers using laser Doppler 
fluxmetry. They concluded that there was a reduced hyperaernic response in patients 
with venous ulcers, possibly as a result of oedema acting as a mechanical barrier to 
vasodilation. 
Chant postulated a mechanical cause for ulceration based on the elevated tissue pressure 
in a mechanically disadvantaged area, the gaiter area, of the lower limb (Chant et al, 
1990). He proposed two hypotheses, firstly, that the presence of oedema in patients with 
venous disease results in a rise in tissue pressure and this causes the postural changes in 
the circulation to be modified. Secondly, the raised vascular and tissue pressures in non- 
compliant areas, the gaiter area (high bone/soft tissue ratio) result in continuously high 
skin tension leading to ischaernia of the skin which then causes ulceration. High tissue 
pressure was seen as a prime determinant of postural responses as well as the prime 
factor in the initiation of venous ulceration. 
Biornechanical studies (Mourad et al, 1988) using an extensometer, on the skin of 
patients with venous ulceration and in patients with lymphoedema, showed that the 
characteristics of skin in lymphoedema differed markedly from controls and those with 
venous ulcers. Patients with chronic venous disease leading to leg ulceration have 
greatly reduced elasticity of their skin. Chant (1992) explains that a rise of pressure in 
the inelastic skin of patients with venous disease leads to a much greater increase in 
tissue tension than in patients with lymphoedema in whom the skin elasticity is not 
reduced. The increase in skin tension in patients with venous disease is the factor which 
leads to ischaernia of the skin leading to ulceration. 
This hypothesis explains why venous ulceration occurs in the ankle region, but not the 
biological events which lead to loss of skin compliance in patients with chronic venous 
disease. 
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ulceration with the gaiter area as the site most commonly affected in the lower limb. The 
extent and severity of the disease can be assessed by clinical and physiological methods 
described earlier. A vast majority of patients show a wide spectrum of skin changes of 
varying severity which precedes venous ulceration. 
At present, there is no standardised objective method of assessing the mechanical 
properties and degree of skin change in these patients, so that the response to treatment 
can be objectively monitored. 
1.11 Hypotheses 
" The development of lipodermatosclerosis precedes the appearance of venous ulcers 
in every case. This can be identified easily by clinical examination because of the 
changes in mechanical properties of the skin. The changes in the skin can be 
measured using a mechanical sensor in the form of a tissue tonometer. 
" Patients with the more severe forms of venous skin changes (LDS, ulceration) 
according to the CEAP classification have the greatest disturbances in tissue 
properties as demonstrated by tissue tonometry. 
" Patients with LDS when assessed clinically and divided into those more severely 
affected and less severely affected show corresponding measurements of tissue 
tonometry. 
" Treatment of patients using compression hosiery which is well known to be effective 
in the management of LDS. The effect of this type of management is measurable 
when assessed by tissue tonometry. 
" Ultrasound imaging of the skin and subcutaneous tissues in patients with venous 
disease reflects the same changes shown by tissue tonometry. 
" Duplex ultrasonography is widely used in the assessment of venous disease. Air 
plethysmography is required to achieve a quantitative assessment of the severity of 
the venous pump impairment in patients with venous disease. 
" The severity of the venous pump damage predicts the severity of the skin damage in 
particular patients, as reflected by tissue tonometry. 
1.12 Aims 
To standardise the calibration, repeatability and reproducibility of the methodology 
of the tissue tonometry measurements 
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" To investigate whether the tonometer can differentiate between the mechanical 
properties of the skin in normal controls and in patients with lower limb chronic 
venous disease. 
" To use an in vitro model, the sponge-in-glycerol model, to obtain displacement 
versus time curves so as to apply a simple visco-elastic mathematical model, the 
Kelvin-Hooke model, on the curves obtained to calculate the spring and dashpot 
constants to explain its mechanical behaviour. 
" To compare the clinical assessment of the severity of liposclerotic skin changes made 
by an experienced vascular surgeon using the CEAP method with the tissue 
tonometry parameters of skin compliance in patients with bilateral LDS. 
" To measure skin and subcutaneous layer thickness in control and patient groups with 
lower limb venous disease using a 7.5 MHz transducer and correlate this with 
displacement versus time curves obtained using the tissue tonometer. 
" To measure the effects of compression stocking treatment for 6 weeks on the 
mechanical properties of the skin of patients with lower limb chronic venous disease 
using a tissue tonometer and to compare this with limb volume changes after 
compression stocking wear. 
" To assess the inter-variability between examiners and the ease of use of the CEAP 
method of classification and scoring of lower limb venous disease. 
" To correlate duplex-derived parameters of lower limb venous reflux with air 
plethysmography measurements and the clinical severity of venous disease classified 
by the CEAP method with tissue tonometry. 
79 
"rt 
i, 
p 
I 
SECTION 11 
Protocols & Methodologies 
1% 
I 
80 
2.1 Protocol for quantifying lower limb venous reflux using duplex ultrasound 
scanning 
In this thesis, all colour duplex ultrasonic mode imaging, B-mode (brightness mode) 
imaging and spectral Doppler mode measurements were performed by me using the 
Acuson 128XP/lOv (Acuson, Mountain View, California, USA) computed sonography 
system with ART (acoustic response technology) using a 5- or 7.5- MHz linear array 
transducer. 
2.1.1 Methodology 
Patient preparation 
The ultrasound examination was done with the patient in the standing position so that 
the veins were under hydrostatic pressure, as in pathological conditions. The limb to be 
examined was externally rotated and completely relaxed and non-weight bearing with 
all the weight transferred to the contralateral limb. 
Venous segments that were as close to the gaiter area as possible without interfering 
with the cuff positioned on the calf were examined: the SFV in the distal thigh, distal 
popliteal vein segment, proximal PTV segments, LSV at knee level and proximal SSV 
segment. Measurements at the valve cusps were avoided due to the presence of turbulent 
flow and all measurements were carried out on segments just above or below the cusp. 
In the quantification of blood volume flow within a vein, the size of the pulsed Doppler 
gate insonated the entire vessel in order to account for all the blood cells which travel at 
different velocities with the slowest velocities present towards the vessel walls and the 
fastest present in the centre of the vessel (see figure 1.4.3.1). 
The method used below has been previously described by Bemmelen et al in the 
quantification of venous reflux (van Bernmelen et al, 1989). The long saphenous vein 
and superficial femoral vein were examined with the patient in the standing position and 
facing the examiner, with the leg to be examined slightly flexed and externally rotated 
with the body weight supported by the contralateral limb. The sapheno-popliteal 
junction, short saphenous vein and popliteal vein are examined with the patient standing 
and facing away from the examiner with the knee on the side being examined slightly 
flexed so as to relax the popliteal fossa and the weight distributed on the contralateral 
limb. A pneumatic calf cuff with a width of 12cm that could be rapidly inflated and 
deflated automatically to a pressure of 120mmHg was placed around the calf and used to 
induce reverse flow. A standardised measuring method was adopted throughout in all 
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the vein segments examined after augmentation of blood flow by the standardised cuff 
inflation method in the calf. A standardised rapid cuff inflation and deflation unit 
constructed by the author (Middlesex Hospital Vascular Laboratory, 1995) with a calf 
cuff width of 12cm was used to augment flow in the vessels (see section 2.7). The cuffs 
were inflated for approximately 3 seconds with the deflation requiring only 0.3seconds. 
Initially a B-mode cross-sectional 2D image of the vein segment of interest was 
obtained after insonation of the vessel with plenty of scanning gel applied between the 
transducer and the skin to avoid distortion of the underlying superficial vessels that may 
be compressed with the transducer. The system software cursors were positioned to 
measure the vessel diameter. A longitudinal B-mode image of the same vessel at the 
same site as the diameter measurement is used to obtain a frozen spectral Doppler 
display of flow in the vessel after calf compression and release to demonstrate both the 
antegrade and retrograde flow. 
2.1.2 Data Analysis 
To calculate reflux or retrograde volume bloodflOw 
The formula used to calculate the reflux volume blood flow is 
TAV x area x AT 
where, Q= reflux volume flow (ml), TAV = time averaged velocity (metres / sec), Area 
= cross-sectional area (mm2) at the Doppler sample gate and AT =a multiplier to 
express flow within the duration of reflux (seconds). 
The formulae (702/4 or 7cr2) where D is the cross-sectional diameter of the vein in mm. 
obtained from the B-mode 2D imaging mode and r is the radius of the vein in mm. is 
used to calculate the cross-sectional area of the vein and the TAV and AT can be 
calculated from the axial Doppler reflux velocity waveforms on the frozen spectral 
Doppler strip as described earlier. 
To calculate the peak efflux and peak reflux velocity ratio 
From the frozen spectral Doppler strip, the peak efflux or antegrade flow velocity is 
measured by placing a single calliper marker to measure the angle corrected velocity 
parameter of the Doppler signal at that specific point in time. The same is repeated to 
measure the peak reflux or retrograde flow velocity (see figures 2.1.1 and 2.1.2). The 
peak efflux and peak reflux velocity ratio is calculated by dividing the peak efflux 
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form. 
Figure 2.1.2 Spectral Doppler analysis used to calculate the peak 
reflux velocity by placing a cursor at the highest point of the retrograde 
waveform. 
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Figure 2.1.1 Spcctral Dopplcr aiialýsis used to calculatc the peak CI-Ilux 
velocity by placing a cursor at the highest point of the antegrade wavc- 
velocity value by the peak reflux velocity value (Pk efflux vel (m/s) / Pk reflux vel 
(m/s)). 
To calculate the time parameters and TAVparameter 
The time parameters and TAV measurements are calculated by the ACUSON 128 
system computer software. The duration of the efflux flow and reflux flow in seconds 
can also be obtained by placing the calliper markers at the start and end of the 
waveform. The efflux and reflux time ratio is calculated by dividing the efflux time 
value by the reflux time value (efflux time (secs) / reflux time (secs)). 
The valve closing times, VCT, which is the reflux time parameter calculated from the 
spectral Doppler trace, were calculated for all the incompetent vein segments and added 
up to give the total valve closing times, tVCT, in seconds, for each patient. The relevant 
segments of veins in the normal controls were measured for comparison. 
To calculate area measurements 
The area measurements in cm2 of the efflux flow and reflux flow are traced with a sonic 
digitiser pen (Science Accessories Corporation model GP-7) on the frozen spectral 
Doppler display to calculate the reflux index ( efflux area (cm 2) / reflux area (CM2) 
The Doppler Efficiency Index (EI d) is calculated as follows: 
EI d= AA - AR x 100 
AA 
where AA represents the area of the efflux or antegrade flow and AR represents the area 
of the reflux or retrograde flow (figure 2.1.3). 
Measuring height, weight, Body Mass Index and Body Sur fiace Area. 
The heights and weights of the subjects were measured using a tape measure and a 
weighing scale. 
The body mass index (Kg/m2) which is (weight (Kg)/ heighO (m)) and the body surface 
area (m2) which is calculated by the ACUSON 128 system were recorded for each 
subject. 
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Area of antegrade flow ( 
Doppler baseline 
Figure 2.1.3 Schematic diagram of a spectral Doppler trace obtained after flow 
augmentation in a vein. The area of antegrade flow (efflux) after compression of 
the calf muscles indicated by the blue shaded area which has been traced over using 
a digitiser pen and the area of retrograde flow (reflux) after release of the calf 
muscles indicated by the red shaded area (reflux) which has also been traced over 
to give an area measurement. The areas measured above and below the Doppler 
baseline are used to calculate the ratio of efflux and reflux flow to get the reflux 
index. 
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Area of retrograde flow (reflux) 
2.2 Protocol for air plethysmography measurements of venous function and 
arterial perfusion. 
The air plethysmograph used throughout in this thesis is the APG-1000C (ACI Medical 
inc., Sun Valley, California). It is fully computerised with all data analysis performed on 
the computer screen by means of cursors with a thorough and easy guide on where and 
how to position the cursors for calculation of the parameters (APGO Air- 
Plethysmograph, Models APG-IOOOC and APG-IOOOCP, Instruction and Service 
Manual, Version 2.11). 
Methodology 
Patient preparation 
The subject was prepared in the same way for all the parameters to be measured with 
calibration performed prior to the start of each parameter and in the order described 
below. The lower limb sensing cuff comes in two sizes, a 14 inch cuff and a 12 inch 
cuff. The largest sensing cuff that would fit the subject's leg but not interfere with the 
foam block or the back of the most distal thigh with the leg slightly bent was selected. 
When applying the sensing cuff to the calf, the zipper was located on the anterior 
surface. The tubing that leads from the cuff to the main control unit were taped to the 
thigh. The subject's arms were placed by their sides and not rested on the abdomen to 
avoid pressure on the abdominal veins. 
The subjects lay on the examination table with the heel of the limb to be examined 
elevated on a foam support, 15cm high, with the leg externally rotated and the knee 
slightly bent. In this thesis, I have standardised the knee bend by using a boomerang 
(Wagga Wagga, Australia) with a fixed 145 degree angle in all the subjects by placing 
the boomerang behind the knee during subject preparation to get a standardised knee- 
bend angle. After setting the 'bias pressure' to 6 mmHg and ensuring that the calibration 
syringe was completely withdrawn, the sensing cuff, in position as described above, was 
inflated to the selected pressure which was actively maintained by the internal pump or 
bleed-off valve as necessary. For all air plethysmography tests performed in this thesis a 
10 minute stabilisation period was allowed for each subject to ensure temperature 
equilibration prior to calibration and all the tests were performed at the same time of day 
(between 14.00 and 15.00 hours) for all subjects. The machine was re-calibrated prior to 
each measurement made in every subject. Steps were also taken to ensure that the 
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subject being examined was not in direct sunlight or near a radiator to prevent false high 
readings in cuff pressure as a result of thermal heating of the air in the sensing cuff. 
Calibration 
Calibration was performed in two parts. Firstly, the calibration syringe was pulled out to 
its stop position with the sensing cuff at a stabilised bias pressure of 6 mmHg on the 
subject and the pressure saved. One hundred ml of air was slowly injected into the cuff 
from the calibration syringe and after allowing 5 seconds for the pressure to reach a 
steady state it was saved to store the cuff pressure. The calibration syringe was then 
withdrawn back to its 100 ml mark and the calibration signals sent to the computer. 
Calibration must be performed whenever the sensing cuff is applied to a limb and for 
studies done in this thesis, calibration was performed prior to each parameter 
measurement. The methodology for all the APG parameters recorded are described 
below in the order performed: outflow fraction; resting arterial inflow; venous filling 
index; ejection fraction and residual fraction. This is shown diagramatically with the 
typical traces obtained in figure 2.2.1. 
2.2.1 Methodologyfor Outflow Fraction (OF) testingfor chronic obstruction 
When performing outflow studies, the thigh occlusion cuff (10 cm wide) was applied as 
far proximally as possible with the rapid deflation device attached to the cuff and the 
inflation bulb. With the subject properly prepared and the system calibrated as described 
above, the thigh cuff was inflated to 70 mmHg and the veins allowed to fill completely 
by observing the volume indicator on the screen. After applying finger pressure to the 
long saphenous vein or any other visible thigh veins, which were identified with duplex 
scanning, the cuff was rapidly deflated to drop the thigh cuff pressure. This would result 
in a decrease in calf volume as blood exits past the thigh cuff. If the outflow fraction 
calculated as described below, is greater than 35% then a second outflow test without 
superficial venous occlusion is not necessary. 
Data analysis 
Analysis of the outflow tests are carried out by the computer's software by placing the 
cursors as described in the figure 2.2.2. 
The outflow fraction (OF) was calculated by the formula: 
OF (%) = (VINQ x loo 
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Thigh cuff deflated 
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released 
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Figure 2.2.2 Measurement of outflow fraction. The thigh cuff is inflated 
to allow veins to fill and with the superficial veins occluded the thigh cuffs 
are then deflated. The 1 second outflow is measured. 
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Figure 2.2.3 Measurement of arterial inflow (AI). The knee 
tourniquet is inflated and the slope of the line is the arterial inflow 
rate in ml/min. 
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where, (V I) is the volume of blood that exits the calf in the first second and (VC) is the 
venous capacitance. 
2.2.2 Methodologyfor Arterial inflow (AI) measurement 
The subject was prepared as described in section 2.2. The 10cm cuff was placed just 
above the knee ensuring that it was not interfering with the sensing cuff. The rapid 
deflation device was attached to the cuff and to the inflation bulb. After calibration, the 
above knee cuff was rapidly inflated to 70 mmHg which resulted in an initial steep 
volume increase followed by a less steep but mostly linear volume increase. The initial 
steep rise is an artefact that arises as a result of inflation of the cuff and the measurement 
starts after this artefact on the linear portion of the trace for 25 seconds. The arterial 
inflow (AI) was calculated by the system's software in ml/minute by the following 
formula: 
Al =3x ml increase in 20 seconds. 
Data analysis 
Analysis of the outflow tests were carried out by the computer's software in mls/minute 
by placing the cursors as described in figure 2.2.3. 
2.2.3 Methodologyfor Venous reflux testing (Venous Filling Index) 
The subject was prepared and the system calibrated as described in section 2.2. The limb 
to be examined was elevated to a 45 degree angle by holding the heel of the foot and 
avoiding touching the sensing cuff. The subject was instructed to keep the knee slightly 
bent and to allow the full weight of their leg to be supported by the examiner. 
The recording was started and the trace observed as it dropped to a baseline. At this 
point, the calf had reached its zero functional venous volume as the blood was drained 
towards the heart. The subject was guided off the examination couch slowly whilst 
ensuring that the sensing cuff was not touched at any time. The subject was asked to 
stand still with no weight on the test limb that had the sensing cuff and with both feet 
side by side. Weight must be supported by the untested limb with the subject 
maintaining balance by holding onto the walker support. An increase in volume would 
be observed on the screen and when this volume had reached a plateau by observing 
both the trace and the volume indicator on the screen, the recording was stopped to give 
the maximum venous volume. 
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Data analysis 
To calculate the venous filling index (VFI), the zero point which is the lowest point just 
as the trace starts to rise and is zero for volume and for the time of the start of the 
increase in the calf volume from standing up was selected on the screen. The maximum 
venous volume was also selected and is the point when the veins had completely filled 
after standing up. The VFI is calculated by the system's software in ml/sec by the 
formula, as shown in figure 2.2.1: 
VFI = 90%VVNFT90 
This increase represented the functional venous volume (VV) volume which is a result 
of filling of the veins as the subject moved from the supine to the upright position due to 
arterial inflow and venous reflux if present. The time taken to reach 90% of filling was 
defined as the venous filling time 90 (VFT90). 
2.2.4 Methodologyfor Calf muscle pump testingfor Ejection Fraction (EF) 
Immediately following the VFI test for reflux and with the subject remaining standing 
with no weight on the tested limb and the veins filled to their maximum venous volume, 
the EF test was selected on the screen and the subject asked to perform one tip-toe 
movement following these strict guidelines. Full body weight was placed equally on 
both legs side by side and the subject asked to go up on tip toes as high as possible and 
hold for about two to three seconds and then to return to the standing position with the 
weight supported equally by both legs. Then the subject was asked to return to the initial 
position with no weight on the tested leg and the knee slightly bent with both feet side 
by side. The result of calf muscle contraction compressing the deep veins will appear as 
a decrease in volume on the trace. After the veins had refilled, the subject was asked to 
repeat the single tip-toe movement. This procedure was repeated until the subject 
understood the exercise and repeatable calf ejections were produced. The recording was 
then stopped and the trace that represented the subject's best effort was used for 
analysis. 
Data analysis 
To calculate the ejection fraction (EF) the lowest point of the ejected curve and the refill 
volume was selected on the computer screen and the traces analysed by the system's 
software to calculate the ejection fraction. 
91 
The % ejection fraction (EF) was calculated by the forinula as shown in figure 2.2.1: 
EFM = (EV / VV) x 100 
where, EV is the ejected volume and VV is the venous volume found in the VFI (reflux) 
test. 
2.2.5 Methodologyfor Residual Volume Fraction (RVF) testing 
After completing the ejection fraction test with the subject standing with no weight on 
the tested limb and with the veins full and a volume plateau reached, the RVF test 
procedure can be started. This time, the subject was asked to perform ten tip-toe 
movements approximately one per second following the same protocol described above 
for the EF test. After this exercise, the subject allowed the veins to refill by standing 
again without weight on the tested limb. Once refilled, the subject was asked to return to 
the examination table and elevate the limb to approximately 45 degrees. The subject was 
reminded that the knee should be kept slightly bent and that the full weight of the limb 
be supported by the examiner's hand placed under the heel. Care was taken for the 
sensing cuff not to be touched at any time during the manoeuvres. When the trace 
reached a new baseline representing venous emptying, the recording was stopped. 
Data analysis 
The RVF test was analysed by selecting the lowest tip-toe point and the ending baseline 
and the traces are analysed by the system's software to calculate the residual volume 
fraction. It was calculated from the formula as shown in figure 2.2.1: 
RVF (%) = (RV/VV) x 100 
where RV is the residual volume and VV is the venous volume. 
An important point to remember while calculating the RVF is the ending baseline. The 
difference between the beginning baseline at the start of the VFI test and the ending 
baseline in the RVF test should be less than 20%. If they were significantly different 
(20% or more), the beginning baseline should be used as the ending baseline. 
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2.3 Protocol for Venous reflux test by photoplethysmography (ppg). 
The model PPG13 Vasculabo Photoplethysmograph (PPG) (Medasonics, Mountain 
View, California) was used in this thesis. It serves as a preamplifier and power supply 
and was used with the model PH77 PHOTOPULSEO photoplethysmograph sensor 
Methodology 
The subject was examined in the sitting position with the lower limbs dependent and 
with the transducers attached using a double-sided tape 5cm proximal to the medial 
malleolus. A stable trace was established, and the subject was asked to perform a series 
of 10 dorsiflexions and plantarflexions at the ankle to activate the calf muscle pump. 
This produced an emptying phase in which the falling content of haernoglobin resulted 
in increased amounts of light reaching the photodetector. The subject was then asked to 
rest and the refilling phase recorded. If the test showed an abnormal response, a 
tourniquet cuff (5 cm dia) was placed above the knee and inflated to about 80- 
1 10mm. Hg (depending on the size of the thigh) to occlude the superficial veins in the 
thigh and the test repeated as described above. If the test still showed an abnormal 
response, it is repeated with below knee cuffs inflated to 40-60 mmHg to occlude the 
calf veins. 
Data Analysis 
The time taken for the trace to return to the baseline level was referred to as the PPG 
refilling time. It was measured by placing the start cursor at the end of the exercise 
phase and the end cursor at the end of the refilling phase where the trace started to level 
off. In normal subjects, this refilling time is greater than 20 seconds (figure 2.3.1) 
whereas abnormal subjects with incompetent veins will have refilling times of less than 
20 seconds (figure 2.3.2). 
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(arbitrary 
5 second interval 
Time (seconds) 
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Figure 2.3.1 Normal PPG trace with the refilling times (the start 
and finish times shown by the red stars) lasting longer than 20 
seconds during the recovery period (yellow-shaded area) after 
exercise by dorsiflexions of the ankles (green-shaded area). 
Limb volu 
(arbitrary 
Time (seconds) 
Figure 2.3.2 Abnormal PPG trace with the refilling times (the 
start and finish times shown by the red stars) lasting less than 20 
seconds during the recovery period (yellow-shaded area) after 
exercise by dorsiflexions of the ankles (green-shaded area). 
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5 second interval 
2.4 Protocol for measuring resting ankle brachial pressure indices (ABPI). 
Subject preparation 
The subject is examined in the supine position after lying relaxed in a comfortable 
ambient temperature room for 10 minutes. 
Measuring ann pressures 
A standard 12 inch sphygmomanometer cuff, or other suitable cuff (depending on size 
of limb) was placed around the arm just above the elbow. The brachial pulse was 
located with a hand-held bi-directional Doppler (Dopplexe, Huntleigh Healthcare) by 
positioning the 8MHz probe over the brachial pulse after applying gel and holding and 
manoeuvring the Doppler probe at a 45 degree angle between the forefinger and thumb 
until a good Doppler signal is obtained. The cuff was inflated until the Doppler signal 
disappeared and slowly deflated until the signal returned. The pressure at that point was 
noted as the brachial, systolic pressure. The same procedure was repeated in the other 
arm. 
Measuring ankle pressures 
The sphygmomanometer cuff was placed around the leg just above the ankle and 
using the Doppler probe as described above, either the dorsalis pedis artery or posterior 
tibial artery pulse was located. The cuff was inflated until the Doppler signal 
disappeared and slowly deflated until it returned. The pressure at this point was noted as 
the ankle systolic pressure. Both pedal ankle systolic pressures were measured and 
recorded. 
Data Analysis 
To calculate the ankle brachial pressure index (ABPI), the ankle systolic pressure 
reading was divided by the brachial systolic pressure using the higher of the brachial 
pressures and the higher of the ankle systolic pressures in the calculation. 
Normal ankle brachial pressure index is equal to or greater than 0.90. 
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2.5 Protocol for using the calibrated stand for site reproducibility 
A specially designed calibrated stand by the author was used in site reproducibility for 
sequential measurements using tissue tonometry (section 2.8) and in the indirect method 
of measuring limb volume by the disc model method (see section 2.6) 
It consisted of a calibrated column on a tripod stand which was fixed with a moveable 
disc and a marker pen attached that can be moved up and down the column and can be 
clamped on the calibrated column at a selected height (figure 2.5.1). 
Subject preparation 
The subject was investigated bare-footed on a flat surface with the marker pen 
positioned and parallel to the flat surface, checked with a spirit level, and pointing to 
the selected site of the lower limb 
For subsequent visits, the reference points noted from the calibrated column, that is, the 
height of the marker and the positioning of the heel and toes in relation to the legs of the 
tripod, were used to re-locate the same sites previously used on the medial and lateral 
aspects of the subject's limb. 
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Calibrated stand 
Marker pen 
Moveable penholder 
Legs of tripod 
Figure 2.5.1 Schematic diagram of the stand with a fixed calibrated 
column and a moveable attachment with a pen holder that can be fixed to 
the calibrated column. The legs of the tripod can be used as markers to the 
body landmarks such as the heel and big toe to ensure site reproducibility 
on sequential visits. 
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2.6 Protocol for the indirect method of quantification of lower limb volume 
The disc model method (Kaulesar-Sukul et al, 1993) was used to quantify the lower 
limb volume using a non-stretch tape measure and a calibrated stand designed by the 
author in section 2.5). 
Patient preparation 
The subject was investigated bare-footed on a flat surface with the calibrated stand and 
fixed marker pen which is parallel to the flat surface, checked with a spirit level, and 
pointing to the medial aspect of the lower limb. 
Disc model method 
The starting height corresponding to just above the medial malleolus was noted on the 
calibrated column. A mark was then placed on the skin. The calibrated stand was then 
moved to the lateral aspect of the limb and a mark placed on the medial aspect at the 
same height. A non-stretch tape measure was used to measure the circumference of the 
disc by ensuring that the tape measure goes around the disc over both markers on the 
medial and lateral sides of the limb to avoid potential errors encountered like slipping 
when using a tape measure. The circumference of the disc was measured 3 times and an 
average value taken. In patients with varicose veins in the calf region, extreme care was 
taken with the tape measure to contour it around the calf so as not to compress the veins. 
The disc with marker attached was moved up the column by 3cm and the same repeated 
until all 10 discs had been marked for the Disc model method. 
The volume of the limb was the sum total of the circumference of all the individual 
discs. For subsequent visits, the reference points noted from the calibrated column, that 
is, the height of the marker and the positioning of the heel and toes in relation to the legs 
of the tripod, were used to re-locate the same sites previously used on the medial and 
lateral aspects of the subject's limb. 
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2.7 Rapid inflation and deflation device 
The rapid inflation and deflation cuff device was constructed by the author in our 
laboratory and is shown diagramatically below (figure 2.7.1). 
It consisted of two solenoid valves, one connected to a compressor (JAVAC pump, 
JAVAC, U. K. Ltd. ) which pumped air into the valve and a pressure manometer to 
monitor the pressure in the chamber. By means of a foot switch (Dewnaswitch, 
Skelmersdale, Lancs. ) the air was allowed into the cuff through one of the solenoid 
valves and then rapidly deflated within 0.3 seconds by pressing the foot switch which 
allowed the air to leave rapidly through the other solenoid valve. The pressure in the cuff 
was monitored by a pressure manometer. The cuffs were inflated for approximately 3 
seconds with the deflation requiring only 0.3 seconds. 
3 -way tap m Pu p 
Sphygmomanometer 
Air 
2 way switch 
Wide bore tubing 
Solenoid valves 
Limb 0 
Calf cuff 
Foot smvitch 0 
Figure 2.7.1. Schematic diagram of the rapid cuff inflation and cuff deflation device. 
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2.8 Protocol of calibration, reproducibility and methodology of tissue 
tonometry. 
Calibration of the tissue tonometer 
The tonometer was calibrated prior to and after each measurement. The calibration was 
performed by resting the tonometer on a level surface. A spirit level was placed on the 
casing that houses the sensing device to ensure that the cantilever bar was parallel to the 
level surface after both supports have been adjusted for height. The plunger with the 
selected weight attached was released unto a metal block of known thickness by means 
of the cable release mechanism and the plunger was allowed to drop to the level surface 
after removal of the metal block. The deflection on the screen was equivalent to the 
thickness of the metal block, and was used to calibrate subsequent measurements. A 
3.3mm. thick metal block, measured by a micrometer, was used in all studies. 
Calibration check 
The tonometer's calibration was checked using 4 brass discs of different thickness as 
measured by micrometer before and after 6 hours of recording on a 25% glycerol soaked 
sponge tissue (natural sponge cell, Boots p1c). The calibration was performed by resting 
the tonometer on a level surface as described above. The 4mm diameter plunger with the 
selected 30g weight attached was released unto the brass disc of known thickness by 
means of the cable release mechanism and the plunger was allowed to drop to the level 
surface after removal of the disc. The deflection on the screen was equivalent to the 
thickness of the disc. The same procedure was repeated on the remaining three brass 
discs of varying thickness. The different thickness of the brass discs used as measured 
by a micrometer were 1.8mm, 2.6mm,, 3.3mm and 5.6mm. Tonometry recordings on a 
25% glycerol soaked sponge was performed for 6 hours and the calibration check 
repeated as described above. 
Calibration reproducibility 
A calibration reproducibility check was done before and after measurements to ensure 
that there was no significant drift in signal output between measurements. 
The tonometer was calibrated before and after 5 minutes of recording on compression 
sponges soaked in 25% and 50% of glycerol diluted with water. A 4mm. diameter 
plunger and a 30g weight attached was used in all the measurements. Thirty recordings 
were made on different sponges with fifteen sponges soaked in 25% glycerol and the 
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other fifteen sponges soaked in 50% glycerol. The measurements were made on two 
separate days with the gain altered on the second set of measurements (50% glycerol). 
This was to check whether altering the gain would affect the reproducibility of the 
calibration. 
Patient methodology 
Reproducibility of tissue tonometry sites 
In all the tissue tonometry measurements performed to measure the mechanical 
properties of the skin, three different sites were measured on the medial aspect of the 
gaiter area to obtain a mean value. To ensure that identical sites were measured on the 
contralateral limb and in sequential measurements, a specially calibrated stand with a 
fixed marker pen, designed by the author, was used (see section 2.5). The subject was 
marked in the standing position and bare-footed on a flat surface, with the marker pen 
positioned, and parallel to the flat surface, checked with a spirit level, and pointing to 
the medial aspect of the lower limb. The first site was located 6cm above the medial 
malleolus, the second site was located 10cm above the medial malleolus and the third 
site was located 12cm above the medial malleolus. The starting height was noted on the 
calibrated column and the positioning of the small toe and the heel in relation to the legs 
of the tripod stand was also noted for future reference. A mark was then placed on the 
skin. For subsequent visits, the reference points noted from the calibrated column, that 
is, the height of the marker and the positioning of the heel and toes in relation to the legs 
of the tripod, was used to re-locate the same sites previously used (that is, same median 
line and same height above the medial malleolus) on the medial aspects of the subject's 
limb. With the three identical sites marked in both lower limbs using the reference 
points obtained from the calibrated stand, the subjects were then examined by tissue 
tonometry. 
Tissue tonometry 
All subjects were examined in the supine position with the test limb externally rotated 
and the knee slightly flexed so that the tissue tonometer could rest on the gaiter area as 
shown in figures 1.5.4,1.5.5 and 1.5.6. After calibration, the tissue tonometer was 
positioned on the gaiter area of the lower extremity by contouring one end, the fixed 
contoured end, around the calf and the other end, which can be adjusted, resting on the 
medial malleolus or other suitable location. To improve equipment stability during 
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measurements, a Velcro cuff was placed around the calf so that the contoured end of the 
tonometer would rest on it to prevent it from sliding or falling off. The 4 mm dia 
plunger with the selected weight of 30g attached was positioned just above the skin area 
marked previously with the specially designed calibrated stand without causing any 
indentation. 
The tonometer was allowed to stabilise on the subject's lower limb for 5 minutes to 
ensure that the ends of the tonometer would have settled on the leg with no further 
sinking into the tissues especially in cases of patients with oedematous ankles. 
The 30g weight was released by means of a cable release mechanism and allowed to 
sink into the skin under gravity. The movement of the plunger was recorded for 5 
minutes. After 5 minutes, the weight was released from the skin and the tonometer is re- 
calibrated. After re-calibrating the tonometer and allowing for the 5 minute stabilising 
period, the same procedure was repeated on the next selected site until all six sites have 
been recorded. The tonometer was re-calibrated after each measurement and if there was 
a significant difference between the pre- and post-calibration figures, the measurement 
was repeated. 
Selection of attached weight and plunger diameter 
Measurements were carried out on one site, located 10cm above the medial malleolus, 
on the medial aspect of the gaiter area of the lower limb of a normal control subject 
(CEAP classification, CO) using different diameters of plungers and different weights 
attached. 
The plunger with the selected diameter and the selected weight attached was positioned 
just above the area of skin of interest. After calibration, the weight was released and 
allowed to sink into the skin under gravity. The movement of the plunger was recorded 
for 5 minutes. The same procedure was repeated, allowing 120 minutes between 
measurements to allow the skin to return to its initial state, until all the different plunger 
diameters and attached weights listed below had been applied. The tonometer was 
calibrated prior to each measurement. The displacement versus time traces obtained 
were analysed using the computer software to calculate the distance and rate constant 
parameters in all three phases. 
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Data Analysis 
The distance and rate constant parameters were calculated by using the specially written 
software as described in section 1.5.2. 
The spring and dashpot constants were calculated from the Kelvin-Hooke model as 
described in section 1.5.3. 
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2.9 Protocol of cutaneous ultrasound measurement of skin and subcutaneous 
layer thickness. 
The subject was examined in the supine position with the limb externally rotated. 
A stand off pad, lcm thick, was placed between the transducer and skin to avoid 
exerting pressure on the area of skin being examined. 
A 7.5 MHz linear array transducer was used and held vertically to the skin surface at 90 
degrees to obtain a B-mode image. 
For correlation between the sonogram. and tonometry readings, it was essential to mark 
the site of interest as both measurements were performed in exactly the same areas 
(Hoffmann et al, 1995 book). The mid-point level of the B-mode image obtained from 
the ultrasound machine on the medial aspect of the gaiter area was marked with a 
marker pen and the same site was used for the tissue tonometry measurement. The B- 
mode image obtained was analysed using the duplex scanner system's software by 
placing the cursors as shown in figure 2.9.1. 
104 
thickness. 
Figure 2.9.1 B modc im, q2c ý\ ith oian, -, c k)\ ci I. i\ to hiý21ihý: ht the 
with CLIFSors placed to measure skin thickness and subcutaneous layer 
2.10 Modification of the CEAP clinical method of classification 
In this thesis, I have standardised a new method of assessing the skin changes in patients 
with lower limb chronic venous disease. Preliminary studies with the tissue tonometer 
carried out on these patients during the initial stages of the thesis showed that there was 
a significant difference in the skin hardness between the group C4 patients with 
pigmentation alone and no palpable evidence of induration as compared to other group 
C4 patients with liposclerotic skin changes with palpable induration (see section 3.1; 
Study 1). The difference was as much as three hundred percent which made it necessary 
to distinguish between these patients as the skin hardness measurement for the group C4, 
which does not differentiate between the two, would have been diluted to give a much 
lower value when compared to groups C5 and C6 which have palpable evidence of 
induration. The group C4 patients were then subdivided into C4a and CO to differentiate 
between the skin hardness in the two groups as shown below and this was adapted 
throughout in this thesis, with the exception of Section 3.7; Study VU, that assessed the 
ease of use of the CEAP classification in its original format. 
Therefore, the only change made to the CEAP method of classification and scoring of 
lower limb venous disease for use in this thesis was as a result of using tissue tonometry 
to analyse the mechanical properties of the skin in venous disease. The changes made 
are detailed in table 2.10.1 below: 
Class 0: No visible or palpable signs of venous disease. 
Class 1: Telangiectases or reticular veins. 
Class 2: Varicose veins. 
Class 3: Oedema. 
Class 4a: Skin changes ascribed to venous disease (e. g. pigmentation with no 
palpable induration or previous ulceration, venous eczema). 
Class 4b: Skin changes ascribed to venous disease (e. g. pigmentation with 
palpable induration and no previous ulceration). 
Class 5: Skin changes as in classes 4a or 4b with healed ulceration. 
Class 6: Skin changes as in classes 4a or 4b with active ulceration. 
Table 2.10.1. Modified clinical classification of lower limb chronic venous disease. 
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3.1 STUDYI 
Standardising of the calibration and measurement techniques of a newly developed 
tissue tonometer for use in analysing the mechanical properties of skin changes in 
patients with lower limb chronic venous disease. 
3.1.1 Rationale 
The clinical sequelae of CVD of the lower limbs range from oedema, haemosiderosis 
and pigmentation, to lipodermatosclerosis (LDS) and venous ulceration. The severity of 
the induration or skin hardness is difficult to assess objectively. A number of studies 
have used measurements of the area of lipodermatosclerosis, but judging the edge of the 
lesion is often very difficult and leads to large variance in the data. Clinical assessment 
of lipodermatosclerosis is the most frequently used method, applying the clinical skin 
severity score index adapted from studies of patients with systemic sclerosis 
(scleroderma) by Kahaleh et al in 1986. This is very subjective and unsuitable for use as 
an outcome measure in clinical studies. A durometer has also been used to determine the 
degree of induration in LDS by Romanelli and Falanga (Romanelli et al, 1995). Previous 
attempts to objectively measure the degree of skin hardness in other conditions, 
particularly systemic sclerosis (scleroderma), have included skin biopsies (Rodnan et al, 
1979), skin elastometers (Bjeffing et al, 1985; Ballou et al 1990), ultrasonography 
(Myers et al, 1986), magnetic resonance imaging (Richards et al, 1991) and tcPo 2 
measurements (Silverstein et al, 1988). The disadvantages of the above methods are that 
they require expensive equipment or considerable experience and skin biopsies are 
invasive and are not practical for sequential measurements. At present, there is no 
standardised objective method of assessing the degree of skin changes seen in patients 
with lower limb chronic venous disease. A tissue tonometer has been developed in our 
laboratory for the objective assessment and quantification of the skin changes seen in 
these patients. A computerised tissue tonometer (see section 1.5.2 for details) was 
developed at our laboratory (UCL Hospitals, Middlesex Hospital Vascular laboratory, 
1995) to objectively assess the mechanical properties of the skin changes in the gaiter 
area of patients with lower limb chronic venous disease. 
3.1.2 Aims 
To standardise the calibration, repeatability and reproducibility of the tonometry 
measurements. 
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To investigate whether the tonometer can differentiate between the mechanical 
properties of the skin in normal controls and in patients with lower limb chronic venous 
disease. 
3.1.3 Methodolou 
3.1.3.1 Calibration check 
The tonometer's calibration was checked using 4 brass discs of different thickness as 
measured by micrometer before and after 6 hours of recording on a 25% glycerol soaked 
sponge tissue (natural sponge cell, Boots p1c) as described in section 2.8. 
3.1.3.2 Calibration reproducibility 
A calibration reproducibility check was done before and after 5 minutes of recording on 
compression sponges soaked in 25% and 50% of glycerol to ensure that there was no 
significant drift in signal output between measurements. Thirty recordings were made 
with fifteen sponges soaked in 25% glycerol and the other fifteen sponges soaked in 
50% glycerol. 
3.1.3.3 Subject preparation 
All subjects were examined in the supine position with the test limb externally rotated 
and the knee slightly flexed so that the tissue tonometer could rest on the gaiter area as 
described in section 2.8. Three different sites were measured in the gaiter area to obtain 
a mean value as described in section 2.8 at 6cm, 10cm and 12cm above the medial 
malleolus. If an open ulcer is present at the above sites, the nearest area of skin with no 
open wound is used and the location noted for measurements on sequential visits. 
Identical sites were measured on the contralateral limb using the specially calibrated 
stand with a fixed marker pen (see section 2.5). This procedure was repeated on the 
other limb using the same heights noted on the calibrated column and the same 
landmarks to ensure identical sites are marked. With three identical sites marked in both 
lower limbs, the subjects were then examined by tissue tonometry as described in 
section 2.8. 
3.1.3.4 Selection of attached weight and plunger diameter 
Measurements were carried out on the gaiter area of the lower limb of a normal control 
subject (CEAP classification, Co) using different diameters of plungers and different 
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weights attached as described in section 2.8 to see the differences between the pre- 
selected weight and plunger diameter and other weights and diameters. The 
displacement versus time traces obtained were analysed using the computer software to 
calculate the distance and rate constant parameters in all three phases. 
3.1.3.5 Reproducibility and repeatability studies in nonnal controls and patient groups 
Reproducibility studies using the tissue tonometer were carried out on normal controls 
and in patients with lower limb chronic venous disease to assess the reproducibility of 
the parameters measured. 
Repeatability studies on one normal control was also performed. 
Five normal controls (2M: 3F; mean age of 31 years; range: 24-36 years) with no 
evidence of lower limb venous disease and three patients with lower limb chronic 
venous disease (IM: 2F; mean age of 65 years; range 60-71 years) were investigated by 
tissue tonometry. Measurements of skin compliance were made on three consecutive 
days at the same time of day and on the same site, marked with a permanent black 
marker pen. The corresponding sites were measured on all the subjects and the site 
location was reproduced using the specially designed calibrated column stand and an 
indelible marker pen. 
Same day repeatability studies were done on one normal control subject (female; age 29 
years) with the same tissue tonometry site used and measured four times at 120 minute 
intervals with the subject instructed to carry on with her normal daily activities between 
measurements. 
3.1.3.6. To differentiate between nonnal controls andpatient groups with significant 
lower limb chronic venous disease by tissue tonometry. 
Eighty six limbs of 69 patients (35F: 34M; mean age of 62 years; range: 28-90 years) and 
42 limbs of 37 normal controls (14F: 23M; mean age of 42 years; range: 20-90 years) 
attending the vascular laboratory for full non-invasive venous assessments were 
investigated and the presence or absence of venous disease was confirmed by duplex 
ultrasonography. Resting ankle brachial pressure indices (ABPI) were also measured to 
eliminate any arterial component. 
Differences in the tissue tonometry parameters between the young and old normal 
control groups (n 42 limbs) were also investigated - twenty one limbs of the Co group 
with a mean age of 28 years and 21 limbs with a mean age of 55 years. Patients were 
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assigned to one of three clinical groups by the author based on the CEAP method of 
classification: normal controls were assigned Co- no visible or palpable signs of venous 
disease, C3-oedema, C4-Pigmentation and lipodermatosclerosis. The C4 group was sub- 
divided into C4a - pigmentation alone without palpable induration and C4b - skin changes 
with palpable induration (see section 2.10 for details). 
The patients in this study were deliberately selected with extreme clinical symptoms so 
as to check the ability of the tissue tonometer to differentiate between normal controls 
and patients with clinically significant oedema and skin changes. 
The tissue tonometer was positioned on the gaiter area of the lower extremity with the 
subjects examined in the supine position as described earlier. Three different sites were 
measured in each subject to obtain a mean value. Identical sites were measured on the 
contralateral limb and in the normal control limbs using the specially calibrated stand as 
described earlier. 
3.1.3. Z Data Analysis 
Non-parametric analysis of the confidence intervals for the difference between the 
medians between normal controls and patient groups for the sample population were 
undertaken using the method described by Campbell and Gardner (Campbell et al, 
1989). 
The overall coefficient of variation (COV %) was analysed for normal controls and 
patient groups in the reproducibility study. 
The overall coefficient of variation (COV %) was analysed for the repeat measurements 
on the same day performed on the same subject. 
The distance and rate constant parameters were plotted as scattergrams for all the 
different classification groups and medians and interquartile ranges were used as 
descriptors. The Mann Whitney U test was applied to test for statistical significance. 
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3.1.4. Results 
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Figure 3.1.1. Calibration curve for tissue tonometer 
(screen deflection as a function of 
plunger displacement) before recording 
on the sponge tissue. 
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Figure 3.1.2. Calibration curve for tissue tonometer 
(screen deflection as a function of 
plunger displacement) after recording 
on the sponge for 6 hours. 
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Pre- and post-measurement calibration 
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Figure 3.1.3 Pre- and post-measurement tonometry calibration readings after 
5 minutes of recording on glycerol-soaked sponge. 
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Distance pararnoter - phase I(0-I sec ) during indial compliance phase 
p=0.70 
I--- --i 
5 
9z 
I 
0 
Figure 3.1.4 Distance travelled by the plunger in phase 1, XO, the initial rapid 
indentation phase, which occurs within I second and reflects the skin compliance. There 
is no statistically significant difference between the young and old normal controls. 
Distance parameter - pbase 11 (I- 10 sees ) 
1.4 
1.2 
E 
0.8 
0.6 
= 0.4 
0.2 
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Co (normal young) Co (normal old) 
Figure 3.1.5 Distance travelled by the plunger in phase 11, the subsequent slower 
indentation phase, XI-Xo, which occurs between I and 10 seconds and probably reflects 
tissue oedema. There is no statistically significant difference between the young and old 
normal controls. 
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Co (normal young) Co (normal old) 
0.70 
Rate constant parameter - phase 11 (I- 10 secs ) 
p=0.53 
11 
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I 
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Co (normal young) CO (normal old) 
Figure 3.1.6 Rate constant parameter, -I/Tau, during phase 11, the subsequent slower 
indentation phase, which occurs between I and 10 seconds and probably reflects tissue 
oedema. There is no statistically significant difference between the young and old normal 
controls. 
Distance parameter - phase Ul ( 10 - 300 secs ) 
I 
0.8 
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0,6 
0.4 
0,2 
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Co (normal young) CO (normal old) 
Figure 3.1.7 Distance travelled by the plunger in phase 111, the subsequent slower 
indentation phase, which occurs between 10 and 300 seconds and probably reflects tissue 
oedema. There is no statistically significant difference between the young and old nomial 
controls. 
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Rate constant parameter - phase III ( 10 - 300 secs ) 
0.27 
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0 
C. ) 
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Figure 3.1.8 Rate constant parameter, -I/Tau, during phase 111, the subsequent slower 
indentation phase, which occurs between 10 and 300 seconds and probably reflects tissue 
oedema. There is no statistically significant difference between the young and old normal 
controls. 
Distance pararneter - phase I(0-I see ) Initial compliance phase 
6- p 0.60 
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p 0.0001 
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1 0 
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Co C3 c42 C4b 
Figure 3.1.9 The skin compliance is significantly reduced in the LDS group as 
compared to the normal controls, oedema and pigmentation alone groups. There is no 
statistical significant difference in skin compliance between the normal control, 
pigmentation alone and oedema groups. 
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Distance parameter - phase 11 (I- 10 sees ) 
2.5- 
p=0.0001 
2- 
p 0.0001 p 0.02 
1.5 -r 
0 
0 
0.5 - 
0 
Q Ci c4a Ctb 
Figure 3.1.10 The plunger travels much further in the oedema and pigmentation alone 
groups as compared to the normal control group and this reaches statistical significance. 
This phase probably reflects tissue oedema. 
Rate constant parameter - phase 11 (I- 10 secs ) 
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Figure 3.1.11 There is no statistically significant difference in the rate constant 
parameter between the groups in phase 11. 
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Distance paramter - phase III ( 10 - 300 secs ) 
p O. Owl 
2- 
p O. Owl p=0.01 
1.5 - 
10 0 
00 
0 
0.5 - 0 
0 
IR 
co C3 C4a C4b 
Figure 3.1.12 The plunger travels much further in the oedema, LDS and pigmentation 
alone groups as compared to the normal control group and this reaches statistical 
significance. This phase probably reflects tissue oedema. There is no significant 
difference between the LDS, oedema and pigmentation alone groups probably reflecting 
the presence of tissue oedema. 
Rate constant parameter - phase III ( 10 - 300 secs ) 
p 0.0001 
1200- 
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1000- 
800- 0 
0 
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0 0 400- 0 
200- 
- 0 
Co C3 c4. C4b 
Figure 3.1.13 There is a significant difference in the rate constant parameter between 
the normal control group and the other three groups as the plunger stops sinking into the 
tissues much earlier in the normal control group as compared to the other three groups. 
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A 4mm. diameter plunger and a 30g weight were used in all the tonometry measurements 
in this thesis. 
In the calibration check study, there was perfect correlation (r--l. 00) between the screen 
deflection as a function of the plunger displacement using different thickness of metal 
blocks before and after 6 hours of continuous recording on a piece of sponge soaked in 
glycerol (figures 3.1.1 and 3.1.2). 
In the calibration reproducibility check study, there was perfect correlation between the 
pre-calibration and post-calibration (r--0.99) figures for both measurements (figure 
3.1.3). 
There was good reproducibility in the measurement of the skin compliance, X0 , in 
normal subjects (COV of 8%) and in patients (COV of 3.8%) on consecutive days (table 
3.1.5). The distance and rate constant parameters in phases 11 and III showed much 
greater variation on different days. 
There was good repeatability in the measurement of the skin compliance X0 with a COV 
of 4.5% on the same normal control subject after four measurements were repeated on 
the same day (table 3.1.6) and again the other distance and rate constant parameters in 
phases II and III proved to be less reproducible than the skin compliance parameter. 
There were no statistically significant differences in the skin compliance and in the 
distance and rate constant parameters in phases H and III between the normal young 
controls, mean age 28 years, and the normal old controls, mean age 55 years (see table 
3.1.2 and figures 3.1.4 to 3.1.8). 
There was a significant difference in the skin compliance measured during phase I 
between normal controls (CO) and patients with liposclerotic skin changes and palpable 
induration (C4b) (table 3.1.1) by as much as three-fold (figure 3.1.9). There was a 
substantial difference in the skin compliance between the C4a group and the C4b group 
(figure 3.1.9). There was no significant difference in the skin compliance between the 
normal controls CO and the C3 (oedema) and C4a groups. 
During phase H, the distance travelled by the plunger was significantly further in the C3. 
C4a and CO groups than in the Co group (figure 3.1.10). There was no significant 
difference in this parameter between the C3. C4,, and CO groups. During phase II, there 
was no significant difference in the rate constant parameter between the CO, C39 C4a and 
CO groups (figure 3.1.11). 
During phase III, the distance travelled by the plunger was significantly further in the 
C3? C4a and CO groups than in the CO group (figure 3.1.12). Interestingly, in the CO 
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group, the plunger travels less than in the C3 and C4a groups though clinically there was 
significant oedema present. 
During phase IR, the rate constant parameter was significantly higher in the Co group as 
compared to the C39 C4a and CO groups (figure 3.1.13). There were no significant 
differences in the rate constant parameter between the C3. C4,, and CO groups. 
3.1.5 Discussion 
Previously assessment of skin damage in venous disease has relied on clinical means 
alone, although Falanga has reported the use of a durometer to add objectivity to this 
measurement. This study set out to evaluate a more rigorous method of investigating the 
mechanical properties of the skin and its response to mechanical deformation. A 
weighted plunger was equipped with a measuring and recording system and the traces 
recorded from patients and control subjects were assessed. 
The measuring system itself proved to be very reliable and introduced no extraneous 
errors. In the calibration check study, there was perfect correlation (r--1.00) between the 
screen deflection as a function of the plunger displacement using different thickness of 
metal blocks before and after 6 hours of continuous recording on a piece of sponge 
soaked in glycerol (figures 3.1.1 and 3.1.2). This demonstrated that the calibration of the 
tissue tonometer was very reproducible and did not drift with time. In the calibration 
reproducibility study, there was perfect correlation between the pre-calibration and post- 
calibration (r=0.99) figures for both measurements (figure 3.1.3). 
In the clinical studies great care was taken to ensure that the same region of skin was 
evaluated on each occasion. There was good reproducibility in the measurement of the 
skin compliance, X0, in normal subjects (COV of 8%) and in patients (COV of 3.8%) 
on consecutive days (table 3.1.5) which was not affected by the physiological variables 
(oedema, blood, subcutaneous layer thickness) and proved to be a stable parameter. The 
distance and rate constant parameters in phases II and III showed much greater variation 
and are clearly much less reliable in assessing the severity of skin damage. There was 
good repeatability in the measurement of the skin compliance X0 with a COV of 4.5% 
on the same normal control subject after four measurements were repeated on the same 
day (table 3.1.6) and again the other distance and rate constant parameters in phases II 
and III proved to be less reproducible than the skin compliance parameter. These 
findings suggest that the plunger displacement in the first second is the most satisfactory 
123 
measure to use, however, the results from all parameters are included in this and 
subsequent chapters for completeness. 
The aim in this investigation was to establish whether an objective measurement of the 
mechanical properties of the skin could improve on clinical assessment. I therefore 
investigated patients venous disease, comparing those with skin changes to those 
without. Most classifications of the clinical severity of venous disease include all types 
of skin changes (eczema, haemosiderosis and lipodermatosclerosis) in one group. This 
is clearly an oversimplification since patients with eczema are at low risk of leg 
ulceration and those with lipodermatosclerosis are at high risk. It became apparent in the 
preliminary work that measurements differed greatly in the patients with palpable 
induration from those with only skin pigmentation. The CEAP clinical classification 
assigns all patients with skin changes to group C4- I subdivided this group for the 
purpose of these studies into C4a for patients with pigmentation alone and C4b for 
patients with skin changes and palpable induration of the skin and subcutaneous tissues. 
This revealed large differences between the C4a and C4b groups for the phase I 
measurement. This clearly showed considerable reduction in skin deformability, 
reflecting the clinical sensation of induration when palpating the skin. The difference lay 
between the C4b patients and all other groups, and the phase I measurement was 
identical between young and old patients, confirming that any changes in skin elasticity 
with advancing age did not alter this measurement. 
The phase R measurements (1 - 10 seconds) showed a difference between the controls 
and all venous disease groups for the distance parameter, although there was substantial 
overlap between groups. Assuming that the mechanical elasticity has been taken up 
within the first second after application of compression, this probably reflects the 
displacement of fluid from the tissues. The duration of this phase is fairly short so it is 
unlikely that is represents substantial movement of extracellular fluid and I believe that 
it probably reflects movement of blood in veins (large and small) in which the applied 
force was sufficient to displace the venous blood. The distance moved by the plunger in 
this phase was greater in all patient groups than control subjects, consistent with the 
increased venous volume in patients with venous incompetence of any type. However, 
the repeatability of these measurements was not very good, reducing their value for the 
assessment of the severity of venous disease. During phase U, there was no significant 
difference in the rate constant parameter between the CO. C39 C4a and C4b groups (figure 
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3.1.11) suggesting that the type of fluid, probably blood, that is being translocated 
beneath the plunger is similar in all the groups. 
The phase III measurements (10 - 300 seconds) represent a period where the venous 
blood has been displaced and the travel of the plunger must be attributable to 
displacement of extracellular fluid, including any oedema. Travel of the plunger was 
least in the control group and greater in the patients with venous disease, without 
lipodermatosclerosis. This is consistent with these patients having an increased amount 
of tissue fluid due to their venous disease. Interestingly, the travel during phase III in the 
CO patients was less than that for the less severely damaged skin. This may reflect an 
interaction of this measurement with the loss of skin compliance. This is greatly reduced 
in patients with LDS and probably limits the plunger travel, even when substantial 
amounts of oedema are present. During phase III, the rate constant parameter was 
significantly higher in the Co group as compared to the C3, C4a and CO groups (figure 
3.1.13). This was because in the Co group, the plunger ceased to sink into the tissues 
much earlier in the phase as there was less tissue fluid to displace. A reduced rate 
constant indicates that the final value was reached more slowly, that is indicating more 
tissue fluids present beneath the plunger in the C3, C4a and CO groups. There were no 
significant differences in the rate constant parameter between the C3, C4', and CO 
groups, suggesting that the type of fluid being translocated beneath the plunger in the 
patient groups is mainly interstitial fluid. 
It has been previously demonstrated that the mobility of fluid flow in the subcutaneous 
tissue increases substantially with oedema (Guyton et al, 197 1). They explained that the 
fluid flow through the tissue spaces is normally restricted by solid elements which are 
packed upon one another and by the high viscosity of the gel-like matrix embedded in a 
network of collagen fibres (Brace and Guyton, 1979). As oedema develops, the tissue 
spaces become greatly enlarged and fluid replaces the gel in the tissue spaces. The 
mobility of the interstitial fluid should indicate the degree of oedema. A non-invasive 
instrument was developed (Mridha et al, 1986), using a well defined step compression 
over an area of skin and continuously recording the resistive force of the tissue, to assess 
subcutaneous oedema and compared normal skin and oedematous skin. He showed that 
fluid flow out of the compressed oedematous tissues was quicker than from normal 
tissues and measurements from the contralateral site of subjects with unilateral oedema 
provided further evidence that the volume and flow rate of the translocated fluid was a 
function of oedema. Their results were comparable to the mathematical analysis of fluid 
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flow from a compressed tissue area (Guyton et al, 1971) and concluded that the lower 
resistance to fluid motion in oedematous tissue was due to the lower viscosity of the 
interstitial fluid, enlarged interstitial spaces and less compacted structure of the solid 
elements in oedematous tissues than in normal tissues. In oedematous tissues, the 
viscosity of the free fluid is lower, the amount of free fluid is greater and the spaces 
between the fibres is greater than in normal tissues making fluid flow easier. When 
oedema with a low surface tension is pitted, the depression follows the surface of the 
pressure head closely but for stiffer tissues (as in LDS skin), the skin will not follow as 
well and the calculation of the translocation volume will be less accurate. However, 
translocation of fluid does take place as shown by the force decay. 
Confidence interval analysis confirms that the X0 distance provides the most reliable 
parameter for distinguishing between the skin changes in patients with liposclerotic skin 
changes (CO) compared to those with haemosiderosis alone (C40. This parameter also 
has a low coefficient of variation. This measurement is likely to be a useful parameter 
and potential candidate as a surrogate endpoint in studies of the efficacy of treatments 
for chronic venous disease. 
3.1.6 Conclusion 
In the above study, I have shown that the tissue tonometer can objectively distinguish 
between the varying hardness of skin in patients with lower limb chronic venous 
disease. The patients were deliberately selected with advanced clinical signs of venous 
disease to fit into their respective clinical classification groups according to the CEAP 
clinical classification method. This was to assess if the tonometer could differentiate 
between the varying degrees of skin changes with increasing severity of the disease. 
This study has shown that tissue tonometry measurement of the skin compliance 
provides an objective means of assessing skin changes in patients with chronic venous 
disease. 
It has also shown that it was necessary to differentiate between patients in the group 
C4, into patients with pigmentation alone and no palpable induration (C4a) and patients 
with liposclerotic skin changes with palpable induration (CO) using the CEAP clinical 
classification method to get a more objective assessment of the skin changes that are 
present in patients with lower limb chronic venous disease. The tissue tonometry 
measurements of distance and rate constant parameters in the subsequent phases II and 
III may possibly reflect increased venous volume and extent of tissue oedema. 
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3.2 STUDYII 
Use of a tissue tonometer in vitro to verify the application of a simple mathematical 
model in the analysis of the displacement versus time curves obtained from a sponge-m- 
glycerol model to explain its mechanical behaviour. 
3.2.1 Rationale 
The displacement versus time curves obtained from the tissue tonometer both in vitro 
(compression of glycerol soaked sponges (natural sponge, Boots plc)) and in vivo 
(normal control subjects and subjects with evidence of lower limb chronic venous 
disease), showed an initial rapid indentation phase followed by a subsequent slower 
indentation phase. 
The model for an ideally visco-elastic material giving both an instant elastic response to 
loading and lacking plastic properties and which generates curves of the type described 
above, has been previously used to describe the effects of applying a loaded plunger on 
a sponge in glycerol model, which show visco-elastic properties, to explain its 
behaviour under compression (Bates et al, 1994). This simple mechanical model, the 
Kelvin-Hooke model, is a combination of a Kelvin element in series with an elastic 
element (Hooke element) (see section 1.5.3) which provides the two elastic spring 
constants (C2 and CI) and the viscous dashpot constant (k). 
3.2.2 Aims 
To standardise the tonometer in vitro using the sponge-in-glycerol model to obtain 
displacement versus time curves. 
To apply a simple visco-elastic mathematical model, the Kelvin-Hooke model, on the 
curves obtained to calculate the spring and dashpot constants and establish its ability as 
a first approach for a sponge-in-glycerol model system in vitro to explain its mechanical 
behaviour, so as to apply it to similar displacement versus time curves obtained in vivo 
(Study III). 
3.2.3 Methodology 
To test the tissue tonometer in vitro, a sponge-in-glycerol model was used. The natural 
sponge was cut into small sections of lcm by lcm square and soaked in 0%, 25%, 50% 
and 100% concentrations of glycerol in a glass beaker with water used as the dilution 
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medium. The tonometer was calibrated prior to each measurement as described in 
section 2.8. The plunger with a weight of 30g attached to a 4mm diameter plunger was 
positioned just above the centre of the sponge with a known concentration of glycerol. 
The weight was released by means of a cable release mechanism and allowed to sink 
into the sponge under gravity. The movement of the plunger was recorded for 5 minutes 
after which, the plunger and weight were released from the sponge. The tonometer was 
re-calibrated after the measurements and if there was a significant difference between 
the pre- and post-calibration figures, the test was repeated. The same procedure was 
repeated on all the different concentrations of glycerol soaked sponges with the 
tonometer calibrated before each measurement. Three tissue tonometry measurements 
were recorded for 5 minutes for each % concentration of glycerol and the mean value 
calculated for analysis. 
Data Analysis 
The displacement versus time curves obtained from the sponge in glycerol model were 
analysed using the computer software to calculate the distance and rate constant 
parameters for the different concentrations of glycerol. 
The Kelvin-Hooke spring-dashpot visco-elastic model was applied to analyse the spring 
and dashpot constants from the traces obtained with the tissue tonometer. 
Regression analysis was applied to show the correlation coefficient between the distance 
and rate constant parameters obtained from the tissue tonometer and the spring and 
dashpot constants obtained from the Kelvin-Hooke model with increasing viscosity. 
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3.2.4 Results 
Displacement versus time curves obtainedfrom sjx)nge-jn-g4v(--eroI mWel 
Destance travekd. X,. b\ plungcr in Phasc 1 
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Figure 3.2.1 The mean value of the distance travelled by plunger in the initial fast 
indentation phase, Phase 1, plotted against increased viscosity . 
DLstance travelled. KAo. bý plunger m Phase 11 
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Figure 3.2.2 The mean value of the distance travelled by plunger in the subsequent 
slower indentation phase, Phase II, plotted against increased viscosity 
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Figure 3.2.3 The mean value of the rate constant parameter in the subsequent slower 
indentation phase, Phase 11, plotted against increased viscosity. 
Distance travelled, X-Xo, by plunger In Phase III 
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Figure 3.2.4 The mean value of the distance travelled by plunger in the subsequent 
slower indentation phase, Phase 111, plotted against increased viscosity, 
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Figure 3.2.5 The mean value of the rate constant parameter in the subsequent 
slower indentation phase, Phase 111, plotted against increased viscosity. 
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Figure 3.2.6 The mean value of the spnng constant, C2, in the initial fag 
indentation phase, Phase 1, plotted against increased viscosity 
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Figure3.2.7 The mean value of the spring constant, C1, in the subsequent 
slower indentation phase, Phase 11, plotted against increased viscosity. 
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Figure 3.2.8 The mean value of the dashpot constant, k, in the subsequent 
slower indentation phase, Phase II, plotted against increased viscosity. 
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Figure 3.2.9 The mean value of the spring constant, C I, in the subsequent 
slower indentation phase, Phase III, plotted against increased viscosity. 
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Figure 3.2.10 The mean value of the dashpot constant, k, in the subsequent 
slower indentation phase, Phase III, plotted against increased viscosity. 
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25 50 
0, 'o Gh cerol soaked m sponge 
25 
-N) 
01 
% CAyceml soaked m sponge 
Tissue tonometer parameter / phase r value 
Glycerol concentration 
range 
Xo parameter during Phase 1 -0.93 0%, 25%, 50% & 100% 
Xj-XO parameter during Phase 11 -0.33 0%, 25%, 50% & 100% 
Xj-XO parameter during Phase 11 0.97 0%, 25%, 50% 
Rate Constant parameter, -1/Tau, during Phase 11 0.98 0%, 25%, 50% & 100% 
Xj-XO parameter during Phase 111 -0.006 0%, 25%, 50% & 100% 
Xj-XO parameter during Phase 111 1.00 0%, 25%, 50% 
Rate Constant parameter, -I/Tau, during Phase 111 -0.21 0%, 25%, 50% & 100% 
Rate Constant parameter, -Ifrau, during Phase 111 -0.53 0%, 25%, 50% 
Spring constant, C2. of the series Hooke element 0.95 0%, 25%, 50% & 100% 
Spring constant, C1, (Kelvin element) during Phase 11 0.78 0%, 25%, 50% & 100% 
Spring constant, C1, (Kelvin element) during Phase 11 -0.91 0%, 25%, 50% 
k, dashpot constant parameter during phase 11 0.83 0%, 25%, 50% & 100% 
k, dashpot constant parameter during phase Il -0.91 0%, 25%, 50% 
Spring constant, C1, (Kelvin element) during Phase 111 0.34 0%, 25%, 50% & 100% 
Spring constant, C1, (Kelvin element) during Phase 111 -0.94 0%, 25%, 50% 
k, dashpot constant parameter during phase 111 0.25 0%, 25%, 50% & 100% 
k, dashpot constant parameter during phase 111 -0.89 0%, 25%, 50% 
Table 3.2.1 Correlation coefficient (r values) obtained from regression analysis for 
each parameter of each phase with varying glycerol concentration. 
The plunger travelled the furthest (Xo in mm), during phase I, in the 0% glycerol soaked 
sponge and least in the 100% glycerol soaked sponge with a linear decrease between the 
0% and 100% glycerol soaked sponges (figure 3.2.1). 
During phase 111, the distance travelled by the plunger (XI-Xo in mm) increased linearly 
from 0% to 50% glycerol concentration but interestingly at 100% glycerol 
concentration, the plunger travelled significantly less into the tissues (figure 3.2.2). 
The rate constant parameter during phase H, gradually increased as the viscosity of the 
glycerol increased but the rise was not significant (figure 3.2.3). 
During phase III, the distance travelled by the plunger (XI-Xo in mm), the pattern of 
sinking of the plunger into the sponge was similar to that of phase II with the distance 
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travelled by the plunger increasing linearly from 0% to 50% glycerol but was 
significantly reduced in the 100% glycerol (figure 3.2.4). 
The rate constant parameter during phase III, was higher in the 0% glycerol but there 
was no significant change in the 25 %, 50% and 100% glycerol (figure 3.2.5) groups. 
The initial rapid deformation of a visco-elastic material as explained by the Kelvin- 
Hooke model depended on its C2 elastic spring constant or Hooke element. In figure 
3.2.6, there was a linear increase in the C2 elastic spring constant with increasing 
viscosity from 0% to 100% glycerol soaked sponges. During phase I, there was a 
decrease in the C2 value as the viscosity increased with an increase in the final value of 
X, - X0. 
C1, the spring constant of the series Kelvin element, decreases as the final distance 
travelled by the plunger increases. In figures 3.2.7 and 3.2.9, the C, spring constant in 
phases H and III decreased between the 0%, 25% and 50% glycerol soaked sponges as 
the distance travelled by the plunger increased between these concentrations. Ci 
increased quite significantly between the 50% and the 100% glycerol soaked-sponges as 
the distance travelled by the plunger was significantly reduced at the 100% glycerol 
concentration (figures 3.2.2 and 3.2.4). 
During phases H and III, the distance travelled by the plunger increased (figures 3.2.2 
and 3.2.4) and the dashpot value, k, decreased from 0% to 50% glycerol concentration 
(figures 3.2.8 and 3.2.10). The dashpot constant, k, increased quite significantly between 
50% and 100% glycerol concentration. 
Regression analysis was done to calculate the correlation coefficient between the tissue 
tonometry parameters and glycerol concentration (see table 3.2.1) 
There was very good negative correlation between the distance travelled X0 (mm) during 
phase I and the increase in the viscosity of the glycerol (r = -0.93). 
There was poor correlation between the distance travelled, XI-X0, and the increase in 
glycerol viscosity from 0% to 100%, during the slower indentation phase (phase 11) (r = 
-0.33). However, the distance travelled by the plunger increased linearly with the 
increase in glycerol viscosity from 0% to 50% glycerol with a very good correlation 
(r--0.97). This same trend is repeated for the distance travelled, Xj-XO during phase III 
(r---0.06 and r--1.00). 
The Kelvin-Hooke model was applied to see if the tissue tonometry readings would fit 
the model. The spring constant C2 increased linearly with the increase in glycerol 
concentration (r--0.95). 
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There was moderate correlation between the Kelvin spring constant C, and increasing 
viscosity (r--0.78) from 0% to 100% during phase H. However, with the removal of the 
100% glycerol, this was the case with resulting good correlation (r-- - 0.91) as C1 
decreases the distance travelled by the plunger increased (Figure 3.2.7). 
This pattern was the same for the dashpot constant, k, during phase II and for the C, and 
k parameters during phase III (see table 3.2.1). 
3.2.5 Discussion 
This study was under taken to assess the performance of the tonometer system in vitro. 
There was no attempt to simulate the real mechanical properties of the skin and 
subcutaneous tissues with this model, and the findings differ in a number of respects 
from those which were obtained in volunteers and patients. 
During the initial fast indentation phase I, the plunger travelled the furthest in the 0% 
glycerol soaked sponge and least in the 100% glycerol soaked sponge with a linear 
decrease in the distance travelled (XO in nun) by the plunger between the 0% and 100% 
glycerol soaked sponge (figure 3.2.1) during phase I. This phase reflects the fall in 
compliance of the sponge and with the increasing viscosity of the glycerol. This was 
possibly because as the cells within the sponge became filled with fluid of increasing 
viscosity, it increased the resistive forces to plunger travel. 
During phase U, the slower indentation phase between I and 10 seconds, the distance 
travelled by the plunger (XI-X0 in mm) increased linearly from 0% to 50% glycerol 
concentration but interestingly at 100% glycerol concentration, the plunger travelled 
significantly less into the tissues (figure 3.2.2). This suggests that the solvent used 
(water) to dilute the glycerol may have had a softening effect on the sponge. 
During phase III, the distance travelled by the plunger (XI-Xo in mm) in the slower 
indentation phase lasting about 290 seconds, the pattern of sinking of the plunger into 
the sponge was similar to that of phase II with the distance travelled by the plunger 
increasing linearly from 0% to 50% glycerol but was significantly reduced in the 100% 
glycerol (figure 3.2.4) again possibly due to the reasons explained in phase 11 distance 
parameter above. The rate constant parameter during phase H, gradually increased as the 
viscosity of the glycerol increased but the rise was not significant (figure 3.2.3). 
The rate constant parameter during phase IH, was higher in the 0% glycerol but there 
was no significant change in the 25%, 50% and 100% glycerol (figure 3.2.5) groups. 
However, a reduced rate constant means that the final distance travelled by the plunger 
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was reached more slowly. Therefore, the plunger sank into the 25%, 50% and 100% 
glycerol soaked sponges for longer as compared to the 0% glycerol sponge in which the 
resistive forces of the dilution medium (water) to the plunger within the sponge cells 
were less than those of the glycerol which is more viscous and thus provides a greater 
resistive force. 
The initial rapid deformation of a visco-elastic material as explained by the Kelvin- 
Hooke model depended on its C2 elastic spring constant or Hooke element. It represents 
the initial ability of the interstitial matrix to undergo elastic deformation without flow. 
In figure 3.2.6, there was a linear increase in the C2 elastic spring constant with 
increasing viscosity from 0% to 100% glycerol soaked sponges. 
According to the Kelvin-Hooke model, C1, the spring constant of the series Kelvin 
element, is inversely related to the final distance travelled by the plunger. An increase in 
the final value that the plunger reaches (XI - XO) is as a result of a decrease in C1. In 
figures 3.2.7 and 3.2.9, the C, spring constant in phases H and III decreased between the 
0%, 25% and 50% glycerol soaked sponges as the distance travelled by the plunger 
increased between these concentrations. C, increased quite significantly between the 
50% and the 100% glycerol soaked-sponges as the distance travelled by the plunger was 
significantly reduced at the 100% glycerol concentration (figures 3.2.2 and 3.2.4). 
According to the Kelvin-Hooke model, the dashpot constant, k, is proportional to the 
resistance to flow. Therefore an increase in the dashpot constant will cause an increase 
in the time the plunger takes to level off. During phases II and III (figure 3.2.8 and 
3.2.10), the distance travelled by the plunger increased (figures 3.2.2 and 3.2.4) and the 
dashpot value, k, decreased from 0% to 50% glycerol concentration. The dashpot 
constant, k, increased quite significantly between 50% and 100% glycerol concentration 
suggesting a softening effect of the solvent on the sponge. In this model, the k value is 
lower at 50% glycerol than at 0% glycerol but is higher at 100% glycerol than at 50% 
glycerol suggesting that this parameter is less sensitive at lower viscosities than at 
higher viscosities. 
There was very good negative correlation between the distance travelled X0 (mm) during 
phase I and the increase in the viscosity of the glycerol (r = -0.93)(table 3.2.1). As the 
glycerol viscosity increased, the sponge compliance which is reflected by the Xo 
distance parameter linearly decreased. According to the Kelvin-Hooke model, the X0 
parameter should depend only on the initial elastic compressibility and not on the 
viscosity of the fluid in the matrix. This clearly was not the case in the sponge in 
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glycerol model which could be attributed to the mechanical properties of the sponge. 
This is composed of cells filled with air initially and when it is soaked in the glycerol 
solution, these air cells become filled with the glycerol and as the viscosity of the 
glycerol solution is increased the resistance in these cells increases thus providing a 
greater resistance to the plunger as it sinks into the tissues. This change of resistance in 
the cells of the sponge tissue probably affect the mechanical properties. The greater the 
resistance, the less the distance travelled by the plunger. In another study on the sponge 
in glycerol model with a tissue tonometer (Bates et al, 1994), it was found that the 
distance travelled X0 was not significantly different between 25%, 50% and 75% 
concentration of glycerol soaked sponges but was significantly reduced in the 100% 
glycerol concentration. The weight used on the plunger in his study was significantly 
higher (152g) than the weight applied in this study (30g). It is possible that the weight 
applied in the Bates' study was too heavy and compressed the sponge rapidly in the 
25%, 50% and 75% glycerol concentration. This was demonstrated in study I table 3.1.4 
as I tried different weights and plunger diameters and found that the X0 parameter 
generally increased with increasing weights for the same sponge in glycerol model. 
There was poor correlation between the distance travelled, Xj-XO, and the increase in 
glycerol viscosity from 0% to 100%, during the slower indentation phase (phase H) (r = 
-0.33)(table 3.2.1). However, the distance travelled by the plunger increased linearly 
with the increase in glycerol viscosity from 0% to 50% glycerol with a very good 
correlation (r--0.97) (table 3.2.1). A possible explanation for this is that the 100% 
glycerol solution provided too great a resistance within the open cells of the sponge for 
the 30g weight applied to counteract and hence the distance travelled is less than in the 
other concentrations. This same trend is repeated during phase III probably for the same 
reasons as above (table 3.2.1). 
For the 30g weight applied to the 100% glycerol concentration model, the distance and 
rate constant parameters calculated by the tissue tonometer was not suitable proving too 
high a resistance for it to counteract. The 0%, 25% and 50% sponge in glycerol model 
appeared to have a very good correlation. 
The Kelvin-Hooke model was applied to see if the tissue tonometry readings would fit 
the model. From the above model, the Xo parameter and the elastic spring constant of 
the Hooke element, C2. which provides a measure of the tissue compliance, should 
depend only on the initial elastic compressibility and not on the viscosity of the fluid in 
the matrix. The spring constant C2 increased linearly with the increase in glycerol 
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concentration (r--0.95) (table 3.2.1) which was similar to the values for the X0 parameter 
above. This is not surprising as C2 is inversely related to Xo. 
There was moderate correlation between the Kelvin spring constant C, and increasing 
viscosity (r--0.78; table 3.2.1) from 0% to 100% during phase II. This was not as the 
Kelvin-Hooke model predicted because as the value of C, decreases the final distance 
travelled by the plunger should increase. However, with the removal of the 100% 
glycerol, this was the case with resulting good correlation (r-- - 0.91) as C, decreases the 
distance travelled by the plunger increased (table 3.2.1). 
This pattern was the same for the dashpot constant, k, during phase 11 (table 3.2.1). This 
fits with the Kelvin-Hooke model because k is expected to be lower as the final distance 
travelled by the plunger increased (Figure 3.2.2). 
The same pattern is repeated for the C, and k parameters during phase III (table 3.2.1; 
figure 3.2.4) 
3.2.6 Conclusion 
In the sponge in glycerol model, the application of the Kelvin-Hooke model appeared to 
fit the data and this model would now be applied in vivo to analyse the mechanical 
properties of the skin of patients with lower limb chronic venous disease using a tissue 
tonometer. 
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3.3 STUDY III 
Use of a tissue tonometer in vivo to assess the skin changes of patients with lower limb 
chronic venous disease and the application of a simple mathematical model in the 
analysis of the displacement versus time curves obtained to explain its mechanical 
behaviour. 
3.3.1 Rationale 
In study I, I have shown that patients with liposclerotic skin changes with no palpable 
induration (C40should be differentiated from patients with liposclerotic skin changes 
and palpable induration (C4b) as a result of the significant differences in the skin 
compliance between the two groups (p<0.0005) (Figure 3.1.9; Table 3.1.1). The CEAP 
method of classification does not differentiate between these two groups as they are both 
included in the C4 group. I have proposed separating these two groups into C4a and C4b 
respectively based on the evidence provided by the mechanical properties of the skin 
compliance as measured by the tissue tonometer. 
The Kelvin-Hooke model has been previously applied (Bates et al, 1994) to 
displacement versus time curves obtained with a tissue tonometer to measure post- 
mastectomy lymphoedernatous arms and was shown to fit the tonometry results 
remarkably well. 
In this study, I will apply the Kelvin-Hooke model, on the resulting displacement versus 
time curves obtained for all in vivo measurements to explain the mechanical properties 
of the skin changes in patients with lower limb chronic venous disease as compared to 
normal controls as classified by the CEAP method. This simple mechanical model was 
applied in vitro in study Id using a sponge in glycerol model and found that the tissue 
tonometry findings fitted the data quite well. 
3.3.2 Aims 
Assessment of skin changes with a tissue tonometer in patients with lower limb chronic 
venous disease classified according to the CEAP method of classification to obtain 
displacement versus time curves. 
To calculate spring and dashpot constants from the displacement versus time curves 
obtained by applying the Kelvin-Hooke model to explain the mechanical behaviour of 
the skin in groups of patients and normal controls. 
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3.3.3 Methodology 
One hundred and eighty one limbs of 102 subjects (56M: 46F; mean age of 56.1 years; 
age range: 20-83 years) with lower limb venous disease demonstrated by duplex 
ultrasound scanning in the vascular laboratory studied. Patients were classified 
according to the CEAP method of classification from Co to C6. The CEAP modification 
was applied here to separate patients with skin changes and no palpable induration, C4a, 
from those with skin changes with palpable evidence of induration C4b. Resting ABPI 
were also measured to exclude any arterial disease. The subjects were classified as 
follows: Co (n=20), CI (n=26), C2 (n= 17), C3 (n=25), C4a (n=23), C4b (n=26), C5 (n=24) 
and C6 (n=20). Three different sites were measured in the gaiter area to obtain a mean 
value as described in section 2.8 at 6cm, 10cm and 12cm above the medial malleolus. If 
an open ulcer is present at the above sites, the nearest area of skin with no open wound 
is used and the location noted for measurements on sequential visits. Identical sites were 
measured on the contralateral. limb using the specially calibrated stand with a fixed 
marker pen (see section 2.5). This procedure was repeated on the other limb using the 
same heights noted on the calibrated column and the same landmarks to ensure identical 
sites are marked. With three identical sites marked in both lower limbs, the subjects 
were then examined by tissue tonometry as described in section 2.8. 
The traces obtained were analysed using the computer software to calculate the distance 
and rate constant parameters and the spring and dashpot constants as described in the 
Kelvin-Hooke model. 
Data Analysis 
The distance and rate constant parameters were plotted as scattergrams for all the 
different classification groups and medians and interquartile ranges were used as 
descriptors. The Mann Whitney U test was applied to test for statistical significance. 
The spring and dashpot constants were calculated from the Kelvin-Hooke model and 
plotted as scattergrams with the descriptors and statistical tests used as described above. 
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3.3.4. Results 
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Figure 3.3.1 Distance travelled by plunger (nun) during phase I in normal subjects and 
in patients with CVD classified according to the CEAP method of classification with the 
2-Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Phase H Distance parameter (XrXO) vs CEAP 
classification 
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Figure 3.3.2 Distance travelled by plunger (mm) dunng phase 11 in normal subjects and 
in patients with CVD classified according to the CEAP method of classification with the 
2-Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Phase H Rate constant pammeter (-lfFau) vs CEAP 
classification 
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Figure 3.3.3 Rate constant parameter (secs -1) during phase 11 in normal subjects and in 
patients with CVD classified according to the CEAP method of classification with the 2- 
Tailed P values corrected for ties (Mann-VAiitney U test) applied to test for statistical 
sign. ificance between the different CEAP groups. 
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Phase III Distance parameter (XI-Xo) vs CEAP classification 
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Figure 3.3.4 Distance travelled by plunger (mm) during phase III in normal subjects 
and in patients with CVD classified according to the CEAP method of classification with 
the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied to test for 
statistical significance between the different CEAP groups. 
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Phase III Rate constant parameter (-I/Tau) vs CEAP 
classirication 
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Figure 3.3.5 Rate constant parameter (secs -) during phase III in normal subjects and 
in patients with CVD classified according to the CEAP method of classification with the 
2-Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Figure 3.3.6 Series Hooke element, C2, in normal subjects and in patients with CVD 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Figure3.3.7 Series Kelvin element, Ci, during phase 11 in normal subjects and in 
patients with CVD classified according to the CEAP method of classification with the 2- 
Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Phase H Dashpot constant (k) vs CEAP classification 
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Figure 3.3.8 Dashpot constant, k, during phase 11 in normal subjects and in patients 
with CVD classified according to the CEAP method of classification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Figure3.3.9 Series Kelvin element, Ci, during phase III in normal subjects and in 
patients with CVD classified according to the CEAP method of classification with the 2- 
Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Phase III Dashpot constant (k) vs CEAP classification 
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Figure 3.3.10 Dashpot constant, k, during phase III in normal subjects and in patients 
with CVD classified according to the CEAP method of classification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Total distance (XI-Xo in mm) travelled by the plunger 
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Figure 3.3.11 Distance travelled by plunger (mm) during phases II and III in normal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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The distance travelled X0 by the plunger during phase 1, was significantly reduced in the 
C4b, C5 and C6 groups to as much as one third, of that in CO, C1, Ci, C3 and C4a groups 
(figure 3.3.1). 
There were no statistically significant differences in the skin compliance between the 
CO, C 19 C29 C3 and C4a groups and between the C4h, C5 and C6 groups. 
The distance travelled Xj-XO by the plunger during phase 11 was significantly higher in 
the Q), C3, C4aq C09 C5 and C6 as compared to the CO group. There was no significant 
difference between the CO and C, groups and between the C,, C3, C4a, C4b, C5 and C6 
groups (figure 3.3.2). 
There were no significant difference in the rate constant parameters during phase 11 
between any of the groups (figure 3.3.3) with a wide scatter in the data points of this 
parameter amongst the groups. 
The distance travelled by the plunger during phase III showed a significant increase 
between the groups with no significant clinical evidence of oedcnia (CO, C, and C-') and 
the groups with significant clinical evidence of oedema present ( CA, C4. and C(, ) (figure 
3.3.4). Interestingly, there were no statistically significant difference between the CO, C, 
and Q) groups and the CO and C5 groups. 
There were no significant difference in the rate constant parameters during phase III 
between any of the groups (figure 3.3.5) with a wide scatter in the data points of this 
parameter amongst the groups. 
Q), the elastic spring constant of the Hooke element, is significantly increased in the 
CO, C5 and C6 groups as compared to the CO, C1, C2), C3 and C4a groups. There were no 
significant differences in the C, parameter between the CO, C1, Q), C; and C4a groups 
and between the CO, C5 and C6 groups (figure 3.3.6). 
There was a significant decrease in the C, parameter during phase 11 between the C() and 
C, groups and the C2, C3, C4a, CO, C5 and C6 groups (figure 3.3.7). 
There were no significant difference in the dashpot constant parameter, k, during phase 
11 between the normal controls and the patient groups (figure 3.3.8). 
There was a significant difference in the C, and k parameters during phase III between 
the groups with no clinical evidence of tissue oedema (CO, C, and C-0 and the groups 
with clinical evidence of tissue oedema W3, C4a, C4t, and C6) with the exception of the 
C5 group (figure 3.3.9 and figure 3.3.10). 
Again, there was a significant increase in the total distance travelled by the plunger 
during the creep phase (Xj-XO for phases 11 and 111) between the CO and C, groups and 
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the C2, C31 C4a, CO and C6 groups (figure 3.3.11). However, the C5 group showed a 
similar trend as with the other parameters as having a lesser significant difference with 
the CO and C, groups. 
3.3.5. Discussion 
This study was conducted in a much larger range of patients than was included in Study 
1, in order to assess whether the conclusions drawn from the initial series were valid 
when applied to a further, larger group of subjects. Patients and controls with all 
severities of venous disease recognised by the clinical part of the CEAP method of 
classification (CO to C6)- Separate groups of patients were included in my C4,, and C4b 
groups, in the same manner as for the earlier study. 
The distance travelled X0 by the plunger during phase 1, the initial fast indentation 
phase, which reflects the skin compliance, was significantly reduced In the C41, C5 and 
C6 groups to as much as one third, of that in CO, C I, C2, C3 and C4a groups (figure 3.3.1 ), 
a highly statistically significant difference (P<0.0005). This was almost identical to my 
earlier observations on the more limited groups of patients Ind confirms that they were 
representative of the patitient groups. The data from this study demonstrates that 
patients in the CO. C5 and C6 groups had almost identical values for this parameter, 
confirming my justification for identifying patients with LDS separately and assigning 
them to group C4b- In addition, the graphs show very little overlap in this measurement 
between the patients with LDS and those without, confirming its potential For use as a 
surrogate endpoint for the evaluation of treatments for venous disease. 
The distance travelled X1-XO by the plunger during phase 11, the subsequent slower 
indentation phase, probably reflects the amount of blood present beneath the plunger 
from the considerations presented in section 3.1. Patients with any severity of venOLIS 
disease of C, (uncomplicated varicose veins) or greater had an increase in this 
parameter. This is consistent with my earlier proposal that this measurement reflects an 
increase in the venous volume due to dilated veins (small and large) in the skin and 
subcutaneous tissues. A number of plethysmographic studies have also shown increased 
venous volume in patients with venous disease compared to controls, so this observation 
is not surprising. In the C5 and C6 groups, this parameter decreased compared with the 
measurement in patients with less severe venous disease. This again suggests the 
likelihood that the travel of the plunger was limited by the reduced tissue compliance in 
the patients with severe LDS. 
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There were no significant difference in the rate constant parameters during phase 11 
between any of the groups (figure 3.3.3) with a wide scatter in the data points of' this 
parameter amongst the groups. The wide scatter of these data and overlap in both the 
distance and rate constant parameters makes it less likely that this could be used its an 
indicator of the severity of venous disease. 
The distance travelled by the plunger during phase III showed a significant increase 
between the groups with no significant clinical evidence of oedema (CO, C, and C, ) and 
the groups with significant clinical evidence of oedema present ( C3, C4,, and C6) (Figure 
3.3.4). Interestingly, there were no statistically significant difference between the CO, C, 
and C2 groups and the CO and C_5 groups. Again, this probably reflects reduced tissue 
compliance preventing accurate assessment of oedema. 
There were no significant difference in the rate constant parameters during phase III 
between any of the groups (figure 3.3.5) with a wide scatter in the data points of' this 
parameter amongst the groups. This parameter is of' use in assessing the severity of 
oederna, but has the limitations that the reproducibility Studies showed it to have it large 
coefficient of variation on repeated measurement. In addition, the interaction with 
reduced tissue compliance in patients with LIDS means that it would not be useful in 
these patients. The considerable overlap between patient groups means that it would be 
of limited value in distinguishing different severities of venous disease. 
Q), the elastic spring constant of the Hooke element which is it measure of' the skin 
compliance (the higher the constant the lower the compliance), is significantly increased 
in the CO, C5 and C6 groups as compared to the CO, C1, C,,, C3 and C4,, "I-OLIPS (figure 
3.3.6) (remember that C2 is inversely related to the X0 parameter calculated in figure 
3.3.1). There were no significant differences in the C, parameter between the CO, C1, 
C3 and C4a groups and between the CO, Cs and C6 groups. 
According to the Kelvin-Hooke model, the C, parameter which is the spring colistant of 
the Kelvin element, is inversely related to the final distance travelled (XI-XO) by the 
plunger. In other words the value of C, should be lower in oedernatous limbs. There was 
a significant decrease in this parameter during phase 11 between the CO and C, oroups L, 
with no clinical evidence of tissue oedema, and the C-), C3, C4, k, C4h. C5 Ind C(, groups 
which have clinical evidence of tissue oedema (figure 3.3.7). This parameter may be 
useful in indicating the amount of expansion of venous volume especially during the 
earlier stages of the creep phase which occurs within the first 10 seconds (phase 11). 
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There were no significant difference in the dashpot constant parameter, k, during phase 
11 between the normal controls and the patient groups (figure 3.3.8). 
There was a significant difference in the C, and k parameters during phase III between 
the groups with no clinical evidence of tissue oedema (CO, C, and C, ) and the groups 
with clinical evidence of tissue oedema (C3, C4a, CO and CO with the exception of' the 
C5 group (figure 3.3.9 and figure 3.3.10). According to the Kelvin-Hooke model, its the 
distance travelled by the plunger (XI-Xo) increased due to the increase in tissue fluids 
present beneath the plunger, the value of the C, and k parameters will decrease. This is 
expected as the C, and k values are inversely related to the Xj-XO values. Interestingly, 
the C. j group had a higher C, and k values than the other groups with clinical evidence 
of tissue oedema present possibly reflecting a wider spread of patients with varying 
degrees of the extent of the liposclerotic changes as can be seen from the X0 parameter 
in figure 3.3.1. 
3.3.6. Conclusion 
This study has shown that the earlier observations are correct when applied to a new, 
larger group of patients. This investigation confirms that the skin compliance in patients 
with venous disease can be reliably assessed by the tonometer. It also continues to 
Justify the separation of patients into C4a and C4b groups. The latter group (LDS) is 
clearly very similar to the patients with open or healed venous ulcers. The Kelvin-Hooke 
model appeared to fit the data quite well in assessing the mechanical properties of the 
skin of patients with lower limb chronic venous disease. 
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3.4 STUDY IV 
To correlate the clinical assessment of the hardness of liposclerotic skin changes with 
tissue tonometry measurements of skin compliance. 
3.4.1. Rationale 
Doctors generally demonstrate the principles of tonometry by palpating skin and 
subcutaneous tissues with their fingers to see how soft or hard it is by the extent with 
which their fingers will sink into the tissue. However, this method of assessment ofthe 
skin compliance is subjective and qualitative. Similarly, the clinical assessment of skin 
compliance and oedema is also subjective and qualitative. There is no objective 
measurement of the ease of indenting the skin surface or the ease with which fluid 
moves away from compression of the tissues with the thumb as the pressure applied by 
the thumb is arbitrary. Therefore changes in the skin compliance or the extent and rate 
of pitting cannot be quantitatively assessed. 
The severity of the induration or skin hardness has never been objectively quantified. 
The clinical assessment of lipodermatosclerosis at present uses the clinical skill severity 
score index adapted from studies of patients with systernic sclerosis (scicrodernia) 
adapted by Kahaleh et al in 1986. This is very subjective and clinical assessment will 
vary from laboratory to laboratory. 
Recently a durometer has been used to determine the degree of induration in LDS by 
Romanelli (Romanelli et al, 1995) based on previous work done on the assessment of' 
skin hardness in patients with systernic sclerosis (sclerodernia) by Falanga (Falanga et 
al, 1993). 
1 have previously objectively assessed the skin in patients with lower linib chronic 
venous disease using a tissue tonometer developed in our laboratory and shown that the 
skin compliance is reduced to about a third in patients with liposclerotic skin changes 
and palpable induration (C4b) as compared to patients with liposclerotic skin changes 
without palpable induration W40, patients with varicose veins and clinical evidence of 
oedema (C3) and normal controls (CO). 
Results obtained in vitro and in vivo with the tissue tonometer developed in our 
laboratory (see study 11 and 111) have been shown to fit a simple visco-clastic 
mathematical model used to analyse the skin compliance. The X0 (nirn) distance 
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parameter during the initial rapid indentation phased and the spring constant, Q), 
calculated from the Kelvin-Hooke model are used as indicators of the skin compliance. 
3.4.2. A im 
To compare the clinical assessment of the severity of liposclerotic skin changes made by 
an experienced vascular surgeon with the tissue tonometry parameters ofskin 
compliance (Xo (mm) and the C, spring constant (g/nini)) in patients with bilateral LDS. 
3.4.3. Methodology 
Thirty two limbs of 16 patients (9M: 7F; mean age of 64.1 years; range 43-79 years) 
referred to the vascular laboratory with bilateral lipodermatosclerosis (modified CEAP 
class C4b) were assessed clinically by an experienced specialist registrar in VaSCUIar 
surgery followed by tissue tonometry measurements performed by the author. They all 
had a full non-invasive venous duplex ultrasound examination to confirm presence of 
lower limb venous disease. Resting ABPI were measured to eliminate any arterial 
disease. The clinician used the CEAP method of scoring the liposcicrotic skin changes 
as I point for less severe CEAP class C4h and 2 points for more severe CEAP clISS C4h- 
Tissue tonometry measurements were carried out on the medial aspect oftlic gaiter area 
above the medial i-nalleolus on all 32 limbs as described in section 2.8. Three sites on 
each limb ( 6cm, 10cm and l2crn above the medial nialleolus) were measured to get 11 
mean value. The results of scoring of the liposclerotic skin changes by the clinician 
remained unknown to the author who performed the tissue torionictry measurements. 
Data Analysis 
The tonometry parameters ofX0 in mm and the spring constant C-, were plotted against 
the clinical severity scores of I and 2 points for less severe LDS and more severe LI)S 
respectively, as scored by the clinician. The rnedian and inter-cluartilc ranges were 
calculated and the Wilcoxon test was applied to test for statistical significance. 
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3.4.4. Results 
Distance travefled, Xo, in phase 1 
2- P=0.0033 
1.5 
0.5 
0 
more severe LDS less severe LDS 
Figure 3.4.1 The distance travelled by the plunger in the first second is plotted 
against the clinical severity of the LDS as classified by a vascular surgeon. 
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Figure 3.4.2 The spring constant, C2, calculated from the Kelvin-Hooke model 
is plotted against the clinical severity of the LDS as classified by a vascular surgeon. 
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Differentiating between the clinical severity of skin changes within the CEAP class C41, 
was similar between the X0 and C2 parameters obtained by tissue tonometry and the 
clinical severity as classified clinically by a vascular surgeon and this difference reached 
statistical significance (figures 3.4.1 and 3.4.2) (p=0.0033 for the X0 paranictcl- and 
p=0.0051 for the C-, parameter). There was some overlap in the tissue tonometry 
parameters of skin compliance between the less severe and more severe liposcici-otic 
skin changes. 
3.4.5. Discussion 
The aim of' this investigation was to determine whether the severity of' LDS SLIoocsted 
by a clinician correlated with that measured by the tonometer. III fact, there was very 
little overlap between the two groups when assessed by the X,, parameter in phase 1. 
This is a remarkable achievement for both the clinician and the measuring techniquc and 
confirms that this measurement reliably assess the severity of' LDS. The other phases of' 
the tonometer trace showed differences between clinical CEAP stages but did not appear 
to reliably reflect the severity of lipodermatosclerosis, the most important clinical 
indicator of the severity of venous disease. Consideration of these was thcrefOre omitted 
in this study. In this study, I was only interested in the C2 elastic spring constant of' tile 
Hooke element, which represents the initial ability of' tile interstitial n1atriX to undergo 
elastic deformation without flow. The other parameter of' interest was the X(, parametcr 
which is the distance travelled by the plunger during phasc 1, the initial fast indentation 
phase. Both these parameters reflect the skin compliance and are inversely related. The 
X0 parameter is calculated from the straightest part ofthe torionieter curve which occurs 
within I second as the Plunger was released unto the skin. 
The skin compliance parameters as measured by tissue tonometry has been previously 
shown to be very reproducible in patients (COV=3.9%) and in normal controls (COV = 
8%) and has also proved to be quite a sensitive method of' investigation III 1111S StLIdV. it 
has the advantage over clinical examination of being very reproducible and entirely 
objective, being uninfluenced by the other clinical features ofthe limb. 
3.4.6. Conclusion 
This study demonstrated that the tissue tonometry measurements of skill compliance 
provided an objective way ot'differentiating between the clinical severity ofliposclcrotic 
skin changes in patients all of whom were affected by LDS. 
160 
3.5 STUDY V 
Tissue tonometry measurements of skin compliance and its correlation with ultrasound 
measurement of thickness of the skin and subcutaneous tissues. 
3.5.1. Rationale 
The distance travelled by the plunger during the initial fast indentation phase, X0 in nim, 
should depend only on the initial elastic compressibility or skin compliance. There was 
a variable range of values of the X0 parameter in studies I and III within the normal and 
patient groups and this may possibly reflect variation in skin thickness or skin and 
subcutaneous fat thickness. 
Current methods of studying the skin includes histology and electron microscopy but the 
most practical modality is ultrasound imaging. 
Ultrasound does not have the resolution of histology but a major advantage of using 
ultrasound is it provides real-time imaging capability and it is non-invasive. 
Ultrasound examination of the skin itself is best performed with 20-MHz transducers 
but has limitations which include the narrow field of view which is less than 2cin in 
width and the inability to visualise the subcutaneous tissues beyond it depth of 
approximately 1.5cm. These limitations emphasise the need for lower frequency 
transducers in the 7.5 to 10 MHz range to image structures that lie beyond the scope of 
the 20-MHz transducers and also because of their low cost and wider availability. 
The use of 7.5- andIO-MHz transducers are ideal for use in the ultrasound imaging of, 
the subcutaneous tissues with the added advantages ofbeing low cost, versatile, quicker 
to perform, more widely available than any other cross-sectional Imaging modality 
currently available and display a pictorial cross-section of the skin and subcLitancous 
tissues in a visual way. 
3.5.2. A ims 
To measure skin and subcutaneous layer thickness in the normal and patient groups 
presenting with lower limb venous disease using a 7.5 MHz transduccr. 
To obtain displacement versus time using a tissue tonometer within the same groups 
above. 
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To determine the correlation between the distance and rate constant parameters obtained 
with tissue tonometry and the ultrasound measurements of skin and subCLItaneous layer 
thickness. 
3.5.3. Methodology 
Thirty seven limbs of twenty nine subjects (I 3M: 16F; mean age of 66 years; range: 47- 
75 years) confirmed with presence of lower limb venous disease by duplex ultrasound 
scanning in the vascular laboratory and twelve limbs of twelve normal controls (8M: 4F; 
mean age of 29 years; age range: 21-37 years) with no evidence of lower firnb venOUS or 
arterial disease were also investigated. The subjects were classified according to the 
CEAP method of classification: and CO (n= 12), C-) (n=7), C4,, (n=5) and C4t, (n=25). 
3.5.3.1. Ultrasound 
The subject was examined in the supine position using a 7.5MHz linear-array probe its 
described in section 2.9. 
3.5.3.2. Tissue tonometry measurements qI'skin coinl)liance alul tissue tonicitY 
The tissue tonometer was positioned on the same site as the ultrasound mcasurernent as 
described in section 2.8 on the medial aspect of the gaiter area of the lower extremity 
with the subject in the supine position. 
Data AnalYsis 
The traces were analysed for distance parameters as described in section 1.5.2. 
The Pearson correlation coefficient values were calculatcd fOr the ultrasound 
measurements of skin and subcLitancous layer and the tissue tonoinctry measurements of' 
distance parameters (XO, XIAO during phase 11, and XIAO during phase 111) between the 
CEAP groups investigated. 
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3.5.4. Results 
Ultrasound-deiived skin thickness vemus CEAP 
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Figure 3.5.1 Ultrasound-defived skin thickness in mm plotted against CEAP 
classification with the differences between the groups indicated by the p values. 
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Figure 3.5.2 Ultrasound-derived subcutaneous layer thickness in mrn plotted against 
CEAP classification with the differences between the groups indicated by the p values. 
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Figure 3.5.3 Regression analysis to show the 
correlation between ultrasound-derived 
skin thickness measurement and tissue 
tonometry measurement of distance 
travelled during phase I in normal controls 
and patients with venous disease (C2, 
C4a, C4b) 
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Figure 3.5.4 Regression analysis to show the 
correlation between ultrasound-derived 
subcutaneous layer thickness 
measurement and tissue tonometry 
measurement of distance travelled during 
phase I in non-nal controls and patients 
with venous disease (C2, C4a, C4b). 
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Figure 3.5.5 Regression analysis to show the 
correlation between ultrasound-derived 
skin thickness measurement and tissue 
tonometry measurement of distance 
travelled during phase 11 in normal 
controls and patients with venous disease 
(C2, C4a, C4b). 
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Figure 3.5.6 Regression analysis to show the 
correlation between ultrasound-derived 
subcutaneous layer thickness 
measurement and tissue tonometry 
measurement of distance travelled during 
phase 11 in normal controls and patients 
with venous disease (C2, C4a, CO). 
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Figure 3.5.7 Regression analysis to show the 
correlation between ultrasound-derived 
skin thickness measurement and tissue 
tonometry measurement of distance 
travelled during phase III in normal 
controls and patients with venous disease 
(C2, C4a, CO). 
30T 
u0.. 
:i XI-XO mm 
cn 
Figure 3.5.8 Regression analysis to show the 
correlation between ultrasound-denved 
subcutaneous layer thickness 
measurement and tissue tonometrv 
measurement of distance travelled during 
phase III in normal controls and patients 
with venous disease (C2, C4a, ('4b). 
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Summary of results 
Pearson correlation value 
Tissue tonometry 
measurements (COX29C4. and CO) Ultrasound measurements 
Skin (mm) Subcutaneous Layer (mm) 
X0 (MM) 0.02 -0.02 
Xj-XO (mm) phase 11 -0.05 0.29 
Xj-XO (mm) phase 111 0.13 0.28 
Pearson correlation value 
Tissue tonometry 
measurements (COX2 and C4a) Ultrasound measurements 
Skin (mm) Subcutaneous Layer (mm) 
XO (mm) -0.31 0.10 
Xj-XO (mm) phase 11 -0.16 0.53 
Xj-XO (mm) phase 111 -0.09 0.34 
Pearson correlation value 
Tissue tonometry 
measurements (C4b) Ultrasound measurements 
Skin (mm) Subcutaneous Layer (mm) 
X0 (MM) 0.15 -0.32 
Xj-XO (mm) phase 11 -0.02 -0.05 
Xj-XO (mm) phase 111 0.33 0.03 
Table 3.5.1 Summary of the Pearson correlation values between ultrasound 
measurements and tissue tonometry. 
There was no significant difference in the skin thickness layer between normal controls 
and patient groups with a wide scatter of data points present (figure 3.5.1). 
There was a significant difference in the subcutaneous layer thickness between the Co 
group and the disease groups, C29 C4a and CO (figure 3.5.2). 
There was no significant correlation between the ultrasound-derived skin and 
subcutaneous layer thickness and the X0 and Xj-XO parameters during phases 11 and III 
obtained from tissue tonometry (see figures 3.5.3 to 3.5.8 and table 3.5.1). 
3.5.5. Discussion 
Ultrasound is widely used to evaluate changes in the thickness of subcutaneous fat 
associated with various clinical conditions in humans (Gooding et al, 1986; Heckmatt et 
al, 1988). Ultrasound has also been used to measure the thickness of subcutaneous fat at 
various sites in normal subjects (Maruyama et al, 1991) using a thin stand-off pad to 
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improve the examination of the skin and superficial subcutaneous tissues which results 
in the skin being closer to the focal zone (Fornage et al, 1984). 
Previous studies done using a 7.5MHz linear-array probe, described the skin's 
appearance as a thin, regular layer of tissue that is more echogenic and sharply 
demarcated from the underlying hypoechoic subcutaneous fat (Fornage et al, 1986; 
Miyauchi et al, 1983). The interface between the echogenic skin and the hypoechoic 
subcutis has been shown to be clearly depicted in most areas of the body, allowing 
measurement of the skin thickness, although with less accuracy than at higher 
frequencies. However, in oedematous skin or inflamed tissues using a 7.5- or 10-MHz 
transducer, it has been shown that the skin is markedly thickened and its echogenicity 
usually decreased with the interface between the dermis and subcutaneous fat often 
blurred (Fornage et al, 1995). 1 did not find any significant differences in skin layer 
thickness between normal controls and patient groups (figure 3.5.1) though the C4b 
group had much higher values present but with a wide scatter of the data points. There 
was a significant increase in the subcutaneous layer thickness between normal controls 
and patient groups which have clinical evidence of tissue oedema present (figure 3.5.2) 
possibly reflecting increased interstitial tissue spaces. 
There was no significant correlation between the skin and subcutaneous layer thickness 
and the Xo and XI-Xo parameters obtained from tissue tonometry (figures 3.5.3 to 3.5.8; 
table 3.5.1). This may reflect the difficulty in making reliable measurements of tissue 
thickness in liposclerotic skin where the tissue boundaries are indistinct. The skin is 
more echogenic and sharply demarcated from the underlying hypoechoic subcutaneous 
fat making the measurement of the skin thickness easy in normal subjects with no 
significant evidence of oedema or inflammatory disease. Lipodermatosclerosis (LDS) 
generally comprises of tissue induration and a sharp inflammatory phase (Schmeller et 
al, 1992 book) and in the chronic phase, the inflammation of the tissues is manifested by 
increased echogenicity which is equal to that of the superficial underlying aponeural 
layer making it practically indistinguishable from the acute phase with the tissue 
echogenicity remaining dense. I therefore looked at the correlation between the 
tonometry parameters and the ultrasound-derived measurements of skin and 
subcutaneous layer thickness in the CO groups alone as compared to the non- 
liposclerotic groups, Coo C2 and C4a. Again, there was no significant correlation present 
(table 3.5.1). 
168 
No association between skin or subcutaneous thickness measurements and any other 
marker of the severity of venous disease could be shown. 
3.5.6. ConcIusions 
Ultrasound measurements of skin thickness and subcutaneous tissue thickness using a 
7.5 MHz linear array probe showed no significant association with other markers of the 
severity of skin damage, especially in patients with the more severe forms of venous 
disease. There was no significant correlation between the ultrasound measurements and 
tissue tonometry parameters, which were previously found to correspond well with the 
clinical severity of the skin damage. 
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3.6. STUDY VI 
The use of tissue tonometry in the assessment of the effects of compression stocking 
wear on the skin compliance in patients with lower limb chronic venous disease. 
3.6.1. Rationale 
The clinical sequelae of lower limb chronic venous disease includes oedema and 
lipodermatosclerosis. The site that is mainly affected is in the lower third of the lower 
limb, mainly in the medial aspect of the gaiter area (Callam et al, 1992). 
Lipodermatosclerosis has been described as a spectrum disease characterised by skin 
induration and hyperpigmentation (Kirsner et al, 1993). It has been previously shown 
that there is a correlation between the healing of venous ulcers and the degree of 
induration (Nemeth et al, 1989). The treatment of patients with lipodermatosclerosis 
have also included the use of compression stockings (Burnand et al, 1980). 
Current methods of quantifying lower limb oedema include water displacement 
volumetry which has been shown to be a sensitive method and is often used as the 'gold 
standard' but this method is very messy and time consuming. The disc model method 
which is a circumferential measurement using a tape measure is another method that is 
used to quantify the limb volume. This method has been shown to have a very good 
correlation with water displacement volumetry (r = 0.99) (Kaulesar-Sukul et al, 1993). 
The effects of compression therapy on the mechanical properties of the skin has never 
been objectively investigated. In this study, the effects of compression stocking wear on 
the mechanical properties of the skin in patients with lower limb chronic venous disease 
and the effect on the limb volume would be assessed by tissue tonometry and a 
circumferential measurement method respectively. 
3.6.2. Aims 
To objectively measure the effects of compression stockings in lower limb chronic 
venous disease using a tissue tonometer to assess the skin compliance. 
The use of a circumferential method to assess the limb volume before and after 
compression stocking wear. 
To assess the outcome of compression treatment on the displacement versus time curves 
obtained from the tissue tonometer. 
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To assess the effects of compression treatment on the spring and dashpot constants 
calculated from the application of the Kelvin-Hooke model. 
3.6.3. Methodology 
Sixteen limbs of eight patients (3M: 5F; mean age of 66.6 years; range 58-75 years) 
referred from the out-patients clinic to the vascular laboratory for non-invasive venous 
studies were investigated. All the subjects had a full non-invasive venous assessment 
with duplex ultrasound to confirm the presence of venous disease and document the 
extent of the disease. Resting ABPI were also measured to confirm the absence of any 
arterial component with indices greater than or equal to 0.9. Subjects with evidence of 
peripheral arterial disease, diabetes, cardiac or renal disease were excluded from the 
study. The patients were investigated by tissue tonometry measurements and 
circumferential limb volume measurements. Informed consent was obtained from all the 
patients prior to the investigations. None of them had previously worn any form of 
compression stockings at least 6 months prior to the study. Three of the 8 patients were 
already on the waiting list for varicose vein surgery within the next 6 months. 
They were all classified according to the CEAP method of classification by the author 
with the modification made to the C4 group applied. Of the 16 limbs, 7 limbs were 
classified as C3 (varicose veins with oedema) and 9 limbs were classified as CO (skin 
changes with palpable induration and no previous ulcers). 
At the initial visit, week 0, all the patients were assessed in the supine position with the 
tissue tonometry measurements made in the gaiter area. The tonometer calibration was 
checked before and after each measurement. Three different sites were measured in all 
the limbs (at 6cm, 10cm and 12cm above the medial malleolus) and the mean value 
obtained for analysis. The limb volumes were measured by the disc model method. 
A specially calibrated stand, designed by the author was used to mark the tonometry 
sites and the circumferential limb volume sites for reproducibility in sequential 
measurements. 
After the tonometry measurements and circumferential limb volume measurements had 
been made, class 2 compression stockings (Venosan 2002, Saltzman, Switzerland) were 
prescribed and the patients measured in the surgical appliances department. They were 
instructed to wear it at all times except for when in bed. They were instructed to return 
in 6 weeks time when the tissue tonometry measurements and circumferential limb 
volume measurements would be repeated. 
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To ensure that the same tonometry sites and disc sites were measured on the second visit 
after 6 weeks, the specially calibrated stand was used to re-locate the previous 
tonometry and disc sites by using the previously noted heights on the column and the 
location of the big toe and heel in relation to the legs of the tripod stand. The tissue 
tonometry parameters and limb volume parameters measurements were repeated as in 
the previous visit. 
Data Analysis 
Displacement versus time curves were obtained from the tissue tonometry 
measurements and the distance and rate constant parameters were calculated by the 
system software for all three phases. 
The spring and dashpot constants were also calculated from the Kelvin-Hooke model. 
Medians and inter-quartile ranges were calculated and used as descriptors and the 
Wilcoxon ranked sums test was applied to test for statistical significance between the 
limb volume measurements by the disc model method and the distance parameter, rate 
constant parameter, spring and dashpot constants for all three phases obtained with the 
tissue tonometer after compression stocking wear. 
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3.6.4. Results 
Tissue tonometry 
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compression stocking wear. 
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Figure 3.6.4 Circumferential limb volume as measured by the disc rmKicl nwthtki 
before and after compression stocking wear 
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Phase I Phase 11 Phase III 
X0 
(MM) 
X0 
(MM) 
Xl-Xo 
(MM) 
Xl-Xo 
(MM) 
-1/Tau 
(secs) 
-1/Tau 
(secs) 
XI-X 0 
(mm) 
Xj-XO 
(MM) 
-1/Tau 
(secs) 
-1/Tau 
(secs) 
_ 
pre- post- pre- post- pre- post- pre- post- pre- post- 
median 1.68 2.34 1 . 66 0.46 2.44 3.07 0.60 0.50 73.92 65.55 
LQ 0.94 1.52 0.44 0.40 2.27 2.52 0.20 , 0.35 , 61.20 1 45.45 
UQ 2.31 2.84 1.10 0.48 3.03 4.20 0.83 1 0.73 1 115.3 1 76.36 
Table 3.6.1 Median and interquartile values of the tissue tonometry parameters of the 
mechanical properties of the skin in patients with lower limb chronic venous disease 
before and after compression stocking wear. 
C2 C, k C, k 
(spring constant) (spring constant) Dashpot 
constant 
(spring 
constant) 
Dashpot 
constant 
Phase I Phase 11 Phase 11 Phase III Phase III 
median 1 1.97 5.00 1 11.89 1 5.56 1 400.08 
LQ 1 1.43 3.00 1 8.77 1 3.97 1237.14 
UQ 1 3.53 7.52 1 17.54 116.32 12043.97 
Table 3.6.2 Median and inter-quartile range values for spring and dashpot constant 
parameters before compression stocking wear in the same group of patients in table 
3.6.1. 
C2 Cl k C, k 
(spring 
constant) 
(spring 
constant) 
Dashpot constant (spring constant) Dashpot 
constant 
Phase I Phase 11 Phase 11 Phase III Phase IT 
median 1.40 1 7.23 23.92 6.58 515.40 
LQ 1.16 1 6.83 19.60 4.54 193.44 
UQ 2.17 1 8.28 34.80 9.60 808.76 
Table 3.6.3 Median and inter-quartile range values for spring and dashpot constant 
parameters after compression stocking wear in the same group of patients in table 3.6.1. 
Phase I I Phase II I Phase III 
X0 
(MM) 
XO x 
(MM) (M] 
Xj-Xo 
(MM) 
Xj-Xo 
(MM) 
ý 
I/Tau 
(Sees) 
-1/Tau 
(secs) 
Xj-Xo 
(MM) 
XI-Xo 
(mm) 
-1/Tau I/Tau 
(secs) (secs) 
pre- 10ý: , DS t re post- pre- post- pre- post- pre- post. 
p value 0.007 
ý0.04 
0.19 0.74 0.12 
Table 3.6.4 p values obtained from the Wilcoxon ranked sums test to test for 
statistical significance between tissue tonometry parameters before and after 
compression stocking wear. 
Phase I Phase Il I Phase III 
C2 C2 Cl Cl kI k Ci Ci k k' 
pre- post- pre- I post-, 
_ 
pre- I post- pre- pre- l post- 
p value 0.003 0.06 0.03 _ 0.57 0.41 
Table 3.6.5 p values obtained from the Wilcoxon ranked sums test to test for 
statistical significance between the spring and dashpot constants obtained from the 
Kelvin-Hooke model before and after compression stocking wear. 
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There was a significant increase in the distance travelled, X0, during phase I (p = 0.007) 
after 6 weeks of compression stocking wear (figure 3.6.1). The distance travelled, Xj- 
X0, during phase R after stocking wear decreased significantly (p = 0.036) (figure 3.6.2). 
Interestingly, in the distance travelled, Xj-XO, during phase III, there was no significant 
difference in this parameter after stocking wear (p = 0.74) (table 3.6.4). There was also 
no significant difference in the rate constant parameters during phases II and III after 
stocking wear (table 3.6.4). 
There was a significant difference in the spring constant parameter of the Hooke 
element, C2, after compression stocking wear (p = 0.003) (table 3.6.5). 
In phase II, the C, and k parameters were significantly increased after stocking wear (p 
0.06; p=0.03) (table 3.6.5) However, during phase 111, there were no significant 
differences in the C, and k parameters after stocking wear (table 3.6.5). 
After 6 weeks of compression stocking wear the median fall in limb volume was 
significantly reduced (median fall in limb volume = 273.3 mls; p=0.0004) (figure 
3.6.4). 
3.6.5. Discussion 
Compression treatment has been used since at least the time of Hippocrates and remains 
the most effective non-operative treatment for patients with lower limb chronic venous 
disease and venous ulceration. A study reporting the results of using compression 
therapy in the management of venous ulcers showed that there was a 97% healing of 
ulcers in patients who were compliant with stocking use as compared to 55% who were 
non-compliant (p< 0.0001) (Mayberry et al, 1991). Patient compliance using 
compression therapy has been a major criticism as some patients may be initially 
intolerant of compression in areas of hypersensitivity adjacent to an active ulcer or at 
sites of previously healed ulcers. Another potential hazard of compression therapy is the 
exacerbation of underlying arterial insufficiency. It has been recommended that patients 
with ulcers of mixed aetiology including arterial insufficiency should not be given 
compression therapy (Callarn et al, 1987). 
The exact mechanism by which compression therapy works remains unknown. 
Investigators using invasive and non-invasive techniques have not been able to show 
significant changes in ambulatory venous pressure or venous recovery times with the 
use of compression therapy (Mayberry et al, 199 1). Others have shown significant trends 
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towards improvement on the venous haemodynamics using air plethysmography with 
compression stockings (Ibegbune et al, 1997). 
Other reported mechanisms suggest that compression therapy has a direct effect on 
subcutaneous pressure with the supine peri-malleolar subcutaneous pressures increasing 
with elastic compression in limbs with chronic venous disease (Nehler et al, 1993). 
Improvements in skin and subcutaneous tissue microcirculatory haemodynamics may 
contribute to the benefits of compression therapy. It has been demonstrated by laser 
Doppler fluxmetry that there is cutaneous hyperaernia in patients with venous disease 
but not in normal controls (Christopoulos et al, 199 1). This was reduced by compression 
treatment for 30 minutes. 
Previous studies using mechanical impedance measurements has shown that in 
oedematous tissues the skin becomes stretched and less distensible and with the 
reduction of the oedema, distensibility tended towards normal values (Sodeman and 
Burch, 1983). The use of compression stockings have been shown to cause a decrease in 
leg volume (Kakkar et al, 1982; Pierson et al, 1983) in patients with lower limb oedema. 
In this study patients were treated for a relatively short period using class 11 compression 
hosiery. This treatment is widely prescribed in the management of chronic venous 
disease, although it is only in recent years that objective assessment of the efficacy of 
this line of management has been undertaken. Clinicians who use such treatments are 
aware that rapid improvements in ulcers and damaged skin may be observed. But could 
these changes be measured objectively? 
There was a significant increase in the distance travelled by the plunger of the tonometer 
amounting to an increase of about one third in X0, during phase I (p = 0.007) 
demonstrating that the skin compliance had improved (figure 3.6.1). The distance 
travelled, XI-Xo, during phase II after stocking wear decreased significantly (p = 0.036) 
indicating that the amount of tissue fluid present beneath the plunger had decreased 
(figure 3.6.2). Interestingly, in the distance travelled, X1-X0, during phase 111, there was 
no significant difference in this parameter after stocking wear (p = 0.74) (table 3.6.4). It 
is possible that although the oedema was decreased in the skin of this group, resulting in 
reduced distance travelled by the plunger, the improvement in tissue compliance caused 
an increase. The two effects may have cancelled each other out. There was also no 
significant difference in the rate constant parameters during phases 11 and III after 
stocking wear (table 3.6.4). 
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There was a significant difference in the spring constant parameter of the Hooke 
element, C2, after compression stocking wear (p = 0.003) (figure 3.6.3). The C2 
parameter decreased significantly and as this constant is a measure of the initial ability 
of the skin to undergo elastic deformation after force had been applied to it and the 
lower the value, the better the compliance of the skin. 
The spring constant, C1, of the Kelvin element and the dashpot constant, k, provide a 
measure of the subsequent deformation, XI-Xo, for a given load. This gives a measure of 
the amount of tissue oedema present. As they are inversely related , the C, and k 
parameters would be lower if the distance travelled by the plunger in the viscous creep 
phase increases and vice versa. In phase U, the C, and k parameters were significantly 
increased after stocking wear (p = 0.06; p=0.03) (tablee 3.6.5) as a result of the 
decrease in the Xj-XO parameter (table 3.6.1) indicating reduced tissue fluids beneath 
the plunger. However, during phase 111, there were no significant differences in the C1 
and k parameters after stocking wear (table 3.6.5). 
The results shown by tissue tonometry could have been attributable to measurements 
being made in different positions on the limb from on the first occasion. However, great 
care was taken to avoid this by the use of a device to ensure that all measurements were 
made at the same level above the sole of the foot on each occasion. Had the location of 
measurement been different, the observations would have included much more variance. 
In fact, for the phase I distance, all except three observations showed a change in the 
same direction, confirming that a real effect of compression treatment had been 
observed. 
After 6 weeks of compression stocking wear, the median fall in limb volume was 273 
ml as measured by the disc model method, about a 10% fall in limb volume. This 
finding is consistent with the expected influence of compression stockings on the 
Starling equilibrium between intravascular and extracellular compartments, reducing 
limb oedema. Measurements were made immediately after removing the stocking at the 
second visit so that the changes in volume may have also been attributable to a reduction 
in the venous volume (the volume of blood in the small and large veins). This is 
suggested by the reduced distance parameter during phase 11, which probably mainly 
reflects the volume of blood in the veins. 
The measurements reported here show that very distinct changes in the mechanics of the 
skin and limb volume can be measured in patients following a short period of 
compression treatment. 
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3.6.6. Conclusion 
The response to compression treatment used for 6 weeks can be readily assessed by 
tissue tonometry. This technique is sensitive enough to show changes in skin 
compliance as well as indicating some reduction in the volume of the venous 
compartment. Circumferential limb volumetry was used to confirm that compression 
treatment had also influenced a conventional measure of the efficacy of treatment and 
showed a 10% reduction in limb volume following treatment. 
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3.7. STUDY VII 
The CEAP method of classification and scoring of lower limb venous disease - ease of 
use and inter-exan-fter variability. 
3. Z1. Rationale 
In the past, research into lower limb chronic venous disease had relied mainly on the 
clinical appearance of the clinical sequelae of the disease such as varicose veins, skin 
changes and ulceration without any objective methods of testing of the venous system to 
confirm the diagnosis. This has led to non-uniform diagnosis between centres resulting 
in poor correlation of results between the different treatment practices in lower limb 
chronic venous disease. 
The CEAP system of classification was introduced because there was a need for uniform 
diagnosis and meaningful scientific communication between research centres. 
The methods of classification, grading and reporting of lower limb venous disease used 
throughout in this thesis are based on the recently devised Clinical, (A)Etiological, 
Anatomical and Pathophysiological method (CEAP) of classification and grading of 
lower limb chronic venous disease. 
The CEAP classification presents a new level of diagnosis in lower limb chronic venous 
disease and has been criticised for being too complex as it requires more detailed 
analysis of the disease involving several tables (Beebe et al, 1995). However, the 
requirements for the CEAP method of classification are similar to those used for 
diagnosing peripheral arterial disease, which has been in use for some time. A feature of 
the CEAP method of classification of lower limb chronic venous disease is the scoring 
system of chronic venous dysfunction that is incorporated within the system, based on 
the thought that though the grading of symptoms is subjective, the grading of signs is 
objective. This provides a numerical base for the scientific comparison of limb 
condition and evaluation of results of treatment based on the number of anatomic 
segments affected (anatomic score), grading of symptoms and signs (clinical score) and 
disability (disability score). 
The initial evaluation of patients with suspected chronic venous disease relies on the 
history taking and physical examination of the patient. A patient presenting with 
symptoms that may be related to venous disease should have a non-invasive test to 
confirm or exclude the presence of venous dysfunction. 
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In order to assess the ease of use of this classification system, I have measured the inter- 
variability between different examiners with varying degrees of experience in the field, 
by applying the kappa measure of agreement between the examiners as described by 
Cohen et al in 1960. 
3.72. Aim 
To assess the inter-variability between examiners and ease of use of the application of 
the CEAP method of classification and scoring of lower limb venous disease. 
3.73. Methodology 
Twenty eight limbs of 14 patients (6M: 8F; mean age of 56.6 years; age range: 25 -75 
yrs) referred to the vascular laboratory for non-invasive venous assessment of their 
limbs were classified and scored for lower limb venous disease according to the CEAP 
method. 
Each limb was classified and scored for the disease by three different examiners with 
varying degrees of expertise in the field with their results remaining unknown to each 
other. Examiner A is an experienced vascular surgeon (senior specialist registrar in 
vascular surgery) who is also a research fellow in the vascular laboratory. Examiner B, 
the author, is an accredited vascular technologist with 6 years experience in the duplex 
ultrasound examination of lower limb venous disease. Examiner C is a trainee vascular 
technologist with 1 year experience of lower limb venous investigations, which also 
includes duplex ultrasound examination. 
The method of clinical classification and whether the patient is symptomatic or 
asymptotic, required all three examiners to take a history and examine the patient 
clinically, following the strict guidelines of this method of classification. However, due 
to the nature of the CEAP method of classification, the other classification details of 
aetiology, anatomy and pathophysiology could only be completed using information 
obtained from duplex ultrasound scanning. In these cases, only one examiner (examiner 
B) performed the duplex ultrasound investigation and produced a standard report from 
which the other examiners could complete their classification of the disease. This was 
necessary as examiner B was the most experienced in duplex ultrasound scanning thus 
avoiding the variations that may occur between different examiner's reports. 
Similarly, for the scoring of the disease, the clinical score and disability score were 
obtained from direct correspondence with the patient, following the strict guidelines of 
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this method of scoring. For the anatomical score, again, the examiners had to acquire 
their information from the report produced by examiner B after duplex ultrasound 
scanning. The data from all three examiners were examined and the kappa measure of 
agreement was applied to compare the inter-examiner variability between the three 
examiners using examiner A, the clinician and vascular surgeon, as the reference 
standard. 
Statistical analysis 
The method for the kappa measure of agreement is used for analysis and is described 
in details in see section 2.11. 
The maximum value of kappa is 1, which represents perfect agreement, and kappa will 
I 
take the value zero if there is only chance agreement. 
3.7.4. Results 
CEAP Method of classification CEAP Method of scoring 
Pt No Clinical A/S Etiologic I Anatomic Pathophysiologic Clinical Disability Anatomic Examiner 
I CO A E A p 0 0 0 A 
I CO A E A p 0 0 0 It 
I CO A E A p 0 0 0 C 
I CO A E A p 0 0 0 A 
I CO A E A p 01 0 0 It 
I CO A E A p 0 0 0 C 
2 C() A E A p 0 0 0 A 
2 C, A E A p 0 0 0 it 
2 CO A E A p 0 0 0 C 
2 CO A E A p 0 0 0 A 
2 CO A E A p 0 0 0 11 
2 CO A E A p 0 0 0 C 
3 CO A E A p 0 0 0 A 
3 CO AI E AI p 0 0 0 It 
3 CO A E A p 0 0 0 C 
3 CO A E A p 0 0 0 A 
3 CO A E A p 0 0 0 It 
3 CO A E A p 0 0 0 C 
4 CO A E A p 0 0 1 A 
4 C, A E A p 0 0 1 It 
4 CO A E A p 0 0 1 C 
4 C, A E A p 0 0 A 
4 C, A E A p 0 0 It 
4 C, A E A p 0 0 C 
5 C2 S Ep Asy PR 1 3 A 
5 C2 S Ep Asy PR 1 3 11 
5 C2 S Ep Asp PR 3 C 
5 C2 S Ep Asp PR 2 A 
5 C2 S Ep Asp PR 2 11 
5 C2 S Ep Asp PR 2 C 
6 C2 S Ep A. q PR 3 A 
6 C2 IS Ep As PR 3 11 
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CEAP Method of classification CEAP Method of scoring 
Pt No Clinical A/S Etiologic Anatomic Pathophysiologic Clinical Disability Anatomic Examiner 
6 C2 S Ep As PR 1 1 3 C 
6 C, S Ep As PR 3 1 3 A 
61 Ci S1 Ep As PR 3 3 B 
6 ci S1 Ep As 1 PR 3 1 3 
C 
7 c-, A Ep As PR 1 0 3 A 
7 CI A Ep As PR 1 0 3 B 
7 C2 A Ep As PR 0 0 3 C 
7 C, , S Ep As PR 2 1 4 A 
7 ci S Ep As PR 2 1 4 B 
7 C2 S Ep As PR I 1 4 C 
8 C, S Ep As PR 2 1 2 A 
8 C, 3 S, Ep As PR 2 1 2 11 
8 C2 s Ep As 1 A 
PR 1 1 2 C 
8 C, 
_ S Ep As 
s 
A PR 2 1 2 A 
8 C3 L Ep As As PR 2 2 B 
8 C2 - S Ep A 
ýq 
As 
g 
PR 1 2 C 
9 C4 S Es s PD As pD PR 3 2 A 
C4 S Es A___ As. p. D PR 3 2 6 11 
9 C, S ES Asp. D PR 3 2 6 C 
9 C4 S Es As. P. D PR 3 2 7 A 
9 C4 S Es A. 3. P. D PR 3 2 7 it 
9 C4 S Es A. S. P. D PR 3 
_2 
7 C 
10 C4 S Es Ajs. P. D PR 4 2 4 A 
10 C4 S ES As. p. D PR 4 2 4 B 
10 C4 S Es Asf. D PR 4 2 4 C 
10 C4 S Ep As PR 4 2 3 A 
10 C4 S Ep As PR 4 2 3 11 
10 C4 S Ep As 1 PR 4 2 3 C 
11 C4 S Ep As PR 7 2 2 A 
11 C4 S Ep As PR 6 2 2 11 
11 C4 S Ep As PR 6 2 2 C 
11 C4 S Ep As PR 7 2 2 A 
11 C4 S Ep As PR 7 2 2 B 
11 C4 S Ep As PR 7 2 2 C 
12 C6 S Es As r) As r) PR 12 2 5 A 
12 C6 S Es SD PR 12 2 5 11 
12 C6 S Es ASD PR 10 2 5 C 
12 C6 S Ep s As PR 11 2 2 A 
12 C6 S Ep As PR 11 2 2 11 
12 Cei S Ep As PR 11 2 2 C 
13 C4 S Ep As PR 7 2 2 A 
13 C4 S Ep As PR 7 2 2 11 
13 C4 S Ep As PR 7 2 2 C 
13 C4 S Ep As PR 7 2 2 A 
13 C4 S Ep As PR 7 2 2 B 
13 C4 S Ep As PR 7 2 2 C 
14 c-% S Ep As PR 8 2 2 A 
14 C-5 S Ep As PR 8 2 2 11 
14 cý5 Ep As PR 8 2 2 C 
14 C-5 Ep As PR 10 2 2 A 
14 C5 S Ep As PR 10 2 2 1; r111 
C4 1S Ep As PR 8 2 2 
C 
Table 3.7.1 Inter-variability of the ceap method of classification and scoring of lower 
limb venous disease between different examiners. 
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Examiner A 
CEAP method of classification CEAP method of scoring 
Clinical Etiological A/S Anatomical Patho- 
physiological 
Clinical Disability Anatomical 
Examiner 
B 
0.875 1.00 1.00 - 1.00 1.00 0.90 1.00 1.00 
Examiner 
C 
0.60 1.00 1.00 1.00 1.00 0.52 1.00 1.00 
Table 3.7.2 Summary of the kappa measure of agreement between the different 
examiners. 
There was perfect agreement between all three observers in all the parameters measured 
with the exceptions of the clinical methods of classification and scoring parameters 
(tables 3.7.1 and 3.7.2). 
There was excellent agreement between examiners A and B in the clinical methods of 
classification and scoring parameters. 
There was fair to good agreement between examiners A and C in the clinical methods of 
classification and scoring parameters. 
3.7.5. Discussion 
The aim of this study was to assess the ease of use of the CEAP method of 
classification. This involves use of both clinical skills and the interpretation of objective 
vascular laboratory tests in order to establish the complete classification of a patient. 
There was perfect agreement between examiners A and B in all the parameters assessed 
with the exception of the clinical classification and clinical scoring parameters which 
had excellent agreement. The disagreements lay in the clinical examination of patients 
and therefore it is not surprising that the person with the least experience of clinical 
skills fared least well in this part of the assessment. The perfect agreements between the 
classification paramctcrs of actiology, anatomy and pathophysiology and in the 
anatomical scoring parameter were expected as all three examiners relied on the 
accuracy of the duplex ultrasound report analysis produced by examiner B. The duplex 
ultrasound report provided details of the pathophysiology and anatomy of the limb under 
investigation and all the examiners had to do was follow the detailed instructions 
described in the CEAP method to classify and score the disease. This system if used by 
vascular surgeons would rely on vascular technologists to provide the aetiological, 
anatomical and pathophysiological aspects of the classification in addition to their 
clinical classifications to get the full picture. 
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The slight difference in the clinical classification parameter between examiners A and B 
arose as a result of examiner A not identifying the presence of some dermal flares in I 
limb (rt leg of pt no 4) which were identified by examiner B who had the advantage of 
close-up view of the limb while performing the duplex scan. The reason for the slight 
discrepancy in the clinical scoring parameter between examiners A and B was due to 
one of the limbs (rt leg of pt no 11) classified by examiner A as having moderate 
oedema whereas examiner B classified it as having significant oedema. 
Between examiners A and C, there was also perfect agreement in all the parameters 
assessed with the exception of the clinical classification and clinical scoring parameters 
which had a fair to good agreement. For the same reasons as described above, the 
perfect agreement between the classification parameters of aetiology, anatomy and 
pathophysiology and in the anatomical scoring parameter was expected. However, the 
discrepancy in the clinical classification parameter between examiners A and C is most 
likely to be due to the lack of clinical experience of examiner C in identifying details of 
the disease. In 4 limbs, examiner C failed to clinically identify the presence of oedema, 
failed to identify presence of localised pigmentation in 2 limbs and classified I limb 
with previous episodes of ulceration as liposclerotic with no evidence of previous 
ulceration. These differences between examiners A and C appear largely due to the fact 
that examiner C, a trainee vascular technologist, did not appreciate the difference 
between moderate and significant in the clinical aspects of chronic venous disease. 
There were also some discrepancies in the clinical scoring between examiners A and C 
with examiner C underscoring in 7 limbs again reflecting a lack of clinical experience in 
assessing lower limb venous disease. 
This study confirms that, in a limited range of patients, the parts of the CEAP 
classification based on vascular laboratory investigation are very reliable and depend 
exclusively on the accuracy of the vascular laboratory report. The repeatability of 
venous duplex ultrasound investigations was not tested in this investigation, although 
the results of this type of study have been reported elsewhere in the literature. The 
clinical classification and scoring depend greatly on the clinical skills of the examiner 
and experience is required to achieve consistent results in this type of examination. 
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3.7.6. Conclusions 
The worry expressed by some authors (Darke and Ruckley, 1996) of this method of 
classification 'requiringfeats of memory or constant reference to keys' should be easy 
to overcome. It was envisaged as a method of categorising data when entered into 
computer databases, when used to its fullest extent. Data categorised in this way could 
then be used to compare the patients in clinical studies performed in centres separated 
by great distances. This study confirms in a simple way, that provided reliable clinical 
examination is performed by a skilled clinician and that vascular laboratory testing is 
performed by a trained vascular technologist, reliable classification of patients with 
venous disease can be obtained using the CEAP system. 
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3.8. STUDY VIII 
Correlation of the CEAP method of classification and scoring of lower limb chronic 
venous disease with objective non-invasive methods of quantifying the clinical sequelae 
of the disease. 
3.8.1. Rationale 
The tissue tonometer developed in our laboratory has been shown to be a reliable and 
reproducible method of objectively assessing the skin changes in patients with lower 
limb chronic venous disease. 
The quantification of venous reflux plays an important role in venous disease research. 
Techniques such as air plethysmography and duplex scanning are well established in 
quantifying reflux with the former providing a measure of total limb volume and the 
latter providing volume measurements in individual veins. 
The majority of clinical investigations performed using air plethysmography involve 
patients with lower limb venous disease. The haemodynamic characteristics associated 
with progressive chronic venous disease have also been investigated with the parameters 
obtained from APG (Welkie et al, 1992). 
It has been shown that the combination of air plethysmography and duplex ultrasound 
scanning provides the best means of assessing venous reflux (Bays et al, 1994) and for 
the complete evaluation of limbs with chronic venous disease (van Bernmelen et al, 
1993). 
3.8.2. Aims 
To correlate duplex-derived parameters of lower limb venous reflux quantification with 
the clinical severity of the disease as classified by the CEAP method. 
To correlate air plethysmography-derived parameters of venous function and arterial 
perfusion with the clinical severity of the disease as classified by the CEAP method. 
To correlate photoplethysmography-derived parameters of venous function and arterial 
perfusion with the clinical severity of the disease as classified by the CEAP method. 
To correlate the tissue tonometry-derived parameters of the mechanical properties of 
lower limb skin changes with the clinical severity of the disease as classified by the 
CEAP method. 
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To correlate the Doppler-derived resting ankle brachial. pressure indices (ABPI) and 
APG-derived arterial perfusion within the CEAP groups. 
Materials 
The Acuson 128XP/lOv (Acuson, Mountain View, California, USA) computed 
sonography system with ART (acoustic response technology) using a 5- or 7.5- MHz 
linear array transducer was used for all the measurements below. 
A tissue tonometer designed and built by PDCS and standardised by JF. 
A model PPG 13 Vasculabo Photoplethysmograph (PPG) (Medasonics, Mountain View, 
California). 
An air plethysmograph , APG- 1 OOOC (ACI Medical inc., Sun Valley, California). 
A standardised rapid cuff inflation and deflation unit constructed in our laboratory 
(Middlesex Hospital Vascular Laboratory, 1995) with a calf cuff width of 12cm was 
used to augment flow in the vessels. 
A sonic digitiser pen was used to calculate area measurements from the spectral Doppler 
display. 
Methodology 
Eighty two limbs of 41 subjects (18M: 23F; mean age of 57.2 years; age range 21-90 
years) referred to the vascular laboratory for non-invasive venous investigations were 
entered in the study. They all had an initial full standard non-invasive venous 
assessment at the Middlesex Hospital Vascular laboratory with colour duplex ultrasound 
scanning. All limbs were classified and scored according to the CEAP method of 
classification of lower limb venous disease with a section of the classification system 
modified by the author included in the classification. The CEAP modification was 
applied here to subdivide the classification group C4 to separate patients with skin 
changes and no palpable induration into group C4a, from those with skin changes with 
palpable evidence of induration into group C4b- 
The inclusion criteria for normal subjects include limbs with no evidence of venous or 
arterial disease and for the patient group, limbs with evidence of venous disease. 
Patients with diabetes, cardiac disease, kidney disease or peripheral arterial disease of 
the lower limbs as demonstrated by a resting ABPI of < 0.90 were excluded from the 
study. 
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Subjects underwent full duplex ultrasound investigation of all the veins in the lower 
limb to document the extent of the disease for a full classification and scoring of the 
disease according to the CEAP method. Resting ankle brachial pressure indices were 
also measured to confirm presence or absence of any significant peripheral arterial 
disease The patient was invited to enter the study after patient consent had been 
obtained. On a second visit, the subject underwent 2 hours of non-invasive 
measurements which included air plethysmography, resting ankle brachial pressure 
indices, photoplethysmography, tissue tonometry and the Duplex ultrasound derived 
parameters. 
Duplex ultrasound scanning to quantify the reflux volume flow with the following 
parameters measured from the B-mode image and the frozen spectral Doppler display: 
vessel diameter, time-averaged velocity and duration of reflux. Air plethysmography, 
resting ankle brachial pressure indices, photoplethysmography and tissue tonometry 
were carried out on all the above 82 limbs of selected patients and the correlation of the 
derived parameters with the clinical severity of the disease were analysed. 
3.8.3. Results 
The limbs of the subjects were clinically classified as follows: 
Eight limbs of CEAP class CO (4MAF; mean age of 33.2 yrs; age range 21-55 yrs); 
Ten limbs of CEAP class CI (lM: 9F; mean age of 52.4 yrs; age range 22-90 yrs); 
Ten limbs of CEAP class C2 (IM: 9F; mean age of 51.9 yrs; age range 22-72 yrs); 
Eleven limbs of CEAP class C3 (2M: 9F; mean age of 59.1 yrs; age range 44-90 yrs); 
Thirteen limbs of CEAP class C4a (9MAF; mean age of 62.4 yrs; age range 40-83 yrs); 
Ten limbs of CEAP class CO (IM: 9F; mean age of 64.5 yrs; age range 50-75 yrs); 
Ten limbs of CEAP class C5 (5M: 5F; mean age of 61.8 yrs; age range 50-71 yrs); 
Ten limbs of CEAP class C6 (8M: 2F; mean age of 68.4 yrs; age range 22-90 yrs); 
Of the 82 limbs, 54 (66%) were of the aetiology Ep and 13 (16%) of the aetiology E, 
Twenty five limbs (3 1 %) were asymptornatic and 57 limbs (70%) were symptomatic. 
Reflux was distributed between the superficial, deep and perforator systems of the limbs 
as follows: 36 As (44%), AD (0%), 2 Ap (2.4%), 7 As, D (8.5%), 9 Asy (11%), 2 AP, D 
(2.4%) and II As, PD (13%) and 15 with no evidence of reflux (18%). 
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Duplex-derived reflux parameters results 
Duplex-derived Reflux Fraction vs CEAP classification 
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Figure 3.8.1 Duplex-derived reflux fraction in superficial venous segments in normal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-derived Reflux Fraction vs CEAP classification 
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Figure 3.8.2 Duplex-derived reflux fraction in deep venous segments in nonnal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-derived Reflux Volume Flow vs CEAP classification 
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Figure 3.8.3 Duplex-derived reflux volume flow in superficial venous segments in 
normal subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical si0ficance between the different CEAP groups. 
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Duplex-derived Reflux Volume Flow vs CEAP classification 
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Figure 3.8.4 Duplex-defived reflux volume flow in deep venous segments in normal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-defived Peak Reflux Velocity Ratio vs CEAP classification 
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Figure 3.8.5 Duplex-derived peak reflux velocity ratio in superficial venous segments 
in normal subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-dedved Peak Reflux Velocity Ratio vs CEAP classification 
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Figure 3.8.6 Duplex-derived peak reflux velocity ratio in deep venous segments in 
normal subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-T"ed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-derived Reflux. Timme Ratio vs CF-AP cl2ssif scation 
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Figure 3.8.7 Duplex-derived reflux time ratio in superficial venous segments in normal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney 11 test) applied 
to test for statistical significance between the different CEAP groups 
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Duplex-derived Reflux Time Ratio vs CEAP classification 
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Figure 3.8.8 Duplex-defived reflux time ratio in deep venous segments in normal 
subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
197 
110 
60 
10 
-40 
-90 rz M. -140 >, -190 
-240 
-290 
-340 
_390 
-440 
-490 
-540 0 -590 
Duplex-derived Doppler Efficiency Index (El d) vs CEAP classification 
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Figure 3.8.9 Duplex-derived Doppler Efficiency Index in superficial venous segments 
in normal subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-T"ed P values corrected for ties (Mann-Whitney U test) applied 
to test for statistical significance between the different CEAP groups. 
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Duplex-derived Doppler Efficiency Index (El d) vs MP classification 
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Figure 3.8.10 Duplex-derived Doppler efficiency index in deep venous segments in 
normal subjects and in patients with CVD classified according to the CEAP method of 
classification with the 2-Tailed P values corrected for ties (Mann-Whitnev U test) applied 
to test for statistical significance between the different CEAP groups 
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Duplex-defived total Reflux Volurne Flow vs CEAP classification 
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Figure 3.8.11 Duplex-derived total reflux volume flow in corresponding segments in 
normal subjects with all incompetent segments in patients with CVD classified according 
to the CEAP method of classification with the 2-Tailed P values corrected for ties 
(Mann-Whitney U test) applied to test for statistical significance between the different 
CEAP groups. 
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Figure 3.8.12 Duplex-defived total valve closing times (tVCT) in corresponding 
segments in normal subjects with all incompetent segments in patients with CVD 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Duplex-derived superficial vein diameters vs CEAP 
classification 
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Figure 3.8.13 Duplex-derived superficial vein diameters in normal subjects and in 
patients classified according to the CEAP method of classification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Subject Height vs CEAP classification 
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Figure 3.8.14 Variations in subject heights (cm) in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Body Weight vs CEAP classification 
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Figure 3.8.15 Variations in subject body weight (kg) in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Clinical Score vs CEAP classification 
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Figure 3.8.16 CEAP method of clinical scoring in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Anatomical Score vs CEAP class ification 
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Figure 3.8.17 CEAP method of anatomical scoring in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Disability Score vs CEAP classification 
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Figure 3.8.18 CEAP method of disability scoring in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Figure 3.8.19 Variations in the body mass index in normal subjects and in patients 
classified according to the CEAP method of classification with the 2-Tailed P values 
corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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Body Surface Area vs CEAP classification 
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Figure 3.8.20 Variations in the body surface area in normal subjects and in patients 
classified according to the CEAP method of classification WIth the 2-Tailed P 'Values 
corrected for ties (Mann-Whitney U test) applied to test for statistical sIgnIficance 
between the different CEAP groups. 
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APG-derived Outflow Fraction (%) vs CEAP classification 
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Figure 3.8.21 APG-defived Outflow Fraction (%) in normal subjeos and in patients 
with CVD classified according to the CEAP method of classification with the 2-Talled P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
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APG-derived Arterial Inflow vs CEAP class ification 
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Figure 3.8.22 APG-derived Arterial Inflow (ml/min) in normal subjects and in patients 
with CVD classified according to the CEAP method of classification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical significance 
between the different CEAP groups. 
211 
APG-dedved Venous Filling Index vs CEAP classification 
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Figure 3.8.23 APG-derived Venous Filling Index (n-d/sec) in normal subjects and in 
patients with CVD classified according to the CEAP method of classification with the 2- 
Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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APG-derived Venous Volume (nd) vs CEAP classification 
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Figure 3.8.24 APG-derived Venous Volume (ml) in normal subjects and in patients 
with CVD classified according to the CEAP method of classification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to test for statistical sIgFUfiC&nCC 
between the different CEAP groups. 
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APG-derived Ejection Fraction vs CEAp ciassificstion 
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Figure3.8.25 APG-derived Ejection Fraction(%) m normal abjects and in pat wnt % 
with CVD classified according to the CEAP method of clusification with the 2-Tailed P 
values corrected for ties (Mann-Whitney U test) applied to t" Cof statistical -igniticarwe 
between the different CEAP groups 
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Figure 3.8.26 APG-derived Ejected Volume (ml) in normal abject s and in patiems with 
CVD classified according to the CEAP method of cla&Wfication with the 2-Twkd P 
values corrected for ties (Mann-Whitney U test) applied to test for %tati%tical %AKrulikamc 
between the different CEAP groups. 
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Figure 3.8.29 Distance travelled by plunger (mm) during phase I in normal subjects and 
in patients with CVD classified according to the CEAP method of classification with the 
2-Tailed P values corrected for ties (Mann-Whitney U test) applied to test for statistical 
significance between the different CEAP groups. 
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Correlation Results 
r 
value 
APG-derived parameters versus Duplex-derived parameters 
0.25 APG-derived Venous Filling Index and Duplex-derived total Reflux Volume. 
0.04 APG-derived Venous Filling Index and duplex-derived total valve closing time. 
-0.33 APG-derived Venous Filling Index and Duplex-derived total Doppler Efficiency 
Index. 
0.15 APG-derived Venous Filling Index and Duplex-derived total Reflux Time 
Ratio. 
0.12 APG-derived Venous Filling Index and Duplex-derived total Peak Reflux 
Velocity Ratio. 
-0.41 APG-derived Venous Filling Index and PPG-derived Venous Refilling Times. 
-0.05 APG-derived Arterial Inflow and DoPpler-derived Resting Ankle Brachial 
Pressure Indices. 
-0.19 PPG-derived Venous Refilling Times and Duplex-derived total Reflux Time 
Ratio. 
-0.01 PPG-derived Venous Refilling Times and Duplex-derived total Reflux Volume. 
-0.28 PPG-derived Venous Refilling Times and Duplex-derived total valve closing 
time. 
Table 3.8.3 Regression analysis between PPG-derived, APG-derived and duplex- 
derived parameters to calculate the correlation value between the methodologies. 
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r 
value 
Tonometry-derived parameter of skin compliance versus APG-derived 
parameters, Duplex-derived parameters, PPG-derived parameters, CEAP 
scoring parameters and patient data. 
-0.1 Distance travelled, X0, during phase I and APG-derived outflow fraction. 
-0.14 Distance travelled, X0, during phase I and APG-derived venous volume. 
-0.34 Distance travelled, X0, during phase I and APG-derived venous filling index. 
0.04 Distance travelled, X0, during phase I and APG-derived ejection volume. 
0.21 Distance travelled, X0, during phase I and APG-derived ejection fraction. 
-0.06 Distance travelled, X0, during phase I and APG-derived residual volume 
fraction. 
-0.37 Distance travelled, X0, during phase I and APG-derived arterial inflow. 
0.57 Distance travelled, X0, during phase I and PPG-derived venous refilling time 
(no cuffs). 
-0.07 Distance travelled, X0, during phase I and duplex-derived total valve closing 
time. 
-0.61 Distance travelled, X0, during phase I and diameter of incompetent veins. 
0.08 Distance travelled, X0, during phase I and patient height. 
-0.36 Distance travelled, X0, during phase I and patient age. 
-0.27 Distance travelled, X0, during phase I and patient weight. 
-0.18 Distance travelled, X0, during phase I and patient body surface area. 
0.32 Distance travelled, X0, during phase I and patient body mass index. 
0.12 Distance travelled, X0, during phase I and duplex-derived reflux fraction. 
-0.01 Distance travelled, X0, during phase I and duplex-derived total reflux volume. 
0.27 Distance travelled, X0, during phase I and duplex-derived peak reflux velocity 
ratio. 
0.13 Distance travelled, X0, during phase I and duplex-derived reflux time ratio. 
-0.12 Distance travelled, X0, during phase I and duplex-derived Doppler efficiency 
index. 
-0.75 Distance travelled, X0, during phase I and CEAP clinical score. 
-0.59 Distance travelled, Xo, during phase I and CEAP disability score. 
-0.48 Distance travelled, Xo, during phase I and CEAP anatomical score. 
Table 3.8.4 Regression analysis between tonometry-derived parameter of the skin 
compliance, duplex-derived parameters, PPG-derived parameters, CEAP scoring 
parameters and patient data to calculate the correlation value between the different 
methodologies. 
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3.8.5. Discussion 
In this study the purpose of the investigation was to establish the relationship between 
the severity of the venous disease indicated by the clinical classification (CEAP) and 
duplex ultrasound and plethysmographic methods of investigating the function of the 
venous system. A number of authors have investigated this problem previously but no 
study has tested the CEAP system in this way and neither has the clinical status been 
checked using the tonometry technique to assess skin compliance which I have shown in 
earlier chapters is a very reliable indicator of the severity of venous disease, when used 
in the correct way. 
The use of duplex ultrasound scanning in investigating valvular dysfunction in the 
superficial, deep and perforating veins has suggested that they all contribute to a critical 
level of total reflux and that reflux in the popliteal and tibial veins correlated well with 
the severity of disease (Vasdekis et al, 1989). Using a standardised cuff deflation 
technique, they demonstrated that there was a high incidence of skin changes in limbs 
with a cumulative peak reflux greater than 10ml/sec. They calculated the peak reflux 
volume flow at the time of peak reflux velocity. The diameter of the vein at the site of 
reflux is measured using B-mode instrumentation and the peak reflux velocity (PRV) is 
determined from the velocity waveform after cuff deflation obtained from the spectral 
Doppler analysis using pulse-wave Doppler mode instrumentation. 
In the sample population investigated, 44% had SVI only and 22% had a combination of 
SVI and DVI. These figures were similar to those of Labropoulos et al 1995 and Shami 
et al 1993. Interestingly in my study population none of the patients with skin changes 
was as a result of DVI alone compared to 11% (Labropoulos et al, 1995); and 15% 
(Shami et al, 1993) in earlier studies. The number of patients with skin changes due to 
perforator incompetence only was 2.4% in my sample population, which was very 
similar to Labropoulos et al sample population with 3% (Labropoulos et al, 1995). 
The duplex-derived reflux fraction parameter in the superficial veins were significantly 
higher in the groups (C2-C6) with evidence of significant reflux (i. e. reflux lasting longer 
than 0.5 seconds) as compared to the Co and Ci groups which have no evidence of 
significant reflux (i. e. reflux lasting less than 0.5 seconds). There was no statistically 
significant difference in this parameter between the C2 and C6 groups and between the 
CO and C, groups (Figure 3.8.1). 
There was a significant increase in the reflux fraction parameter of the incompetent deep 
venous system segments in patients in the C3 to C6 groups as compared to those in the 
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CO, C, and C2 groups with no evidence of deep venous incompetence. There was no 
significant difference in this parameter between the CO, C, and C2 groups as there were 
no patients with incompetent deep veins in the C2 patient group. Similarly, there were 
no significant differences between the groups with deep venous incompetence except for 
the C4a and CO groups (p=0.05) and the CO and C6 groups (p=0.04) which showed 
some significance though there was considerable overlap (Figure 3.8.2). 
The duplex-derived reflux volume flow parameter in the superficial veins were 
significantly higher in the groups (C2-C6) with evidence of significant reflux (i. e. reflux 
lasting longer than 0.5 seconds) as compared to the CO and C, groups which have no 
evidence of significant reflux (i. e. reflux lasting less than 0.5 seconds). There was no 
statistically significant difference in this parameter between the CO and C, groups and 
between the C3 and C6 groups but in the C2 group, the reflux volume flow was 
moderately reduced as compared to the other groups with reflux with the exception of 
the C5 group though there was a wide scatter in the data points between these groups. 
(Figure 3.8.3). This would suggest that in the C2 group the amount of venous reflux was 
not as extensive as in the other groups with more extensive clinical sequelae. 
There was a significant increase in the reflux volume flow parameter of the incompetent 
deep venous system segments in patients in the C3 to C6 groups as compared to those in 
the CO, C, and C2 groups with no evidence of deep venous incompetence. There were no 
significant differences in this parameter between the CO, C, and C2 groups as there were 
no patients with incompetent deep veins in the C2 patient group. Similarly, there were 
no significant differences between the groups with deep venous incompetence except for 
the C4a and C5 groups (p=0.05) which showed some significance though there was 
considerable overlap (Figure 3.8.4). 
The duplex-derived peak reflux velocity ratio in the superficial veins were significantly 
higher in the C2 to C6 groups with significant reflux as compared to the CO and C, 
groups with no significant reflux. Again, there were no significant differences in this 
parameter between the C2 and C6 groups and the CO and C, groups (Figure 3.8.5). 
There was a significant increase in the duplex-derived reflux velocity ratio parameter of 
the incompetent deep venous system segments in patients in the C3 to C6 groups as 
compared to those in the CO, C1 and C2 groups with no evidence of deep venous 
incompetence. There were no significant differences in this parameter between the CO, 
C, and C2 groups as there were no patients with incompetent deep veins in the C2 
patient group. Similarly, there were no significant differences between the groups with 
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deep venous incompetence except for the C4a group (p=0.03) which had a lower value 
amongst the C3 to C6 groups but there was considerable overlap in the data (Figure 
3.8.6). 
The duplex-derived reflux time ratio parameter in the superficial veins were 
significantly higher in the groups (C2-C6) with evidence of significant reflux (i. e. reflux 
lasting longer than 0.5 seconds) as compared to the Co and C, groups which have no 
evidence of significant reflux (i. e. reflux lasting less than 0.5 seconds). The reflux time 
ratio was calculated by dividing the valve closing time by the valve opening time 
obtained from the spectral Doppler traces as described earlier. There were no 
statistically significant differences in this parameter between the C2 and C6 groups 
though there was moderate differences between the C2 and C3 groups compared with the 
more severe groups though with some overlap present in the data points. There were no 
significant differences between the Co and C, groups (Figure 3.8.7). 
There was a significant increase in the duplex-derived reflux time ratio parameter of the 
incompetent deep venous system segments in patients in the C3 to C6 groups as 
compared to those in the C0, C, and C2 groups with no evidence of deep venous 
incompetence. There were no significant differences in this parameter between the Co, 
C, and C2 groups as there were no patients with incompetent deep veins in the C2 
patient group. Similarly, there were no significant differences between the groups with 
deep venous incompetence except for the C5 and C6 groups which had a lower value 
amongst the C3 to C6 groups but with considerable overlap in the data (Figure 3.8.8). 
Other studies (Beckwith et al, 1993) which have recently been described proposed the 
measurement of the Doppler curves by analysing the volume of the wave of blood using 
the Psathakis's index (Psathakis et al, 1987) which is a Doppler Efficiency Index (EI d). 
In my study the Doppler efficiency index, EI d, in the superficial venous system were 
significantly higher in the Co and C1 groups as compared to the C2 to C6 groups 
indicating that the valves are more efficient in preventing reflux flow, i. e. having 
competent valves, in the Co and C, groups compared to the groups with significant 
reflux. There were no significant differences between the Co and C, groups but there 
was wide scatter of data between the C2 and C6 groups (Figure 3.8.9). 
The Doppler efficiency index, EI d, in the deep venous system were significantly higher 
in the C0, C1 and C2 groups as compared to the C3 to C6 groups again indicating that the 
valves are more efficient in preventing reflux flow, i. e. having competent valves, in the 
C0, C, and C2 groups compared to the groups with significant reflux. There were no 
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significant differences between the Co , C, and C2 groups but there was wide scatter of 
data between the C3 and C6 groups (Figure 3.8.10). 
There was a significant increase in the duplex-derived total reflux volume flow 
parameter (figure 3.8.11) and in the duplex-derived total valve closing time parameter 
(figure 3.8.12) in all incompetent segments in patients in the C2 to C6 groups as 
compared to those in the CO and C, groups with no significant differences present in 
these parameters between the C2 to C6 patient groups. 
In summary, duplex ultrasonography applied to the superficial venous system appears to 
group the veins into those with reflux and those without. None of the quantitative 
assessments of incompetence revealed increased venous reflux in the more severely 
affected groups. Similarly in the deep veins, patients with the lesser stages of venous 
disease had no significant venous reflux, and all those with the more severe stages C3 - 
C6 had similar levels of venous reflux, with no evidence of more severe reflux in the 
more severe clinical stages of venous disease. These findings indicate that duplex 
ultrasonography is useful in detecting venous reflux, but ultrasound assessments of 
venous blood flow seem to add nothing to the assessment. 
There were no significant differences in the diameters of the superficial veins as 
measured by B-mode ultrasound, between the CO and C, groups. However, there was a 
statistically significant increase in the diameters of the superficial veins between these 
two groups with no significant reflux and the C2 to C6 groups with evidence of 
significant reflux. There was great overlap between the data points in the C2 to C6 
groups (Figure 3.8.13). These findings again show that patients with the more severe 
stages of venous disease have larger veins than those with trivial or no venous disease. 
No trend in patient height was seen between the CO and C6 groups with a very wide 
scatter of data points in this sample population (Figure 3.8.14). Patient height is 
unimportant in determining the severity of the venous syndrome. 
There was a wide scatter in the body weight (Kg) parameter between the CO and C6 
groups but patients in groups C2 to C6 were significantly heavier than in groups Co and 
C1. Patient weight is sometimes blamed as the cause for varicose veins and there is 
some evidence to support this suggestion from this study. However, patients in the more 
severe clinical stages were also older than those in the CO and C, groups, which might 
also account for the differences (Figure 3.8.15). 
The clinical score increased almost linearly with the progression of the disease as more 
symptoms were included in the scoring thus reflecting the severity of the disease. There 
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were no significant differences between the Co and C, groups or the C2 and C3 groups 
(Figure 3.8.16). This aspect of the CEAP system appears to reflect the severity of the 
venous disease more satisfactorily than many of the objective indices! 
There was a significant increase in the anatomical score between the normal control 
groups (CO and CI) and the disease groups (C2 to CO as more segments of the venous 
system were identified as incompetent. There was a significant difference between the 
C2 and C3 groups but not between the C3 and C6 groups indicating that the number of 
segments involved does not correlate with the severity of the disease (Figure 3.8.17). 
Similarly for the disability scoring, there was a significant increase in the disability 
score between the normal control groups (Co and CI) and the disease groups (C2 to C6)- 
However, there was a significant difference between the C2 9 C3 9 C4a groups and the 
C4bq C59 C6 groups indicating the extent of the disability as related to the severity of the 
disease (Figure 3.8.18). 
There was a wide overlap in the data for the body mass index between the groups from 
CO to C6 though the trend show an increase in this parameter with the severity of the 
disease with the exception of the C4a group, possibly reflecting that obesity is a risk 
factor (Figure 3.8.19). Again, the greater age of patients in the more severely affected 
groups makes direct comparison unreliable. Interestingly, only a few of the patients 
could be classified as obese (BMI >30). 
As for the body surface area parameter, there was no significant difference between any 
of the groups with a wide scatter of the data points present between the groups. 
However, there is a trend indicating an increase in the body surface area in the patient 
groups as compared to the normal controls (Figure 3.8.20). 
The haemodynamic characteristics associated with progressive chronic venous disease 
have also been investigated with the parameters obtained from APG (Welkie et al, 
1992). They demonstrated that deterioration in venous haemodynamics paralleled the 
clinical severity of chronic venous disease through to the International Society for 
Cardiovascular Surgery (ISCVS) class 2 group (brawny induration and 
hyperpigmentation) and that once brawny oedema and hyper-pigmentation had occurred, 
ulceration can occur without additional deterioration of venous macrohaemodynamics 
thereby suggesting that progressive clinical deterioration may be the result of 
microcirculatory changes. 
in my study population, there was great overlap in the outflow fraction between the 
groups with no significant difference in this parameter between the normal controls and 
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the patient groups (Figure 3.8.21). The outflow fraction are greater than 35% with 
superficial compression for all the groups. This was not surprising because in the patient 
population in this study, there was no evidence of deep venous obstruction on duplex 
scanning. 
Outflow tests are performed to detect chronic obstructive disease. A reduced outflow 
fraction indicates the presence and severity of the obstruction. Studies using APG to 
quantify chronic venous outflow obstruction and venous outflow resistance (Nicolaides 
et al, 1993) has shown that in limbs with mild to moderate venous obstruction, the 
outflow fraction was 30-38% and in limbs with severe obstruction the outflow fraction 
was less than 30% of the venous capacitance. In the case of chronic obstruction testing 
the degree of collateralisation of the superficial veins can also be measured. Since 
collateralised veins may hide the presence of obstructed deep veins, the test is first 
performed with the compression of the superficial veins and if this proves to be normal 
then a second outflow test to determine degree of collateralisation without compression 
of the superficial veins is not necessary. The degree of superficial collateralisation is 
measured when the outflow test is performed with compression of the long saphenous 
vein (Rulo et al, 1989; Christopoulos et al, 1989). Therefore, normal values for outflow 
fraction are greater than 35% with superficial compression and greater than 40% 
without superficial compression. Limbs without obstruction will empty at least 40% of 
the retained blood volume one second after deflation of a proximally placed tourniquet. 
There was great overlap in the APG-derived arterial inflow parameter in millilitres per 
minute between the normal controls and the patient groups. However, there was a 
statistically significant increase in the arterial inflow between the normal controls Co 
group and the patient groups, Cl to C6. There was also a moderate increase in this 
parameter between the C, group and the more severely diseased groups C4b and C5 but 
not between the C2. C3v C4a groups and the C6 group (Figure 3.8.22). Again, the sample 
numbers were small but the trend showed an increase in the arterial inflow with 
increasing severity of venous disease. This observation has been reported previously in a 
number of papers in which laser Doppler fluxmetry has been used to assess the 
cutaneous circulation. The increased blood flow is perhaps a response to the chronic 
inflammatory processes which involve the limb in patients with chronic venous disease. 
Other studies have shown this parameter to be higher in patients with severe chronic 
venous disease. In a study to assess the venous hypertensive microangiopathy in relation 
to clinical severity (Christopoulos et al, 1991), arterial inflow and perimalleolar skin 
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blood flow were measured with venous-occlusion air plethysmography and laser 
Doppler flowmetry . They showed that there was a marked increase in the resting 
arterial inflow in limbs with complicated varicose veins, skin changes and deep venous 
incompetence as compared to normal limbs and limbs with uncomplicated varicose 
veins. More recently, another study (Christopoulos et al, 1995) in which the 
haemodynamic effect of venous hypertension in the lower limb microcirculation was 
studied, an increase in the resting arterial inflow with increasing incidence of ulceration 
was found. This was considered to reflect the damage in the microcirculation produced 
by chronic venous hypertension. 
There was a significant increase in the APG-derived venous filling index parameter, 
which is a measurement of the amount of reflux present in the whole limb by measuring 
the average filling rate of the veins, between the groups with no significant evidence of 
reflux present (Co and CI) and the groups with significant evidence of reflux (C2 to C6)- 
The median VFI increased between the C2 group and the groups with increasing severity 
of the disease (C3. C4av C4bq C5 and C6), although statistical significance was not 
reached because of the wide scatter between the groups. There was no difference 
between the C3 and C6 groups (Figure 3.8.23). In other words, the VFI parameter is very 
good at differentiating between normal controls and patients with significant reflux but 
cannot differentiate between the disease groups suggesting that the amount of reflux 
flow present in the disease groups has no further effect at the microcirculatory level 
once the clinical sequelae of the disease have been established. This clearly 
demonstrates that VFI assesses the severity of venous reflux, but that this does not 
increase in the more severely affected patients. Some other factor is responsible for the 
development of severe skin changes and leg ulceration. Alternatively, it is possible that 
the severity of the skin changes limits exercise in these patients preventing reliable 
assessment of the VFI. 
Other studies correlating APG-derived VFI parameter with the clinical severity of 
chronic venous disease (Christopoulos et al, 1988) have shown that there was an 
increased incidence of sequelae with increasing values of the venous filling index (VFI). 
Normal limbs will show a VFI of between 0.6 to 1.7 ml/sec and represents the venous 
filling rate from the capillaries at rest as a result of the arterial inflow. A VFI of greater 
than 2.0 mI/sec indicates the presence of venous reflux in addition to the arterial inflow. 
There was great overlap between the groups with no significant difference in the venous 
volume parameter between the normal controls and the patient groups (Figure 3.8.24) 
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but there was an increasing trend from the normal controls to the disease groups. This 
suggests an expansion of the venous compartment in patients with venous disease, and 
is again consistent with previously published data. 
There was great overlap in the ejection fraction parameter, which provides a measure of 
the effectiveness of the calf muscle pump, between the normal control group and the 
disease groups with moderately significant decrease in this parameter between the Co, 
C, and C2 groups as compared to the C4,, and C5 groups. However, the general trend was 
a decrease between the normal controls and the patient groups (Figure 3.8.25). One 
would expect this parameter to be significantly reduced in patients with significant 
disease as compared to normal controls. This was not the case in this study population 
possibly due to bias in the study design in which 'fit' patients are selected who can 
handle the rigours of the air plethysmography procedures. Also since there were no 
significant outflow obstruction identified in any group with duplex scanning and the 
ejection fraction showed similar values within the normal range, this suggested that 
there were no impaired calf muscle pumps among the sample population studied. 
Similarly, there were no significant differences in the APG-derived ejected volume 
between the normal controls and patient groups ((Figure 3.8.26). 
Limbs of patients with superficial venous insufficiency will show a below normal EF 
mainly due to an increased venous volume. A poor calf muscle pump will have an EF 
less than 40%. In limbs with deep venous disease, a decreased EF is the result of both 
increased venous volume and decreased ejected volume (Christopoulos et al, 1987). 
it has been demonstrated that when EF and VFI data are combined, there is a good 
correlation to the incidence of ulceration. There is a high incidence of ulceration in 
limbs with poor calf pump function and severe reflux. Limbs with a good calf pump but 
severe reflux are somewhat protected from ulceration. Limbs with poor calf pumps are 
also protected from ulceration if they have more competent valves (Christopoulos et al, 
1989). 
There was great overlap in the APG-derived residual volume fraction parameter, which 
assesses lower limb venous hypertension by measuring venous emptying during exercise 
and is influenced by venous reflux, between the normal control group and the diseased 
groups with no significant differences in this parameter between the normal control 
groups and the patient groups. However, the general trend was a moderate increase 
between the normal controls and the patient groups (Figure 3.8.27). 
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It has been previously demonstrated that there is a good correlation (r: 0.83) between 
RVF and simultaneous measurement of the ambulatory venous pressure (AVP) which is 
achieved by placing a needle in a vein in the dorsum of the foot and attached to a 
pressure transducer (Christopoulos et al, 1989) (Welkie et al, 199 1). 
There was a significant decrease in the PPG-derived refilling times between the normal 
controls and the disease groups. Also there was a significant decrease in this parameter 
between the less severe disease groups (C2 and CD and the more severe disease groups 
(C4aý C09 C5 and CO (Figure 3.8.28). 
This simple and objective test has been validated by venous pressure measurements 
(Abramowitz et al, 1979; Barnes et al, 1982). Abramowitz et al has shown that the PPG 
data of refilling times has a very good correlation with venous pressure measurements 
(93.9%). Correlation of the PPG refilling times and ambulatory venous pressure 
recovery time has been estimated as 0.88 using a standing exercise and 0.94 with the 
sitting exercise (Nicolaides et al, 1987). Studies using photoplethysmography have been 
carried out in the assessment of patients with chronic venous insufficiency (Abramowitz 
et al, 1979; Barnes et al, 1978). They demonstrated that they could differentiate between 
superficial and deep vein insufficiency by recording photoplethysmographic changes in 
the lower calf following brief periods of dorsiflexion of the foot. The reasoning behind 
the test is that refilling will occur relatively slowly due only to arterial inflow through 
the muscle in the normal case. If the venous valves are not competent, refilling will 
occur quickly as blood runs back down the leg veins. In normal subjects, this refilling 
time is greater than 20 seconds whereas abnormal subjects with incompetent veins will 
have refilling times of less than 20 seconds. The PPG transducer senses the state of 
venous filling from the superficial venules in the skin. Perhaps some aspects of its 
measurement reflects changes in the microcirculation as well as the large vein 
abnormalities. Photoplethysmography has also been applied clinically to evaluate vein 
surgery (Pearce et al, 1983; Yao et al, 1986) and compression therapy (Norris et al, 
1984; Noyes et al, 1987). 
With the advent of new and more sophisticated technology in the form of duplex 
ultrasound scanning and air plethysmography in assessing patients with chronic venous 
disease recent studies have highlighted inaccuracies when using photoplethysmography 
to identify venous reflux. It has been shown that PPG findings do not correlate well with 
duplex scanning which is now fast becoming the 'Gold standard' in the assessment of 
chronic venous disease (van Bernmelen et al, 1992). These authors concluded that 
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though PPG can give an indication of the extent of venous incompetence it cannot 
distinguish between superficial and deep venous incompetence with the use of a 
tourniquet and that it provided no additional useful information for the clinician. 
Another study (Bays et al, 1994) which validated air plethysmography, 
photoplethysmography and duplex scanning in the evaluation of severe venous stasis 
found that though PPG was a sensitive method of detecting reflux (100%) its specificity 
was poor (60%) and that PPG refilling times could not accurately predict the location of 
reflux. 
These inaccuracies may be due to the fact that photoplethysmography can give a 
measure only of the venous refilling time which is an indirect measurement of venous 
reflux. The venous refilling time is measured within the capillary bed which may not 
reflect overall venous function. Also, the capillary blood content is highly temperature 
dependent which may be a potential source of error. It also provides no estimation of 
venous obstruction and therefore no quantitative measure of venous obstruction 
(Struckmann J, 1994). 
The results of the tissue tonometry data are similar to those of study III conclusions for 
figure 3.8.29 and tables 3.8.1 and 3.8.2. 
There is a weak correlation between the severity of reflux measurements and APG- and 
PPG- derived parameters of reflux quantification. The correlation between the PPG- 
derived refilling times and the APG-derived VFI parameter was r-0.41 (Table 3.8.3), 
that is, an increase in the venous filling index resulted in a shortening of the PPG 
refilling time, both indicating venous reflux. This is possibly due to the fact that reflux 
is often found to be present in several vein segments. In the duplex-derived 
measurement of total reflux, the vein segments with significant reflux lasting longer 
than 0.5 seconds are added up to give a total reflux value for the limb. However, it is not 
possible to measure reflux in all the incompetent perforators, muscular veins and deep 
veins if present becomes it would become a laborious and difficult procedure because 
one would have to take into account the time factor for measurements as well since the 
patient's tolerance should be an important factor. Because of these reasons, duplex- 
derived reflux quantification parameters is only used as a research tool for vessels with 
significant reflux and not as a routine measurement. On the other hand, the APG- 
derived venous filling index provides a global evaluation of the severity of reflux in the 
whole limb and is to be regarded as a more reliable indicator of the severity of the 
physiological abnormality. 
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There is a weak correlation between the severity of skin hardness as measured by the 
tissue tonometer parameter, X0, and APG-, PPG-, duplex-derived parameters of venous 
function, the CEAP scoring parameters and patient data. The correlation between the X0 
parameter and the CEAP clinical score was r---0.75 (table 3.8.4), that is, an increase in 
the clinical score resulted in a decrease in the distance travelled X0, both of which 
reflect increasing severity of the disease. 
3.8.6. Conclusions 
The APG-derived parameters, PPG-derived parameter and the duplex-derived 
parameters became abnormal starting between the C2 and C3 groups and continuing 
through to the C6 groups. No physiological parameter shows an increase in value 
between the more severely affected groups. Although numbers of subjects in this 
investigation are relatively small, this confirms that the severity of venous reflux as 
indicated by these tests does not seem to be the cause of the worsening clinical condition 
of these patients. 
The duplex ultrasound quantitative measures of venous reflux show an all-or-none type 
of response, with reflux present or not in the deep or superficial veins. This therefore 
must be regarded as an anatomical test, incapable of providing reliable quantitative 
measures of venous reflux. APG is clearly superior is in this respect. 
The tissue tonometry parameters became abnormal only from the CO group onwards 
consistent with the clinical impression that it is these patients who are at greatest risk of 
the more severe sequelae of venous disease. This does not correlate with any of the 
parameters of venous physiology and therefore it must be concluded that some other 
factor is responsible for the development of the lesser to the more severe stages of 
venous disease. The physiological abnormality must clearly be present, but some 
additional factor is also required for this to result in the appearance of LDS and leg 
ulceration. Perhaps this reflects differences in the tissue response to venous 
hypertension, due to some abnormal sensitivity in microcirculation in these patients. 
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SECTION IV 
General Conclusion 
OW 
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4.1. General Conclusions 
Chronic venous disease (CVD) of the lower limbs has been a major problem since 
ancient times and at present it has severe economic consequences in the western world. 
Its clinical sequelae range from oedema, haemosiderosis and pigmentation, to gross 
lipodermatosclerosis (LDS) and venous ulceration with the gaiter area as the site most 
commonly affected in the lower limb. A vast majority of patients show a wide spectrum 
of skin changes of varying severity which precede venous ulceration. The extent and 
severity of the disease can be assessed by clinical and physiological methods using 
techniques such as plethysmography and ultrasound. 
At present, there is no standardised objective method of assessing the mechanical 
properties and degree of skin change in these patients, so that the response to treatment 
can be objectively monitored. A tissue tonometer was developed in our laboratory for 
the objective assessment and quantification of the skin changes seen in these patients by 
measuring the mechanical properties of the skin. 
in study 1,1 standardised the calibration, repeatability and reproducibility of the 
methodology of the tissue tonometry measurements and investigated whether the 
tonometer can differentiate between the mechanical properties of the skin in normal 
controls and in patients with lower limb chronic venous disease. I have shown that the 
tissue tonometer can objectively distinguish between the varying hardness of skin in 
patients with lower limb chronic venous disease and that the tissue tonometry 
measurement of the skin compliance during phase I provided an objective means of 
assessing skin changes in patients with chronic venous disease. I have also shown that 
the CEAP clinical classification group C4 was not adequate when measuring the 
mechanical properties of skin changes and that it was necessary to differentiate between 
patients with pigmentation alone and no palpable induration (C4,, ) and patients with 
liposclerotic skin changes with palpable induration (CO) to get a more objective 
assessment of the skin changes that are present in patients with lower limb chronic 
venous disease. There was also some evidence that the tissue tonometry measurements 
of distance and rate constant parameters in the subsequent slower phases H and III may 
possibly reflect the amount and type of tissue oedema present. 
I have developed a tissue tonometer that can provide information on the mechanical 
properties of the skin which made it necessary to distinguish between patients with 
liposclerotic skin changes and no palpable induration into groupC4a from those with 
liposclerotic skin changes and palpable induration into C4b. These two groups were 
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originally classed in the same group as C4- I believe that if this method of classification 
is going to be universally accepted and survive, it should be allowed to evolve with the 
developments in new technology which was the original reason for its creation and 
should be flexible enough to adapt to the new technologies as it has shown to be in this 
thesis. 
Although a number of the tonometry parameters showed relatively poor repeatability, 
the measurement reflecting tissue compliance was very satisfactory in this respect with a 
coefficient of variation of only 8% in repeated measurements. This is much better than 
almost any other measurement in the assessment of venous disease and I immediately 
realised that this had potential for use as a surrogate endpoint in the assessment of the 
outcome of treatments for venous disease. However, several further steps would be 
required before it was fully evaluated for this purpose. 
In study II, an in vitro model, the sponge-in-glycerol model, was applied to obtain 
displacement versus time curves so as to apply a simple visco-elastic mathematical 
model, the Kelvin-Hooke model, on the curves obtained to calculate the spring and 
dashpot constants to explain its mechanical behaviour. I demonstrated that in the 
sponge in glycerol model, the application of the Kelvin-Hooke model appeared to fit the 
data quite well and that this model may be applied in vivo to analyse the mechanical 
properties of the skin of patients with lower limb chronic venous disease using a tissue 
tonometer. 
In Study 111,1 applied the Kelvin-Hooke model to the displacement versus time curves 
obtained in vivo in patients with lower limb chronic venous disease classified according 
to the CEAP method of classification and demonstrated that it fitted the data quite well 
in assessing the mechanical properties of the skin of patients with lower limb chronic 
venous disease. Here, a much wider range of patients was included, incorporating those 
in all of the CEAP stages. The method of tonometry clearly identified those in the more 
severe stages of venous disease (C4b - CO, as vastly different from those in the lesser 
stages of the disease, when using the measure of skin compliance. The other parameters 
of venous disease assessing venous volume and oedema were less valuable in assessing 
patients with venous disease. 
In study IV, I compared the clinical assessment of the severity of liposclerotic skin 
changes made by an experienced vascular surgeon using the CEAP method with the 
tissue tonometry parameters of skin compliance in patients with bilateral LDS in order 
to assess whether the tissue tonomcter can differentiate between varying severity of skin 
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hardness and showed that the tissue tonometry measurements of skin compliance 
provided an objective way of differentiating between the clinical severity of liposclerotic 
skin changes. It was apparent from the outcome of this study that the tonometry results 
mirrored the opinion of an experienced clinician in assessing the severity of skin 
damage of a series of patients all of whom were affected by lipodermatosclerosis. 
In study V, I measured the skin and subcutaneous layer thickness in the normal and 
patient groups presenting with lower limb venous disease using a 7.5 MHz transducer 
and correlating them to displacement versus time curves obtained using the tissue 
tonometer within the same groups above. This was to assess whether the skin and 
subcutaneous layer thickness had any influence on the variability of the distance and rate 
constant parameters obtained from tissue tonometry. I demonstrated that there was no 
significant correlation between the ultrasound parameters and tissue tonometry 
parameters and concluded that ultrasound measurements of skin thickness and 
subcutaneous tissue thickness using a 7.5 MHz linear array probe prove not to be useful 
in limbs with oedema, or inflammatory disease. 
In study V1, I objectively measured the effects of compression stockings on the 
mechanical properties of the skin of patients with lower limb chronic venous disease 
using a tissue tonometer to assess the skin compliance. I also applied a circumferential 
method to assess the limb volume before and after compression stocking wear. I 
demonstrated that the response to compression treatment can be readily assessed by 
tissue tonometry and circumferential limb volumetry. The results showed that the use of 
compression by these patients for a period of only six weeks could produce a readily 
measurable change in skin compliance. The magnitude of the change was small (about 
30%) but this might be consistent with a clinically useful change. Due to the great 
repeatability of this measurement it was effective in assess the response to a widely 
recognised treatment. The fact that this was not just a spurious observation was 
confirmed by the measurement of limb volume. Patients in this study were clearly 
wearing their allocated stockings since they showed a decrease in limb volume of about 
10%. 
In study VII, I assessed the inter-variability between examiners and the ease of use of 
the application of the recently devised CEAP method of classification and scoring of 
lower limb venous disease. I showed that there was excellent to very good correlation 
between different examiners of varying experience in the field and that the classification 
and scoring method was easy to use. The best correlations were found for the 
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assessment of those data derived from duplex ultrasonography. All observers used the 
same duplex data on which to base their classification, and non surprisingly came up 
with identical CEAP grading. The differences lay in the clinical aspects of the study, 
emphasising that adequate clinical experience and training is required if consistent 
clinical scoring is to be produced. 
In study VIII, I further investigated the recently devised CEAP classification of venous 
disease which related several aspects of the vein damage to the clinical syndrome to see 
how the physiology of the venous system, as measured by the many different methods of 
measurement in venous disease including duplex assessment and plethysmographic 
techniques were related to the clinical stages of the CEAP classification. I also included 
the measurement of the mechanical properties of the skin using the tissue tonometer 
developed in our laboratory. 
I also correlated the duplex-derived parameters of lower limb venous reflux 
quantification with the clinical severity of the disease as classified by the CEAP method, 
the air plethysmography-derived parameters and photoplethysmography-derived 
parameters of venous function and arterial perfusion with the clinical severity of the 
disease as classified by the CEAP method and the tissue tonometry-derived parameters 
of the mechanical properties of lower limb skin changes in the same population with the 
clinical severity of the disease as classified by the CEAP method. The correlation 
between the duplex-derived parameters, plethysmographic parameters and tissue 
tonometry parameters were also investigated. I demonstrated that the APG-derived 
parameters, PPG-derived parameter and the duplex-derived parameters became 
abnormal starting between the C2 and C3 groups and continuing through to the C6 
groups with no significant differences between the diseased groups. There was 
significant differences in the above parameters between the normal control groups and 
the patient groups. However, the tissue tonometry parameters became abnormal only 
from the CO group onwards suggesting that the tissue response to indentation with a 
loaded weight in assessing the mechanical properties of the skin is a significant factor in 
determining the groups that are most susceptible to venous ulceration. 
This study showed that all patients with grades C3 - C6 venous disease had very similar 
measurements of venous physiology, whatever parameter was assessed. Interestingly, 
there was rather poor correlation between the APG measures and duplex assessments. It 
became apparent that duplex ultrasonography is good at identifying the presence or 
absence of vcnous reflux, but is poor at its quantification. This technique is best used as 
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an anatomical test of the presence or absence of reflux in particular veins. APG provides 
an overall impression of the extent of venous reflux, but did not identify those patients 
with the more severe stages of venous disease as having more severe venous reflux or 
calf muscle pump impairment. This could have been due to patient selection in this 
study, this is, only patients fit enough to perform the APG tests were included and these 
may have had better venous function than the remaining patients who were considered 
unsuitable. Perhaps the clinical outcome is also dependent on how much of the time 
patients spend with their lower limbs elevated or how much exercise they take, factors 
which could not be considered in this study. However, it seems more likely that venous 
physiological abnormalities are only part of the picture in the development of skin 
changes. The response of the skin to venous hypertension probably varies considerably 
in different patients and this may be one of the main explanations for the failure of the 
parameters of venous physiology to predict which patients will develop skin damage. 
There was no correlation between the tissue tonometry measurement that so well defines 
the severity of LDS and any APG, PPG or duplex ultrasound parameter, reflecting the 
lack of a direct relationship between these factors. 
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4.2. Future plans 
Ethics approval has been sought for a study investigating the role of plasma vascular 
endothelial growth factor (VEGF) as a marker of chronic venous disease on various 
parameters including tissue tonometry parameters as described in this thesis, 
microcirculatory parameters as defined by laser Doppler fluxmetry, duplex ultrasound 
derived parameters and clinical parameters as defined by the CEAP method. 
This will study in great detail the relationship between the clinical features of venous 
disease assessed by tonometry and the pathological factors known to be involved in 
venous skin damage, such as VEGF and other endothelial adhesion molecules. 
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Appendix I 
Presentations to learned societies 
Objective assessment of skin changes in venous disease using a tissue tonometer. 
J Farrah, M Saharay, J Scurr and PD Coleridge Smith. 
Presented at the 83d meeting of the Surgical Research Society at Oxford University in 
January 1996. 
Objective assessment of skin changes in venous disease using a tissue tonometer. 
J Farrah, M Saharay, J Scurr and PD Coleridge Smith. 
Presented at the 9th Annual congress of the North American Society of Phlebology in 
San Diego, California in February 1996. 
Objective assessment of skin damage in Chronic Venous insufficiency. 
PD Coleridge Smith, J Farrah, M Saharay and J Scurr. 
Presented at the Deutscher Phlebologenkongress in Berlin, Germany in September 1996. 
Assessment of the severity of venous disease: Comparison between CEAP classification 
and tissue tonometry. 
J Farrah, M Saharay, J Scurr and PD Coleridge Smith. 
Presented at the Venous forum of the Royal Society of Medicine in Manchester in 
October 1996. 
Compression stockings improve skin compliance in patients with chronic venous 
disease of the lower limbs. 
J Farrah, M Saharay, J Scurr and PD Coleridge Smith. 
Presented at the I" Anglo-German symposium on Venous disorders in Berlin, Germany 
in June 1997. 
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Future Presentations 
Assessment of the intervariability and ease of use of the CEAP method of classification 
and scoring of lower limb venous disease between different examiners. 
Farrah J, Saharay M, Lamboume A Boden L, Scurr J, Coleridge Smith PD 
Accepted for presentation at the XHI UIP World congress on Phlebology in Sydney, 
Australia in September 1998. 
Objective assessment of skin changes in venous disease using a tissue tonometer. 
Farrah J, Saharay M, Scurr J, Coleridge-Smith PD 
Accepted for presentation at the XIII UEP World congress on Phlebology in Sydney, 
Australia in September 1998. 
Assessment of skin compliance in patients with chronic venous disease of the lower 
limb after compression stocking wear. 
Farrah J, Saharay M, Scurr J, Coleridge-Smith P. 
Accepted for presentation at the XHI UIP World congress on Phlebology in Sydney, 
Australia in September 1998. 
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Appendir II 
Ethics approval and consent forms 
The University College London Hospitals 
St. Martin's House, 
140 Tortenh2m Court Ro2d, London WIP 9LN 
Telephone: 0171380 
.................... 
Telephone: 0171387 9300 Ext: .......... 
Fax: .............................. 
The Joint UCL/UCLH Committees on the Ethics of Human Research 
Comniittee Alpha Chairman: rrofessor Andre Nlct. ean Please address sit corresi)ondence to: 
Mrs Iwona Nowicka 
Research & Development Directorate 
9th Floor, St Martin's House 
140 Tottenham Court Road, LONDON NVIP 9LN 
Tel. 0171-3809S79 Fax0171-3809536 
Mr P Coleridge Smith 
Senior Lecturer 
Vascular Laboratory 
Department of Surgery 
UCLMS 
The Middlesex Hospital 
Ist Floor, Sir Jules Thom Building 
02 December 1996 
Dear Mr Coleridge Smith 
StudyNo: 96/3513 (Please quote in all correspondence) 
Title: Correlation of the clinical classification of lower limb venous disease with standard 
non-invasive haemodynamic laboratory measu 
, 
rements and the objective assessment of 
the outcome of treatment of lower limb venous disease 
I am -writing to let you know that I have looked at the above project and have given it Chairman's Approval. 
you may therefore go ahead with your study. 
please note that it is important that you notify the Committee of any adverse events or changes (name of 
investigator etc) relating to this project. You should also notify the Committee on completion of the project 
or indeed if the project is abandoned. Please remember to quote the above number in any correspondence. 
yours sincerely 
Andre McLcan 
Chairman 
'da The University College London Hospitals 
If( Cý L University College London Hospitals is in NHS Trust incorporating The Eastman Dental Hospital. The Hospital for Tropical Mseases. The Middlesex Hospital, The National Hospital for Neurology & Neurosurgery, The United Elizabeth 
HOSPITAI G2rrct: Anderson Ho, pitA and Hospital for Women. Soho. and University College Hospital. col2dcc/ijn/3 Dec 96 -S 244 
CONTMENTIAL 
Department of Surgery 
University College London Medical School 
Ae Middlesex Hospital, Mortimer Sweet, Loiu; bu 
telephone: 0 17163 6 8333 
Head of Department and David Patey Professor: I Taylor 
Mr JH Scurr (Ext 9414) Mr PD Coleridge Smith (Ext 9412) 
Fax 0171380 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. coleridgesmith@ucl. ac. uk 
VOLUNTEERS REQUHIED 
Subject Inrormation Shee 
Volunteers are invited to participate in a study of the mechanisms of blood flow in their 
legs. 
We are interested in the things which cause varicose veins and ulcers. 
We are trying to compare the mechanisms of blood flow in normal subjects with no 
known or obvious circulatory problems to those who have varicose veins with or 
without ulcers. 
i 
The information we need from you is very simple. 
Ultrasound scanning is used. to test the veins in the leg. 
We will use an air bag which is placed around the calf to measure changes in leg volume 
lying down and standing and also when performing simple tip-toe exercises. 
We will also examine the skin in the area above your ankle using a special measuring device 
called a tonometer. 
You will only need to make one visit to the Vascular Laboratory at the Middlesex Hospital 
for a period of about 2 hours. 
No pain or needles are involved in this study. 
You do not have to take part in this study if you do not want to. If you decide to take part 
you may withdraw at any time without having to give a reason. 
All data obtained will be treated as strictly confidential. 
if you have any other queries or questions regarding this study, please do not hesitate to ask- 
You can call John Farrah in the Vascular Laboratory on 
0171380 9414 
Mr J Farrah 
Accredited Vascular Technologist 
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QQKFIDENTI 
Depa=ent of Surgery 
University College London Medical School 
Yhe Middlesex Hospital, Mortimer Street, Loidon TVIAT 8,14 
u9U` 832 3.2 tei Phone. - ^J' 71 uU 
Head of Department and David Patey Professor: I Taylor 
Mr JH Scurr (Ext 9414) Mr PD Coleridge Smith (Ext 9412) 
Fax 0171380 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. coleridgesmith@ucl. ac. uk 
An investigation of the mechanisms of blood flow in normal subjects. 
Subject Consent form 
I 
1. Have you read the information sheet about this study 
. 
YES/NO 
2. Have you had an opportunity to ask questions and discuss this study? YES/NO 
3. Have you received satisfactory answers to a your questions YES/NO 
Have you received enough information about this study? YES/NO 
5. Which doctor have you spoken to about this study? Dr ........................................ 
6. Do you understand that you are free to withdraw from this study 
* at any time 
* without gi 
. 
ying a reason for withdrawing 
7 Do you agree to take part in this study? YES/NO 
Signed ................................................................................... Date: ...................................... 
Name in Block Letters: ............................................................................................................ 
Doctor ..................................................................................................................................... 
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! QONiFD: )ENTIAL 
DepWment of Surgery 
University College London Medical School 
Ae Middlesex Hospital, Mortimer SO-ed, Lui- I W1211,151", L! 
telephone: 0171636 8333 
Head of Department and David Patey Prdfessor: I Taylor 
Mr JH Scurr (Ext 9414) W PD Coleridge Smith (Ext 9412) 
Fax 0171380 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. coleridgesmith@ucl. ac. uk 
VOLUNTEERS REQUIRED 
An investigation of the mechanisms of blood flow in patients with venous disease. 
Patient Information Sheet 
Volunteers are invited to participate in a study of the mechanisms of blood flow in their 
legs. 
We are interested in the things which cause varicose veins and leg ulcers. 
The information we need from you is very simple. 
Ultrasound scanning is used to test the veins in the leg. 
We will use an air bag which is placed around the calf to measure changes in leg volume 
lying down and standing and also when performing simple tip-toe exercises. 
We will also examine the skin in the area above your ankle using a special measuring device 
called a tonometer. 
You will only need to make one visit to the Vascular Laboratory at the Middlesex Hospital 
for a period of about 2 hours. 
No pain or needles are involved in this study. 
You do not have to take part in this study if you do not want to. If you decide to take part 
you may withdraw at any time without having to give a reason. 
Your decision whether to take part or not will not affect your care and management in any 
way. 
All data obtained will be treated as strictly confidential. 
if you have any other queries or questions regarding this study, please do not hesitate to ask. 
You can call John Farrah in the Vascular Laboratory on 
0171380 9414 
Nlr J Farrah 
Accredited Vascular Technologist 
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CQa-ID 
Department of Surgery 
University College London Medical School 
0.4 J Ae Middlesex Hospital, Mortimer Strea, Londwot 1,111AI 8, M 
telephone: 0171636 8333 
Head of Department and David Patey Professor: I Taylor 
Mr JH Scurr (Ext 9414) Mr PD Coleridge Smith (Ext 9412) 
Fax 0 1713 80 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. coleridgesmith@ucl. ac. uk 
An investigation of the mechanisms of blood flow in patients with venous disease. 
1. 
2. 
3. 
4. 
5. 
6. 
Patient Consent form 
Have you read the information sheet about this study 
Have you had an opportunity to ask questions and discuss this study? 
Have you received satisfactory answers to all your questions 
Have you received enough information about this study? 
YES/NO 
YES/NO 
YES/NO 
YES/NO I 
Which doctor have you spoken to about this study? Dr ........................................ 
Do you understand-thit you are free to withdraw from this study 
at any time 
without giving a reason for withdrawing 
without affecting your future medical care? 
7 Do you agree to take part in this study? YES/NO 
Signed ................................................................................... Date: ...................................... 
Name in Block Letters: ....................................... t ..................................................................... 
Doctor ..................................................................................................................................... 
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CONFIDENTLAL 
Deparment of Surgery 
University College London Medical School 
Yhe Mddlesex Hospital, Monimer agirvel, LoIdo; -, 
telephone. * 0171636 8333 
Head of Department and David Patey Pr6fessor: I Taylor 
Mr JH Scurr (Ext 9414) Mr PD Coleridge Smith (Ext 9412) 
Fax 0171380 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. colendgesmith@ucl. ac. uk 
VOLUNTEERS REQUDRtED 
An investigation of the effects of compression stockings in patients with venous disease. 
Patient Inrormation Sheet 
Volunteers are invited to participate in a study to -assess the effects of wearing 
compression stockings prescribed by their Vascular Surgeons. 
The information we need from you is very simple. 
You have already had ultrasound scanning to test the veins in your legs and based on this 
report the Vascular Surgeon has decided that wearing compression stockings will help to 
improve the condition of your leg. 
We need to make two measurements on your legs to assess the benefits of wearing the 
stockings: 
to examine the area of skin above your ankle using a special measuring device called a 
tonometer, and to measure the volume of your leg using a tape measure. 
You will only need to make two visits to the Vascular Laboratory at the Middlesex Hospital, 
once before the compression stockings are prescribed and then 4 weeks later after wearing 
the stockings. Ile tests will take about 30 minutes on each visit. 
No pain or needles are involved in this study. 
You do not have to take part in this study if you do not want to. If you decide to take part 
you may withdraw at any time without having to give a reason. 
Your decision whether to take part or not will not affect your care and management in any 
way. 
All data obtained will be treated as strictly confidential. 
if you have any other queries or questions regarding this study, please do not hesitate to ask. 
You can call John Farrah in the Vascular Laboratory on 
0171380 9414 
Nlr J Farrah 
Accredited Vascular Technologist 
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CONTIDENNTIAL 
Departmi-nt of Surgery 
University College London Medical School 
77je Middlesex Hospital. Mortimer Street, iondon WIN 8AA 
telephone: 0171636 8333 
Head of Department and David Patey Professor: I Taylor 
Mr JH Scuff (Ext 9414) Mr PD Coleridge Smith (Ext 9412) 
Fax 0171380 9413 Direct lines 0171380 9412/0850 232525 
E-mail: p. coleridgesmith@uci. ac. uk 
An investigation of the effects of compression stockings in patients with venous disease. 
Patient Consent form 
1. Have you read the information sheet about this study YES/NO 
2. 
3. 
4. 
5. 
Have you had an opportunity to ask questions and discuss this study? 
Have you received satisfactory answers to all your questions 
Have you received enough infonnation about this study? 
YES/NO 
YES/NO i 
YES/NO 
Which doctor have you spoken to about this study? Dr ........................................ 
6. Do you understand that you are free to withdraw from this study 
at any time 
w ithout giving a reason for withdrawing 
without affecting your future medical care? 
7 Do you agree to take part in this study? 
Signed ................................................................................... 
YES/NO 
Date: ...................................... 
Name in Block Letters: ............................................................................................................ 
Doctor ...................................................................................................................................... 
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Appendix III 
Study I 
TONONME TER REPRODU CIBILITY STU DY (normal controls) 
I Phase I P hase 11 Phase III 
uboect Visi ts Xn Xl-Xn -I/Tau XT-Xn -I/Tau - ngy 1 3.10 0 . 27 
2.77 0 . 11 630.00 
Day 2 2.74 0 . 31 2.50 0 . 20 52.50 
Day 3 3.00 0 . 27 
2.53 0 . 01 730.50 
STP EV 0-19 0 . 02 0.15 0 . 10 365.90 
Ave raL-eimean) 2.95 0 . 28 2.60 10 . 11 471,00 
l co v(%) 6.31 8 . 15 5.69 8 9.10 77.69 1 Con fidence Interval - 
011 0 . 03 0.17 0 . 11 414.04 1 Fro m 1.74 0.26 2.43 0 . 00 56.96 I to 3.16 0.31 2.77 0 . 21 885.04 1 
21 Day 1 141 0.39 2.42 0 . 06 62.80 I Day 2 2.47 0.45 2.40 . 0.26 54.60 
21 Day 3 2.28 0.36 14 0.14 46.20 
I s ) 0.10 0.05 4q A0 8.30 
f Ave rpre(mean) 1-39 0.40 
1 L 
0.15 54.53 
I CO V(%) 4.07 11.46 65.65 15.22 
l Co nfidence Interval 0.11 0.05 0.11 19.39 
l Fro m 128 0.35 2 18 9,04 45.14 
I to 150 0.45 13.13 0.27 63.93 
1 1 
3 May 1 2.08 0.31 4.88 0.10 885.10 
31 Da y2 2.34 0.18 2.45 0.02 133.50 
31 Da y3 2,31 0.42 2.14 R09 80.60 
I STI ), 0.14 0.12 1.50 0.04 449.99 
[ Av eruve(mean) 2.24 0.30 3.16 0.07 366.40 
I CO , 39.61 47-53 62.27 122.81 
l Co n idence Interval 0.16 0.14 1.70 0.05 509.20 
I Fro m 2.08 0.17 . 1.46 0.02 -142.80 I to ". 40 2AA 4.85 _ 
0.12 875.60 
1 
4 1 Da y 2.28 0.33 3.62 0.23 324.50 
4 Ma y) 2.31 0.31 2.69 0.20 94.40 
4 1 Da y3 2.24 0.29 2.85 0.01 441.40 
IST DEV 0.03 0.02 . 0.50 0.12 176.55 
lAv erareimean) - 
2-28 0.31 3.05 0.15 286.77 
ICO N, (%) 4 16-28 81.34 61.57 
lCo nfidence Intervat - 
0.04 0.02 0.56 0.14 199.78 
lFr om 11 2.49 0.01 86.98 
Ito 3.62 0.28 486.55 
1 1 
Da y1 2.21 0,82 4.37 0.03 289.60 
5 Da y1 2.31 1,31 1,91 0.03 289.60 
5 Da y3 2.64 0,41 1.51 0,01 106.20 
"I S MEV 0.23 0.45 1.55 0.01 105.89 
Av erave(mean) 2-39 0.85 2.60 0.02 228.47 
CO VM - 9.43 53.22 59.64 49.49 46.35 
Co nfidence Interval 0.25 0.51 1.75 0.01 119.82 
1 Fr om 1.13 1 0-34 0.84 
1 1 
0.01 108.65 
1 Ito 
-1.6-4 
1 1.36 4.35 0.04 348.29 
SAME DAY REPEATABILITY STUDY 30 minute intervals bet ween measurements) 
Phase I Ph-ire If Phase III 
One visit Xn XI-Xn -1frau _%Y-Xn -I/Tau Trice 1 5.2 0.5 3.0 0.1 61.2 
- Trice " 5-5 0,5 . 
19 0.2 79.8 
Trice 3 ý5,2 0.6 3.7 0.1 71.2 
I _ Trice 4 56 03 3.8 0.1 73.3 
1 S'n)FV 0.2 0.1 0.9 0.0 7.7 
efmcan) yer2g M 0.5 3.1 0.1 71.4 . C()N'(%) 4.5 211 28.8 30.8 10.8 
Conndence Interval 0.3 0.1 1.0 0.0 8.7 
From 9.1 0.4 2.1 0.1 62.7 
to 1q. 6 W. 6 12 
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TONOMETER REPRODUCT TLITY STUDY (Datien s) 
Phase I Phase 11 
- Phase III Suboect Visit Xn XI-Xn -1/Tau Xi-Xn -1/Tau I I l'O 0.2 3.4 0.1 70.1 
1 1 1.0 0.4 3.4 0.8 103.7 
1 3 0.9 0.3 2.2 0.1 228.8 
STPEV 0.0 0.1 
- 
0.7 0.4 0 .4 83.6 8 Averan(mcon) 1.0 0.3 3.0 0.3 0- 134 1 
colvl(%) 3.1 25.9 22.1 
A1217 S 
6 -1 62.3 Confidence Interval 0.0 0.1 0.8 04 04 9 94 ,6 From 0.9 0.2 2.3 .0 -0.1 39.6 
to 1.0 0.4 3.8 't 0.8 "ý2 228.8 
-- 
2 1.0 )g 0.6 
- 
5.1 0.8 77.6 
21 2.0 30 0.5 244 0.2 52.4 
21 3.0 2.3 0.1 119.7 
- 
STDFV 0.1 0.1 1.6 ýO4 34.0 Averuee(mcan) 1.0 0.5 3.3 0.3 83.2 
COV(%) 1.7 18.0 49.7 106.7 40.9 
Conridence Interval 0.1 0.1 1.8 0.4 38.5 
From 2.9 0.4 1.4 -0.1 44.8 
to - 
3.0 0.6 5.1 0,8 121.7 
3 1 2.7 OA 2.9 0.7 65.5 
3 --- 2 2.5 064 1.5 0.3 44.4 
3 3 2.7 0.5 3.6 0.4 97,0 
STDEV 0.1 010 1.1 0.2 26.5 
Averave(mcon) 
- 
2.7 0.4 2.6 0.5 69.0 
CONIM 5.0 11.3 41.0 44.5 38.4 
- Confidence Interval 0.2 0.1 1.2 T2 30.0 
From 2.5 0.4 1.4 0.2 39.0 
Ito ). 8 0.5 . 3.8 . 0.7 198.9 
I Irnlculatinp overall % COV in tissue tonometrv nnrnmptprq in nnrmnl contr-n-I-,. ---I 
Sten I IIII 
JAC. Standard Devi tion of each set of obqervations and gauare it to aet variance. 
Phase I Phase If Phase III 
Xn X1 -Xn 1-Irrau Xv -Xn I-IlTau 
0,04 0,00 0.8-5 0.00 186.65 
0,03 0,00 0.02 0.01 133881.75 
10.01 0.00 0.18 001 68.89 
0.02 0.01 2.25 OhOO 202486.87 
0.05 0.20 2.40 000 11211.85 
Ster)') I 
--- Add all sauares ur) I I 
Phase I Phase Il I Phase II I 
- 
Xn 
- 
Xi -Xn 1-1 Ou lx, -x -1/Tau 0.16 0.21 1595 10.04 
/I 
378906.12 
Stcr3 I I 
Divide souaress v of obqervations W). 
Ph se I Phase If llhnzp III 
I Xn - 
Xi-Xn I -IlTau I 
Xi -Xn -1/, rau 0.05 0.07 1 1.9 001 126302.04 
Ster 4 1 
lak-%UUjM= to get Standard Deviation 
Phase I Phase 11 Phase III 
Xn X1 -Xn I -ILEau -Xn -1/Tau 
, 
0.23 0-'17 1 1.41 355.39 
Sten 5 1 
Calculate rrand of all obsmations 
Ph se I Phase 11 Phase III 
Xn X1 An -IlTau xf An -1/Tau 
). q. ) 0.44 2.82 246.32 
Sten 6 
l Calculate ratio of SIVm. nd mean to Let ovemll COV 
Phase 11 Phase III 
Xn X1 An I -Irrau I X1 An -I -I/Tau 
0.08 1 0.61 1 0-50 1 1.08 1 1.44 
1 1 1 
-I -I 
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Calculatinj! ov erall % COV in tissue to nometry parameters in patients. 
Ster) II II I 
Take SD of each . t of observations and scuare it t get variance. Phase I Phase 11 Phase III 
Xn XiL-: Xn I -I/Tau Xi -Xn -Irrau 
000 0.01 1 0.44 0-15 6994.11 
000 001 1 
M 
262 0.13 1156.12 
002 000 () OMO 1.15 0.05 700.70 
Ster 2 
Add all souares ur 
Phase I Phase If Phase III 
E X, -Xn 1 -1/Tau 
2 Xi -Xn - - 
/Tau 
202 002 1 4.2 0.33 1 8850.94 
Ster3 
DividLSquims by no of obwrwitions W). 
Phaqe II Phase II Phase III 
Xn I Xi-Xn 1 --irrau Xy -Xn -Irrau 
0,01 1 0.01 1 1.40 0.11 2950.31 
Stcr) 41 1 
JakC ,; Qg are root I ) get SD Phase I Phase 11 - Phase III 
XA au I -xn X -irrau I 0,08 
! ýý FT3 rA T) 
Calculate rmnd rrH tions 
Phase I Phase 11 Phase III 
Xn Xv An I -I/Tau Xi -Xn 1 -1/Tau 
2,20 0.43 1 2,96 1 0.38 1 95.47 
Ster) 6- 
-I 
I I 
CalculgC ratio of SDILmnd mean to Let overall COV 
Phase I I Phase 11 I ase III , Xn IXi-Xn X,. 
e 
I-Irrau I -lrr au I 0.04 10.19 10.40 10.86 10.57 
Overall COV (% for each tOnQMetrT Daramete r in Datients 
Phase I Phase III 
x Xx ItTau 1XI Tn Firrau 
ICOVM 40.02 186.49 156.90 
Pre- and ost-measurement calibration check for the tissue tonometer 
SuMect No Pre- Post- 
1 40.1 40.3 
2 19,7 39.5 
3 42.4 42,1 
4 428 42.8 
5 41.2 41.1 
6 32,6 32 
7 28.8 29 
8 32.1 32.5 
9 '41.2 313 
10 31.5 31,9 
11 41.3 43.9 
12 41.7 41.5 
13 28.5 28.3 
14 27.5 27 
1, 29 29.2 
16 '19.3 29.3 
17 19,9 40A 
18 42.6 42.3 
19 18.5 28.1 
20 29 19.1 
)1 31.5 31.3 
11) 40.3 40.1 
D 29 29 
14 1-) 32 
'5 41.4 41.2 
26 'it). 1 29 
17 41 41.3 
28 40.6 1 
`2 28.5 
3() 28 28 
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Rate constant Darometer (-IfTau in s"-s*') 
ýuring 
Dhase _ 
Distancemoved -Xn(mm)durini! Dhase III 
normal voune normal old nonnal vo"nL, normal old 
3.0 2.2 0.1 0.1 
4') 2.4 0.6 0.1 
3.6 1.6 0.0 0.1 
2.8 2.1 0.1 0.0 
1 2.1 3.2 0.1 0.1 
2.4 2.1 0.1 0.8 
5.8 2.4 0.1 0.0 
2.0 1.6 0.0 0.3 
2.6 2,5 0.2 0.1 
1.6 3.1 0.2 0.0 
1.8 36 0.0 0.0 
23 2.7 02 0.0 
4,9 2.2 0.3 0.1 
1.3 3A 0.3 0.2 
4.4 1.7 0.1 O'l 
3.6 1.7 0.3 0.0 
2.4 2.5 0.2 0.1 
2.6 2.4 0.0 0.0 
2-6 1.7 0.0 0.0 
;. 6 2.4 0.2 0.0 
2.6 4.5 0.1 0.0 
median ). 6 2.4 media 0.1 0.1 
LO 1.4 2.1 ý 0.1 0.0 
uo 1.6 2.7 1 Jo 0.2 0.1 
Rate conmant varameter (-l/Tavj in sm ") durine i ihase III 
normal voune normal old 
60.4 58.0 
158.5 40.8 
115.1 86.8 
701.5 1946.8 
"1.8 67.7 
61.8 45.2 
1()64,5 149.0 
75.9 259.9 
2, M). 2 41.0 
(, X) -) 149.7 
1114 44.6 
441) 116.9 
4",. 8 . 51.6 . 41S. 8 798.0 
(1 8, th 3114.0 
67.1 379.3 
Fl. f. 8424 
'44.0 341.7 
txl, ) 436.8 
146.8 94.4 
119.5 
mcdo2n 119.5 
68.6 58.0 
uo 290.2 
. 
379.3 
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and rate 
n-t-m #-]IýA IV. -Y. in mml rinrina nhnvp I 
cn Ci 2.6 c4. 2.0 Clh 1.2 
CO cl 3.2 C4, 2.4 
-- 
C4h 1.7 
Q cl 1.9 C4j 2.0 c4h 0.6 
CA 3.1 Ci 2.9 C4, 3.2 Qh 0.6 
Cil 11 Ci 1.4 C4., 2.8 C4h 0.7 
ch 2.4 Ci 2.3 C4., 3.8 Qh 0., 5 
en 18 Ci 1.6 c4. 2.2 c4h 1.1 
Co 2.4 1 Ci 1.1 c41 2.3 C4h 0.4 
cn 4.1 1 Ci 1.1 C4, 3.4 C4h 0,9 
Co 1.6 1 Ci 3,1 c4j 2.9 C4h 1.1 
cn 3.2 1 C-t 15 C4. 2.2 C4h 0.6 
Co 2.4 1 Ci 4.2 C4. 2.8 Qh 1.2 
Cn 16 ci 3.1 cliý 1.8 cth 0.9 
Co 4,5 Ci 12 1.8 C4h 1,1 
Q 3.0 Ci 1.5 median 2.3 C4h 0.4 
cn 4A Ci 1.5 LO 2,0 C4h 0,9 
G 3.5 Cit 1.2 uo 2.9 Qh 1.0 
Q 3.1 01 1,5 Qh 1,3 
en 1) Q ei 30 Cdh 1.1 
Co '2.0 Ci 2.8 C4h 0.3 
Q 14 Ci 2.0 C4h 1.2 
Q 2.1 Ci 30 C4h 03 
Co 3 Ci 33 C4h 0.7 
cn 1.4 C, 2.2 C4h OS 
cn 1 () Ci 1.9 c4), 1. -5 
Q 2.0 C-% 1.7 
C4h 0.8 
c41 1.1 Ci 2.9 
C4h 1.5 1 
Co 2.9 Ci 3.3 C4h 0.8 
1 
- cn 3.8 median 2.7 
c4h 1.6 
cn 2.6 LO 1.6 C4h 0.9 
Cn 16 tio l. 1 C4h 0.7 
Gl 2.4 C4h 0,7 
Cil 3.3 C4h 09 
Co 1,1 Qh 0.6 
Co 0.8 
ch c4h 0.9 
Cn 29 
cn 3.7 C4h 1.1 
Co 1.6 C4h 0,6 
Co 1.5 c4h 0.9 
cn 'l 7 
C4h 0.5 
Co 3.0 
C4h 0.7 
median 1 2-9 
c4h 12 
1,0 2.4 1- 
C4h 1.2 
uo 3.3 median 0.8 
LO 0.7 
uo 1.2 
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Q 30 Ci 30 C4., 46 C4h 38 
cn 42 Ci 1,8 c4, 2.4 C4h 2.4 
Q 36 Ci 36 C4. ý 46 C4h 2.8 
cn 28 Ci 1.9 c4. 3.4 C4h 3.7 
cIn 2.1 Ci 40 4.4 CQ 2.1 
Q 24 Ct 11.1 2.6 Qh 24 
Cn 58 Ci 76 c4. 7.0 Cdh 32 
20 Ci 2.3 c4. ý 2.2 C4h 46 
Co 26 C4, 2.3 C4h 3.0 
Q 16 ci 26 c4., 26 C4h 4.3 
cn 2.2 C, % 2.7 clý 3.8 
C4h 2.6 
ca 24 ci c41 1.6 C4h 2.7 
cn 18 Ct 44 c4.1 3.3 cth 2.4 
cn 1 16 ci 11 C4, 4.4 C4h 4.1 
cn 2.1 cl 2,1 median 3.3 C4h 36 
Q 12 Ci 1.8 LO 2,4 C4h 2.6 
Q 71 cl 2.8 UIO 4.4 C4h 2.4 
Q 24 Ci 2.7 C4h 90 
cn 16 63 C4h 3.2 
cn 25 Cq 40 C4h 2.7 
cn 31 cl 2.5 C4h 46 
cn 36 Ck 46 C4h 4.1 
Q 2.3 Ct 5.1 1 C4h 2.6 
cn 2,7 cl 40 C4h 2.4 
cn 49 Ci 4ýO C4h 2.2 
Q 2.2 Ci 4.1 C4h 2.6 
en 3,1 ci 26 C4h 3,1 
cn 1.7 ci 4,7 C4h 2.2 
Q 1.7 median 3.3 cth 2.1 
Q 2,5 LO 2.6 cAh 2.2 
cü 33 tio 4.2 C4h 4.2 
cn 44 c 5.7 
cn 45 C4b 2.0 
cn 36 Qh 2.5 
Q 2.4 cth t c 2.8 
cn 2,4 cth 1 38 
ch 1.7 c 
G 2.4 
H H 
M 
Co 26 2 
7.2 
- C4h 
Q1 26 
-- - 
Qh 4.8 
median 2.5 F Ctl, 5.8 
1,0 2.1 median 2.8 
tlo 3.2 110 2.4 
uo 3.9 
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cn 0.1 Ci 2.7 LO 0.3 C4h 101 
Cß 08 C. 4 00 uo 0.7 CQ 0.2 
Cn 0.0 C% 0.8 C4h 0.6 
G 03 Ci 0.7 Qh 04 
Co 0.1 cl 0.5 C4h 0.3 
G] 00 Ci% 1.0 C4h 0.3 
Q1 0.0 C. N 0.1 Cil, 1 0.5 
CO 02 Ci 0.8 cäh 1 06 
Q 00 G 0.9 c oo 
Co 03 C-i 1.6 Qh 0.5 
cn 
9 9 
0.1 C. 4 0.4 C4h 0.2 
0.2 Ci 0.7 C4h 0.2 
0.1 median OA CQ 0.4 
, C-n 00 110 0.2 C4h 00 
cn 0.1 110 0.9 cth 0.0 
Co 0.3 c4h 1 0,0 
Co 01 Cth 04 
ch 0.0 C4h 08 
c41 (13 C4h 0.1 
cn 02 C4h 0.0 
Co 00 C4h 0.3 
cn 00 C4h 0.2 
G) 00 C4h 0.2 
c4) 00 C4h Of) 
cn no Qh 0.3 
Cn 0.2 Qh 0. -5 
CA1 (11 4h 0.8 
rnedian 01 medlan 0.3 
110 00 LO 0.1 
(10 02 uo 
Cometer (A au In sem j Rate tonstant Da furine Dhase 
Gl . 60.4 ci 798 c4. 20.4 C4h 53.0 
159.5 C. 4 100.0 
c4. 56.6 c4h 53. -1 155.1 C. 4 11.1 c4. 56.1 C4h 45.6 
701.5 G 49.2 C4. 62.5 C4h 11.0 
g 
g(118 Ci 67,0 C4, 56.1 C4h 30.2 
62.8 C. 4 1 43.1 c4.1 47.7 c4h 32.3 1 
cn . 10645 Ct 
1 73.1 C4., 58.1 C4h 388 
Cn 1 75.9 ei 511 C4, 56.1 Qh 46.5 
Cn 290.2 cl, 545 C4. 22.1 C4h 27.8 
Cn 992 cl 416 C4, 84.7 C4h 56.6 
Q 580 ci 131.3 C4, 342 C4h 285 
Cn 408 ci 72.7 c41 466 Cii, 78.6 
Q 1124 cl, 446 C4, j 62.5 C4h 53.9 
cn Mg el 21.3 C4a 46.9 C4h 79.2 
cn 19468 cl 64.1 rnedian 56.1 C4h 31.5 
Q 67,7 C, % 1500 110 46.7 
C4h 59.2 
cn 45.2 cl 11.5,1 uo 57.7 c4h 74.3 
Cn 1490 ci 80.1 cdh 68.2 
Cm 2599 Ci 898 C4h 390 
cn 410 Cq 54.1 c4h 108.9 
cn 149,7 ci 540 C4h 16 
cn 446 cl 65,21 C4h 71.7 
Co 449 Ci 161.4 C4h 60.3 
ch 1169 ci 1960 c4h 105 
G 4ge 8 57.7 
- 1 
C4h 23.0 
ch 516 Ci 446 c 60.1 
Cn 7980 Ci 375.2 C4h 500 
Q 31140 medien 653 C4h 36.0 
ch 379.3 1,0 51.2 C4h 15.0 
Q 842,4 tio 94.9 Cdh 21.5 
Cn 3158 cth 1 12.9 
Q 686 c4h 31.0 
Q 119 ý, ' 
Qh 32.6 
Cn b7.1 c 18.1 
Q 82.5 C4h 74.2 
G 341.7 C4h 47.7 
Co 4168 CA1, 49.2 
Cß 844 Qh 84.1 
cn 940 C4h 853.8 
c41 'X) 2 c4h 157.8 
14fi 8 C4h 55.7 
590 Qh 66.1 
median 1147 M£ gdian 
110 1 . u) 1 250 
110 2 
-A 
uo 1 64.7 
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Appendix IV 
Studv 11 
Phase 1 (0-1 secs) Phase If (1-10 Secq) 
, 
Phase 11 (1-10 seSs2 Phase 111 (10-300 sees) Phase 111 (10-300 sees) 
Glycerol (%J. Xn (mm) Xi-Xn (mm) -I/Tau (spes ") - - 
Xi-Xn (mm) -1/Tau (secs *') 0 482 0.36 2.44 
_ 
0.28 - 176.60 
0 4.72 0.25 2.85 
- 
0.17 72.00 
0 4,26 0,34 2.55 0.23 63.20 
Averaze 4.60 0.3'ý 2.61 0.23 103.93 
St Dev 1 0.30 0.06 0.21 &05 63.08 
COV% 6.51 1913 8.12 
- 
23.84 60-70 
25 2.57 0.63 3.20 
- 
0.57 59,00 
25 157 0.90 3.45 
- 
0.71 60.60 
25 1.85 0.81 2.64 
- 
1.19 56.30 
Averave 2.33 0.78 3.10 0.82 58.63 
St Dev 0.4" 0.14 0.41 
- 
0.33 2.17 
COV% 17.97 17-71 13.39 39.70 3.71 
50 1.35 088 4.58 
- 
1.39 127.10 
50 1.62 1,14 2.39 
- 
1.58 54,90 
50 1.35 0.85 2.67 1.61 58.40 
Averace 1.44 0.96 3.21 1.53 80-13 
St Dev 0.15 0.16 1.19 0.12 40-71 
COV% 10.98 16.57 37.09 7.89 50.81 
100 0,50 0.15 2.91 0.32 77.70 
100 0.36 0.06 5.98 0.13 93,20 
100 033 0,08 3.96 0.15 77,20 
Averave 0.40 0.10 4.28 0.20 82-70 
St Dev 0.09 0.05 1.56 0.11 9.10 
COV% 2105 50.47 36.43 53.74 11.00 
In vitro reproducibility test of tissue tonometry parameters of distance and rate constants 
using Glycerol diluted with water on an open cell sponge done three times at the same times on 
different days. 
Ci Sgring constaDL Ct SDr*ng constant k DashDot constant Ci sDrine constant k DashDot const 
Glycerol M Phase I Phase II Phase 11 Phase III Phase III 
0 0.68 9.21 
_22.47 
11.72 2070.10 
0 0.70 13.39 38.17 19.13 1377,53 
0 0.77 9.61 24.50 14.09 890.52 
Aver2ee 0.7" 10.74 28.38 14.98 1446-05 
St Dev 1 0.05 2.31 8.54 3.78 592.77 
COV% 6.74 21.50 30-08 25.26 40.99 
25 1.28 5.22 16.70 5.79 141.61 
25 1.28 3.64 12.57 4.65 281.50 
25 1.78 4.08 10.76 2.76 155.58 
Averave 1.45 4.31 13.34 4.40 259.58 
St Dey 0.19 0.81 3.04 1.53 94-95 
COV% 20.06 18-86 22.80 34.74 36.58 
50 2.43 3.72 17.04 2.36 300.39 
50 2.03 2.88 6.89 2.08 114.00 
50 2.43 3.87 10.33 2.04 119.00 
Averave 2.30 3.49 11.42 2.16 177.80 
St Dev 0.23 0.53 5.16 0.18 106.20 
COV% 9.97 15.21 45.20 8.24 59.73 
100 6.65 21.36 62.15 10.14_ 788.20 
100 9,06 52.22 312.25 26.11 2433.28 
100 9.97 43.37 171.74 21.68 1674.01 
Averave 8.56 38.98 182.05 _ 19.31 1631.83 
St Dev 1.72 15.89 125.37 8.24 2n5 
C()V% 20.07 40.77 1 68.87 42.68 50.4( 
In vitro reproducibility test of the Kelvin-Ilooke parameters of springs and dashpots using 
Glycerol diluted with water on an open cell sponge done three times at the same times on different 
days. 
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Appendix V 
Study III 
Limb 
No 
CEAP Clinical 
classirication 
Phase 1 
XA (mm) 
Phase 11 
Xi-Xß (mm) 
Phase 11 
Afrau (sees 
Phase 111 
Xi-Xo (inm) 
Phase 111 
-lfrau (secs 
1 Co 2.46 0.33 2.54 0.20 45.70 
2 Q 307 0.34 2.96 0.18 54.30 
3 Q 262 0,17 3.00 028 325.83 
4 Q 2.57 024 1.91 0.31 57.45 
,11 Q 3.38 0.27 265 0.10 536.50 
61 Q 3.71 0.28 2.55 0. 86.23 
7 cn 2.4 9 0.17 2.10 0.28 101.50 
8 cn 2.56 0.31 2.30 
- -0.06 
64.33 
9 Q 1.75 0,25 03 0.10 60,40 
10 cn 2.57 0.37 4.19 064 158,50 
11 Q 2.28 0.33 3.62 004 155.10 
12 Q 3.10 0.27 2.77 0.12 7 1.50 
13 Q 2.31 041 2.14 0.10 861.80 
14 Q 141 039 2.42 0.06 62.80 
15 Q 2,77 002 5.75 0.12 1064.50 
16 Q '2 44 0.17 2.02 75.90 
17 Co 1.58 1,25 1.55 0.19 99.20 
18 Co 3.23 0.27 2.19 0.12 1 58.00 
19 ch ')ig 0,18 2.39 008 1 4080 
20 Cn 264 0.37 1.77 0.01 1 112.40 
Nfedian 2.57 0.28 2.48 0.11 92.72 
1,0 2.40 0.21 2.1-3 0.07 59.80 
(10 2.84 0.35 2.97 0.19 200.33 
1 ei 3.56 0.57 2.28 - 
0.33 59.40 
2 Ci 181 0.44 2.23 0.01 495.90 
3 Ci 263 0.31 2.85 0.12 1 82.93 
4 Ci 152 0.34 2.06 0.22 1 67.87 
5 Ci 2.31 0.33 1 2.06 0.17 211.60 
6 Ct 351 026 2.99 0.31 68.80 
7 Ct 356 062 2.70 0.18 161.53 
8 Ci 13-) 0.12 1.82 0.01 93.35 
9 Ct 440 0.17 3.13 0.13 903.47 
10 Ci 416 0.1.1 5.09 007 1602.60 
11 Ct 449 1 0.40 1.64 0.10 8680 
12 Ct 30o 1 028 2.13 0.17 194.68 
13 Ct 396 1 029 3.18 005 67.70 
14 Ct 353 0.47 2.10 0.84 45.20 
Ci 3 14 0.33 2.40 0.01 149.00 
16 Ci 294 048 1.59 0.27 259.90 
17 Ci 201 0.38 2.54 0.12 1 41.00 
18 Ci 244 0,10 3.08 0.02 149.70 
19 Ct 205 0.10 3.56 002 4460 
20 Ct 307 0,16 2.34 0.21 44.90 
21 1 Ct 1,39 0.13 2.65 0.02 116.90 
22 1 Ci 188 019 490 
- 
0.34 48680 
23 Ci 1 -gg 014 2.16 0.11 51.60 24 Ci 1,12 0.20 308 0.20 798.00 
25 Ci 291 0.21 1.72 009 3114.00 
26 Ci 333 0.32 4.47 OAI 119.50 
- median 
2.93 0. -10 2.47 0.12 118.20 110 2.31 0.18 2.11 
- 
0.03 67.74 
tlo 3.53 0.38 3.08 0.21 247.83 
Ci 304 1.23 1,80 0.24 179.70 
2 C 1 2 2" 
ob9 2.42 0.89 62.00 
3 , 380 80 2,14 0.75 58,80 
4 C-2 281 014 306 0.26 81.83 
5 C-i 199 1 0.37 2.92 0.39 108.10 
6 c? 295 1 0,35 3.71 0.38 656,5 
7 Ci 150 0.25 3.44 0.29 76.80 
8 ci 2W 0,52 5.26 0.44 78.30 
9 cl 248 1 0,43 1.97 0.21 112.20 
10 ci IM 042 2.0(5 0.02 13580 
11 cl iig 0.12 301 0.06 7980 
12 . C. ) 
- 191 037 355 0.06 11.10 
13 CT 153 oý53 269 0.02 131.30 
14 Ci 145 023 2,11 0.10 64.10 
Cy 0,41 165 0.02 115.10 j 
0.14 72.70 
17 Cy 
1 
220 307 0.80 21.30 
1 p-on 
- 
0.43 . 69 - 
0.24 78.30 
259 
110 2.43 0.36 2.16 0.06 1 64.10 
110 3.27 0.56 3.25 0.39 115.10 
I Cmt 2.51 026 1.90 0.45 70.80 
2 C-4 360 0.45 . 30 0.53 175.20 3 C. % 261 0.67 3.90 068 89.90 
41 C, 4 206 0.45 4.13 040 1 109-20 
5 C. % 2.89 0.63 2.66 - 
0.46 8963 
6 04 341 0.51 3.00 
- 
0.33 240.00 
7 C-4 2.34 0.20 6.36 0.50 42.60 
8 C-4 281 0.55 4.20 0.50 10100 
9 - C-4 2.54 0.62 2.68 0.32 71.07 
10 C., 3.55 0.76 4.73 0.04 88.87 
II C, 3,45 0.52 2.94 0.25 8163 
12 C, 3,20 0.62 1.77 0.29 100.00 
13 C-4 290 085 1.92 0.81 49.20 
14 C, 1.35 0,54 4.01 0.55 67.00 
15 C-4 131 0.48 11.10 0.28 43.10 
16 Cl 1.55 082 7.63 0.90 73.10 
17 cl, 106 1.66 2.29 2.29 53.10 
18 C., 1,01) 065 3.57 0.34 54.50 
19 Ol 3,14 0.72 2.62 0.57 41.60 
20 Ol 310 1.16 444 1.73 44.60 
21 Cq 148 0.22 1.78 error error 
22 C-4 1.22 1.29 2.79 2.70 15000 
23 CA 198 0.38 2.52 0.46 54.10 
24 CIA 300 0.45 4.61 1.01 5400 
25 C, 383 066 3.97 0.92 19600 
median 2.61 0.62 1.3 0 0.50 7 . 08 
110 1.98 0.45 2.62 0.31 53.78 
110 3.14 0.72 4.20 0.75 100.25 
C4a 2.48 0.29 3.09 090 39.10 
C4a ?., ) 1 040 307 0.51 59.60 
C4a 289 092 1,89 0.81 71.57 
4 C4a 2,52 099 4.15 0.87 77.73 
C4a 2.71 061 2.73 0.59 6100 
6 C4a 347 0.82 4.93 0.65 55.70 
7 C4a 2.20 0.31 3.48 0.25 49.50 
8 C4a 300 053 6,31 0.77 64.70 
9 C43 293 0.74 3.01 0.22 13707 
10 C43 262 067 1.98 0.69 72.73 
11 C43 287 0.59 8.59 1.14 223.70 
12 C4a 2.90 067 4.44 0.82 ý56.00 
13 C4a 363 093 2.54 066 50.20 
14 1 C43 1.95 044 460 0.51 20.40 
15 C43 241 0.48 
2.15 
0.16 5660 
16 C43 198 
, 
093 463 0.72 56.10 
17 C43 323 037 3.38 0.27 62,50 
18 C43 224 E 0 7M 0.94 58.10 
19 C4: t 228 089 2.24 0.22 5610 
20 C43 1,37 . 86 2.32 0.01 22.10 21 1 C43 294 0.45 160 0.30 84.70 
22 C4a 2.21 0.57 383 0.31 34.20 
23 C41 1.75 0.48 4.43 0.50 46.90 
median 2.62 0.61 . 3.38 0.59 56.60 
LO 2.23 0.47 2.57 0.29 49.85 
tio 2.9-3 0,84 4.52 0.79 68.13 
I C4h 086 043 401 0.55 28.10 
2 C-th 0.79 062 1.97 0.11 69.50 
3 C4h 0,73 0.95 509 1.31 195.50 
4 Gh 102 0.71 228 0.51 144.10 
i c4h 1.22 094 5.14 061 54.30 
6 C41h 1.53 1.16 2.18 0.65 49.90 
7 c4k 1 AS 0,92 3.33 0.77 42.40 
8 C4h 066 038 1.96 0.18 153.75 
9 cm 089 0.74 -3.75 0.12 58,50 10 -- C4h 1,12 0.73 5.17 0.13 54.70 
II Cý% 1.15 045 381 0.51 530 
12 c4h 172 0.57 2.42 0.69 53.3 
13 C4h 059 1 0.20 2.80 0.03 4560 
14 C4h 01%6 0,55 169 0.19 31.00 
15 C4h 033 0,70 2.13 0.42 30.2 
16 CLS 046 0,118 2.39 0.21 32.3 
17 C4h 109 1.05 3.23 0.37 388 
18 C4h 043 0,219 464 465 
19 CAK 056 M 'S S' 2 Q 28.5 
20 c4h 1 19 5 276 0: 9 1 786 
21 r- 082 1 040 2.48 1 0.10 1 18 10 
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22 c1h 0.91 022 2,77 0.03 74.2 
23 c4h 0,86 0.45 3.77 0.28 47.7 
24 c4h 1.25 0.44 3.33 0.23 49.20 
25 c4h 0.56 0,16 2.53 tono fell off" 
26 C. 1h 1.15 0.59 4.82 0.50 55.70 
median 0.96 0,67 3.33 0.23 54.30 
U) 0.80 0.43 2.33 0-13 44-00 
uo 1.20 0.88 4.62 0.58 64,00 
1 Cl 0,91 063 1.64 0.34 52.20 
2 Cl 0,99 0.33 2.64 0.03 61.10 
3 Cl 1.32 0.33 2.37 0.14 44.40 
4 Cl 1.06 1 081 4.05 0.81 321.55 
5 Cl 0,99 0.10 4.58 0,01 475.57 
6 cq 1.20 1.09 3.59 
- 
1.45 82.07 
7 Ci 0ý8 t 047 2.25 0.07 692.50 
8 Cl 1,88 1.18 1.85 
- 
0.80 43.93 
9 Ci 0.91 0.29 2.20 0.18 65,32 
cq 0.69 0.45 3.33 0.10 1 80.30 
II eq 0.66 0.74 2.60 0.64 1 60.30 
12 cq 0.76 0.19 2.38 0.02 1 10.50 
13 Ci 1,45 037 2.18 0.51 23.00 
14 cq 0.79 0.78 2.56 
- 
0.22 60.30 
15 Ci 1.52 0,42 3.05 
- 
0.23 50-00 
16 cq 0.79 tonometerfell 
17 cq 1.62 0.79 2.22 0.43 36.00 
18 Cl 0.89 0.26 2.12 002 15,00 
19 cq 069 0.31 2.15 0.01 21.50 
20 cq 0,66 0.12 4.20 0.01 12.90 
21 Cl 0,86 0.79 566 0.43 31-00 
22 C% 0.56 0.76 1.99 0.75 1260 
23 Ci 1.42 0.31 2.79 0.16 l 100.40 
24 cq 1.75 1 1.38 5.95 111.70 
median 0.91 0.45 2.56 
ýý 
2 20 
Lo 0.78 0.31 2.19 0.0 31.80 
uo 1.35 0.79 3.46 8 Rl IR 
I Cfi 2.11 1.09 2.28 2.27 52.40 
2 cf. 099 0.26 3.07 1.01 125.40 
3 C6 0.89 0.62 3.27 0.57 67.90 
4 C& 1.01 1.01 2.77 0.93 66.83 
5 cfi 0.96 0.35 3,74 0.21 74,10 
6 cf. 1.09 0.48 4.26 0.26 33,00 
7 cfi 1 ý55 
143 5.32 1.63 118.80 
8 CA 0.46 0.60 2.38 0.73 1 101.20 
9 ch 0.54 0,24 2.16 0.32 129.90 
10 C6 0.94 0.48 . 
3.28 0.43 47.83 
II Ch 0.92 0.78 2.35 048 53.9 
I r. 1.12 1 0.45 4.14 0.71 79.2 
13 CA 016 0.16 3.55 0.06 11.50 
14 CA 0.92 0,84 2.58 0.05 59.2 
15 G 0.99 0.41 2.43 0.22 74.3 
16 CA 1.32 0.57 9.03 0.59 68.20 
17 Ch 1.06 105 3.23 - 
0.37 1 38.00 
18 C6 0.26 024 2.73 0.29 1 108.90 
19 Cfi 1.22 0.01 4.6-1 0.30 3.60 
20 Q (1.49 0.54 407 0.49 71.70 
median 0.97 0.51 3.25 0.43 68.05 
Lo OXO 0.28 2.74 0.30 45.38 
tio 1.12 0.94 3.99 0-93 103.13 
Median and Inter-quartile ranges of tissue tonometry parameters in limbs of normal controls 
and in patients with lower limb chronic venous disease. 
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Limb 
no 
CEAP Clinical 
Classirication 
Phase I (C2) 
(spring constant) 
Phase II (CO 
(spring constant) 
Phase 11 (k) 
Dashpot constant 
Phase III (CI) 
(spring constant) 
Phase III (k) 
Dashpot constant 
I Cn 1.34 10.09 25.62 16.67 762.04 
2 Q 1.07 9.61 28.45 18.57 1008.34 
3 Cn 1.26 18.88 5 . 56 11.90 3878.49 
4 Q 1-28 1 '91 
26.52 10.66 612.15 
-5 
Ch 0.97 12.18 32.27 31.60 16953.96 
6 G1 0.89 11.75 29.91 4424 3815.09 
71 Q 1.32 19.60 41.23 11.96 - 
121365 
R Q 1.28 10.77 24.78 51.99 3344.54 
9 ch 1.88 39.85 32.88 
10 Q 1.28 889 37.24 5.14 814.35 
11 Q 1.44 9.96 36.07 82.21 12750.06 
2 Cn 1.06 12.18 33.73 27.40 19222.37 
11 1 G1 1.4) 802 17.16 32.88 28337.85 
14 1 4 Q 136 8,43 20.40 54.80 3441,67 
is Q 1.19 945.36 27.40 29169.22 
16 6 Ca LIS 19.34 19.07 128.82 
17 Q 2.08 2.63 4.08 17.31 1716.80 
8 18 Ca 1.02 12.18 27.40 1589.30 
9 9 C-D 138 18.27 43.66 41.10 1676.99 
20 20 Ca 1.5 889 15.73 548.04 61599.26 
Tnedian 1.28 11.96 1.09 29.50 3-39-3.10 
LO 1.16 . 43 25.41 17.15 1495.39 
1 10 1.37 15.00 39.27 46.18 17521.06 
. 
1 C1 0,92 5,77 13.15 9.96 591.89 
2 C1 1-17 7.47 16.67 28.82 161062.66 
3 C1 1.25 10.58 27.81 2306.15 
4 
-C, 
1-31 9.72 1999 14.83 1006.17 
', I C1 , 1.42 1 10.00 20.61 19.85 4200.42 
I - Cl . 0.93 12.46 37.24 10.68 734.51 
71 Cl 09') 526 14.23 - 
18.15 2932.21 
C1 142 2 . 42 
49.82 420.49 92 4 
C1 - 0.75 19.26 60.22 24.47 22112.16 
10 Cl 0.79 26.11 132.88 48.95 78446.61 
I C1 073 822 13.48 - 
32.88 2854.17 
12 C, 1.10 11.74 25.01 19.34 3765.59 
13 C1 0.83 11,34 36.06 - 
65.76 4452.25 
14 C1 
I 
0.93 7,00 14.69 3.91 176.94 
15 C1 I ()1 9,96 23.91 '328.82 48994.43 
16 C1 1.12 1089 12.18 3165.21 
17 Cl 1-64 865 21.98 27,40 1123,47 
18 Cl 1.35 31.88 101.28 164.41 24612.30 
19 1 C1 1.60 '42.88 117.06 164.41 7332.72 
-20 C1 1.07 9.13 2 1.17 15.66 70305 
21 C1 137 15.29 67.03 164.41 19219.63 
-22 C1 1-75 17.31 84.80 9.67 4707.95 
-23 CL 1,66 `ýl 49 . 10.73 29.89 1542.47 
'24 -- - Cl 2.94 16.78 51.67 16.12 12862.73 
Cl 1-13 1 . 66 26.93 - 
36.54 113772.9. 
?6 1 C1 ()ýqq 10-18 45.93 328.82 39294.19 
median 1.12 1 . 96 28.54 2760 4.326.33 1 1.0 0.91 . 77 20,15 15: 77 1733.39 - UO 1.42 18.77 51.44 1 97 23987.27 
C, 1 QS 167 4.81 13.70 2462.05 
K 
C, 4.77 11.53 369 229.07 
C, 0.87 4.11 8.80 4.38 257.80 
4 C, 1.17 9.77 29,92 12.79 1046.58 
i C, 8-79 2567 8.52 921.06 
C, 9.49 35.20 8.61 565.14 
C, 13. 44,1 11.17 858.23 
C, fl-31 13.32 7.51 587.87 
C, 7.57 14.91 15.41 2037.82 
C, L4" 1ý3 3 
- At 22326.99 
it Cý I iS 27.40 82.48 54.80 
12 C, 1.72 8.89 31.55 54.80 608.32 
13 C, 0 91 6.20 16.69 16441 .4 
14 1 C, " '17 1430 10,17 32.88 
1i I C. 2 1h 76S 20.26 16441 1892 . 69 
16 c- 0.79 ',. S7 12.15 23.49 1707.52 
17 C, 1.44 20,1; 5 6309 4.11 87.55 
wwdian 1 17 7.83 25.67 13.70 
LO LOS 6.10 14.91 8.52 587.87 
UO 1.4 -W 9.77 -13.3, ý 
1 
54.80 2462.05 
I I C1 01 12.65 
1 '14.03 7.31 
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2 Cit 091 7.31 24.11 6.20 1086.97 
3 cl 126 491 19.14 484 434.72 
4 C-4 1.59 7.26 29.9 8.19 885.76 
5 C-4 1.14 5.1 13.78 7.14 639.64 
6 C-1 0.96 6.47 19.9 10.11 2426.31 
7 0% 1.40 16.44 1 104.57 6.58 280.16 
8 C-q 1.17 5.98 25.11 6.58 664.22 
91 CA 1,29 5.29 1419 
- 
10.24 727.86 
10 1 C-1 0,93 4.33 20.50 89.47 7950.47 
11 1 C', 095 633 18.62 
- 
13,06 1065.74 
12 C-q 1.03 5.3 9.39 11.34 1133.87 
13 C'q 1.13 3.87 7.43 4.06 199.73 
14 1 C'l 21.44. 6.09 24.42 5.98 400,56 
15 Cit 1,42 685 76.04 11.74 _ 506.15 
16 Ct 1,12 401 30.60 3.65 267.08 
17 1 Cl 3.10 1.98 4-54 1.44 
18 Cl 302 506 1806 9.67 527.08 
19 C-% 105 4.57 11.97 5.77 239.98 
'20 C, 106 283 12.59 1.90 84.77 
'21 C., 1) 11) 14,95 26.60 
22 C-% 170 2.55 7.11 1.22 182.68 
23 Cit 1.66 8.65 21.81 7.15 386.72 
74 1 CA 1 P9 7.1 33.69 3.26 17 .8 25 1 Cl 086 498 19.78 3.57 700.53 
median 1.26 C. -ý40 19.78 658 511.75 
1,0 1.05 
l; 7 13.78 3.96 260,30 
- UO 1.66 7.26 25.11 9.78 767.34 
CS. 1.33 11.34 3504 3.65 142.85 
I CS. 1.49 822 25.24 6.45 384.27 
C. I. 1 14 3., 8 6.77 4.08 _ 
292.33 
4 CA. 1.31 3.33 1383 3.79 294.43 
s CA. 1,22 5.39 14.72 5.57 339.97 
6 CA. 095 401 19.77 5.06 291.77 
7 1 CA. 149 10 3690 13.20 653.27 
8 CA. IN 6.20 39.15 4.27 276.30 
9 cd. 1.1) 442 1- 14.91 
10 CA. 126 494 9.80 4.75 345.48 
II CS. 1 15 557 47.87 2.88 645.24 
12 CA. 1.1-3 491 21.79 401 22456 
13 CA. 091 3.54 898 4.98 250.10 
14 CA. 169 7.47 34.38 6.45 131.53 
15 CA, 116 68 16.10 20.55 1163.21 
16 CA. Im 3 '; 4 1637 4.57 256.21 
17 CA. 1 P2 889 3004 12.18 761.16 
18 CA. IA 411 2881 3.50 203.24 
19 CA. 1,44 369 828 14.95 838,50 
20 CA. 098 182 8.87 328.82 7266.96 
'21 1 Ct. 1.12 7.31 1900 10.96 928.37 
-2-2 G. 1,49 577 1, )Og 10.61 362.76 
23 CA. I" 685 30.35 6.58 308.43 
median 1.26 5.39 19.77 5.57 
Lo 1.12 3.92 11.6 4.18 
tio 1.48 7.08 -30.19 11.57 707,22 
C. 383 7.65 30.66 5.98 168.00 
2 1 C-th 4 15 5,30 1045 2989 2077-56 
3 1 CAh 4S 346 17.62 2.51 490.72 
4 1 CAh 321 463 10.56 6.45 929.08 
5 Gh 269 3.50 1 5.39 292.1 
6 CAh 214 284 620 5.08 253.71 
7 Cap, 226 356 11 84 4.26 180.81 
8 c4h 498 8 1693 18.12 2786.12 
9 c4h 169 444 1666 27.40 1603.01 
10 c4h 293 450 23.29 25.29 1383.58 
11 CAh 286 7.31 27.84 6.45 341.72 
12 c4h 191 5.77 13.96 4.77 254.00 
11 Cah 557 1644 46 10961 4998.09 
14 c4h 587 59 2206 17.31 536.50 
is I C. "ý 490 4.70 10.01 7 83 236.44 
16 Cý 7.15 567 13ý55 _ 15.66 505.76 
17 CAh 30, ) 1.13 1012 889 344.82 
18 CAk - 765 11.34 5161 36.54 1698.91 
19 cAk 587 c- 87 14.7 889 2-53.28 
20 c, % 27 31 8.33 3.61 28402 
CAh 401 $22 10,39 3298 5 5.17 _ 
c4h 157 1495 1 41.0 1 ý61 8132.86 c4h I It') 231 27,55 11.74 
4 c4h 2 f-A 717 24ý89 14.30 703.39 
_ 25 Cýh 587 1-055 51.91) 
- 
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26 C. 1h - 
186 5.57 26.86 6.58 
- 
1 366.31 
- median . 
76 5.72 17.80 8.89 505.76 
- '0 
2.86 4.46 12.27 - 5.98 284,02 
- 
uo 4.87 7.60 
- 
27.38 - 25.29 1.383.58 
1 CA 3.60 5.20 
- 
8.53 9.70 506.51 
21 CA 3.32 9.96 26-31 109.61 6697.00 
3 CA 2.49 9.96 23.62 23.49 1 042.83 
4 CA . 11 
4.08 16.51 4.08 . 1311.03 
-5 
CA 3.3 " 31.78 145.45 402.56 19144289 
6 CA 174 3.01 10.80 2.27 186.44 
7 CA 4.04 . 
93 15.57 45.05 31199.09 
8 CA 1 1 ý75 2.80 5.17 4.09 179.54 9 CA 3.60 11.54 25-38 18.27 1193.32 
10 CA 4.74 7.31 24.32 32.12 257907 
11 1 CA 
- 
4.98 4.44 1.55 5.14 309.81 
12 CA 4.33 17.31 41.19 164.41 1726.31 
13 CA 2.17 8.89 19.37 645 148.29 
14 CA 4.16 4,22 10.79 14.95 901.27 
15 Cq 2.16 7.83 23.88 14.61 730.71 
16 CA 4.16 
17 CA 2.03 4.16 9.24 7.65 275.29 
18 CA 3.69 11.65 26.81 164.41 2466.16 
19 CA 4.77 10.61 22.81 328.82 7069.67 
20 CA 4.98 27.40 115.09 328.82 4241.80 
21 cq 3.82 4.16 23.56 7.65 237.06 
22 Cq 1; 87 4.33 8.61 4.38 142.93 
23 CA -) 1-) 10.61 29.59 20.55 2063.36 
24 CA 1.88 2.38 14.18 2.40 268.10 
median 3.60 7-41 22.81 14.95 972.05 
1.0 2.45 4.19 11.18 5.79 260.34 
uo 4.20 10.61 25.84 77.33 2494.39 
I CA 1., 6 1,02 6.88 1.45 75.90 
2 cf. . 3) 
12.65 3883 . 26 408.26 
,4 CA 1.69 5.28 17.24 5.79 393.14 
4 Cf. 3.25 3.13 8.65 3.52 235.58 
5 CA 1.44 9.39 35.14 15.66 1160.27 
6 CA 3.02 6.85 29,18 12.65 417.35 
7 cf, -). I ') 230 12.23 2.02 239.66 
8 CA 7.12 48 13.04 4.50 455.85 
9 CA 6.04 13.47 29.09 10.44 1355.84 
10 CA I Il 6.89 22.61 7.65 365.78 
11 1 CA 1.57 4.22 9.91 6,85 369.24 
12 Cf. 2.94 7.11 30.25 463 366.80 
13 cf, 9.13 20.55 72,96 6- 1 
14 CA 3.57 3.91 10.10 5.76 38 3.25 
15 CA 1.32 802 19.49 14.95 1110.52 
16 CA 2.49 5.77 52.09 5.57 380.10 
17 cf. 'A. 10 3.13 10,12 8.89 337.71 
is cf. 1 . 65 
13.70 37.40 11.34 1234.78 
19 CA ". 70 10961 507.48 10.96 39.46 
20 CA 6-71 609 24.78 6.71 481,15 
median 1-48 . 47 -1 2' '2 Q 7'2 1 Q Q 2Q I., IM 
i 
. 14 1 1 7O 4 60 
I 
'; 8! 7 6 
I "o 1 1 10.21 1 35.70 1 11.67 1 1122.96 
Median and Intcr-quartile ranges of spring and dashpot constants calculated from the Kelvin- 
Ilooke model In limbs of normal controls and in patients with lower limb chronic venous disease. 
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Appendix VI 
Study IV 
Pt No I Age I Leg CEAP Clinical 
Clavsirication 
CEAP LDS 
severity score 
Xo (nun) Series Hooke element 
C2(spri 9constant) 
I1 -51 
1 R C4h 2 1.15 2.86 
I1 -51 
1 L Qh 1 1.72 1.91 
2 78 R C6 2 0.59 5.58 
2 78 CA), 2 0.56 5.88 
-3 63 Cf, 2 0.73 4.51 
31 63 L C-1h 2 0.46 7.15 
4 65 R C-th 1 1.09 3.02 
4 65 L CI 2 0.43 7.65 
5 70 R Qh 2 0.86 3.83 
5 70 L C. 1h 2 1 D9 102 
6 69 R C-Ah 0.56 588 
6 69 CAh 1 1.19 2.76 
7 69 R C-1h 1 1.52 2.16 
7 69 L 
M 
C6 2 0.79 4.16 
81 43 R CA 2 0.89 3.70 
91 43 L C4h 1 1 612 2.03 
91 57 R 2 0.86 3.83 
91 57 L CI 1 -- 0.56 5.88 
10 1 77 R CIh 1 1.42 2.32 
10 1 77 L Cq 1 1,75 1.88 
11 1 63 R C4h 1 1.53 2.14 
11 1 63 L C-1h 2 1.45 2.27 
12 72 R C-Ah 0.89 3.69 
12 72 L C. Ih 1 1.12 2,93 
13 71 R Cq 2 0.91 3.60 
13 71 L CA 1 0.94 3,52 
14 75 R Cf. 1 155 2.12 
14 75 L G% 12 0.46 7.12 
15 50 R C4h ------------- 2 066 4.98 
15 50 L Cl 1 1.32 2.49 
16 52 C4h 2 0.73 4.53 
16 1 52 C& 12 0.99 3,32 
Correlation of tissue tonometry parameters of skin compliance with clinical assessment of the 
severity of skin changes In patients with bilateral LDS. 
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Appendix VII 
Study V 
lA mb no CEAP Skin (mm) 1 Subcutaneotis-Iave r (mmT 
1 G 3.3 5.35 
2 cn 2.5 8.3 
3 Co 2.64 5.1 
4 Co 1.2 13.9 
5 ch 3 8.9 
6 ch 2.8 8.3 
7 ch 2,7 45 
8 Co 2.5 10.8 
9 cn 2.4 7 
10 Co 2.5 7,5 
11 cn 2.8 7 
12 cn 3.5 5.6 
Nf edian 2.75 7.25 
uo 8.45 
1,0 1-0 2.5 5.54 
13 C, 3,1 11.5 
14 el 36 12.8 
15 C, 1,5 15.6 
16 cl 1,4 29.4 
17 cl 3.2 16 
18 C, 3.3 ? 
19 cl 3.5 9.8 
M edian Nfedian 3.2 14.2 
uo (10 
. 
3.4 15.9 
1-0 LO 2.3 11.8 
20 c4ý 2.6 11.2 
21 ctý 3,2 12 
22 Ctý 2.3 6.6 
23 C, &. 1.5 15.6 
24 c4. 1.6 17.9 
Nf edian Nfedian 13 j') 
uo uo 2.6 1-9.6 
LO LO 1.6 11.2 
25 C4h 64 ? 
26 CAh ? 
)7 C-h 1.3 11.4 
28 C4h 1 12.3 
29 Cgh 3,1 8.2 
30 cý 3.6 4.6 
31 cAt. 1 ,') 
3. ) cah 1 10.8 
33 Clh 1.3 14.3 
34 Cii, 1.1 10.5 
35 Cah 1.1 14.4 
36 Ci), 0.8 12.7 
37 Cth 1,8 ? 
;8 Cjh 4,6 9.1 
39 CQ 4 ? 
40 Clh 13 11.6 
41 cm 1.5 106 
42 c1h 4,4 7 
43 Cm 6,6 8.8 
44 CAN (1.7 15.1 
45 CQ 1.8 13.5 
46 cAh -;. 5 4.6 
47 CAh 0.8 ? 
48 0.7 9.8 
49 1 24.6 
M edian Met 12n 1.5 10.8 
tl() 
.1 
t 10 4 
- LO 1 1-0 1 1 
Median and Interquartile ranges of the ultrasound measurements of slidin and subcutaneous layer 
thickness In patients with lower limb, chronic venous disease using a 7NIHz linear array transducer 
probe. 
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Vssue tononxtry 
PHASE I (0-1s) 
Tissue tonometry 
PHASE 11 (1-10s) 
Tissue tonometry 
PHASE III (10-300s 
Limb 
No 
CEAPCIinicjkl 
Clas4rication 
Xo(nun) XI-Xo(nun) -Urau(sees") XI. Xo(nun) -1/Tau (secs 
I C11 
- 
1.75 0.25 3.03 0.1 60.4 
Cl 2.57 037 4.19 - 0.64 158.5 
cn 2.2 0: 13 362 004 155.1 
4 co 3.1 0.27 1 2.77 0.12 701.5 
5 ca 2.31 0.41 2.14 0.1 1 861.8 
6 ch 2.41 0.39 2.42 0.06 1 62.8 
7 Cn 2.44 0.17 1 2.02 001 1 75.9 
91 cn 3.96 0.29 1 3.18 0.05 1 67.7 
9 ca 3.53 047 2.1 0.84 45.2 
10 cn . 14 
033 2.4 0.01 149 
II Cn 3.07 1 2.34 0.21 44.9 
12 ca 1.98 0.14 2.16 0.11 51.6 
13 C, 233 0.12 3.01 0.06 798 
14 C, 3.2 062 1.77 0.29 100 
I" C, 1.91 3.55 0.06 11.1 
16 C, 2.9 1.92 0.81 1 49.2 
17 C, 1.35 0,54 401 0.55 67 
18 C:! 2.31 048 11.1 0.28 43.1 
19 1 C:! _ 
3.1 1.16 444 1.73 44.6 
'20 CA. 241 048 235 0.16 56.6 
21 CA. 1.94 0.93 4.63 0.72 56.1 
22 CA. 313 37 3.38 0.27 62,5 
23 C4. 2, 0.66 4.39 0.83 1 3 56.1 
24 C., 3.76 0,9 2.58 0.66ý 47.7 
25 c4h _ 1.15 045 381 0.51 53.0 
26 C4. 1.72 0.57 2.42 0.69 53.3 
27 C4h 0"; g 0.20 2.80 0.03 
N 
45.6 
28 C. &h 0.16 0.55 3.69 0.19 11 
29 C4h 0.71 070 2.13 42 O In I 
30 C4h 0.46 0.58 2.39 221 21 32.3 
11 C4h 1.05 3.23 0.37 38.8 
-12 clh 041 0.29 4.64 0.09 46.5 
33 C4h R86 - 
0.40 2.95 0.09 27.8 
14 C4h LN . 59 
4.28 0.54 566 
35 C4h R16 - 
0. '6 2.55 0.37 28.5 
16 C4h 1.19 LOIS 2.66 0.91 78.6 
37 c4h 1. Q 4.14 0.71 79.2 
c- n t)9 0-41 2.43 0.22 74. - 
9 C4h R57 9.03 0.59 68.2 
40 c4h 1.05 . 
3.23 0.37 38 
4 Clh 0. '6 024 2,73 0.29 108.9 
42 c4h 1.2) 0.03 4.63 0.3 3.6 
43 c4h 0,49 0,54 407 0.49 71.7 
44 Cý 0.66 0.74 26 1 0.64 60.3 
45 Cah 9.76 0.19 2,38 0.02 10.5 
46 cah 1.41 0.37 2.18 0,51 23 
47 c4h (). 45 3.77 0.28 47.7 
48 c4h 125 OA4 3.33 0.23 49.2 
49 cjh- 05(' 0.16 2.53 1 error I error 
Tissue tonomclry analysis of distance and rate constant parameters in patients with lower 
limb chronic venous disease. 
267 
Appendix VIII 
Studv VI 
Phase I Phase 11 Phase III 
Limb 
No 
Xo 
mm) 
Xo 
(mm) 
XIAO 
(mm) 
, 
XIAO 
(mm) 
VTau 
L.; m -1) 
-IlTau 
LecL') 
XIAO j 
(mm) 
XI-XO 
(mm) 
-, /Tau 
(secs"') 
-I/Tau 
(Secs'l) 
- 
Dre- Dost. Dre- 
I 
DOst- Dre- Dost- nre- nnqt, 
__ 
Dre- DOSt- 
1 281 2.67 0,44 0.47 2.23 5.39 0.01 0.48 495.9 68.37 
2 2.09 
, 
1.91 0.3 0,62 )gg 
- 
2.65 0.64 0.51 66.93 124,53 
3 2.23 2.22 1 1.11 0,52 193 1.67 0.82 0.38 73-73 73.90 
4 1.81 2.81 1 1.36 0.46 1 3.13 3.49 0.86 0.49 53.01 83.73 
_5 1. -11 2.67 1.41 0.65 5.12 2.52 1.63 0.53 118.8 59.00 6 046 2.11 0.60 045 2.38 2.94 0.73 016 101.2 65.20 
7 0.96 1.4) 0.35 0.47 3,74 2.33 0.21 0.3 74.10 65.90 
8 1.02 1.25 0.71 0,44 2.28 307 0.51 0.91 144.1 44.40 
9 0.45 0.79 0.25 0,40 2.74 2.52 0.18 0.17 114.1 105.9 
10 0,99 1.31 0.40 0.41 145 3.54 OA2 0.36 74.13 91.07 
11 3.80 4.36 0.80 L14 2.14 1508 0.75 0.12 58.80 52.70 
12 2.11 2.87 1.01) 0.32 2.28 3.06 2,26 1.48 5240 33.70 
13 3.04 
- 
1.95 1.3 0.35 1,80 4.75 0.24 0.69 179.7 41.70 
14 086 
- 
1.55 0,43 0.18 4fl 2.39 0.55 2.02 28,10 3860 
15 0.79_ 118 0,61 0.47 1.97 8,54 0.11 085 69.50 45.80 
16 2.54_ 3.30 .6 
0.39 . 42 401 0.89 0.54 62.00 . 66 RO 
medoan 1.68 134 0.66 0.46 2.44 3.07 0.60 2 '; Q 21,, 92 65.55 
LO 0.94 1.52 . 44 0.40 2.27 2.51 0.20 06 
;5 6120 1 45-45 
UO 2.31 1 0.48 3.03 410 0.83 0.73 115.3 1 76.36 
Tissue tonometry parameters of the mechanical properties of the skin in patients with lower limb 
chronic venous disease before and after compression stocking wear. 
cl cl . 
k Cl k 
Limb No (soring, constant) DashDot constant (sDrine constant) Dashnot constant 
Zhase I Phase 11 Phase 11 Phase III Phase III 
1.17 7.48 16.67 411.25 203938.88 
1.57 ;. 2. ) 15,61 5.14 344.06 
3 1.8 2.46 868 401 295.82 
4 1.82 2.42 757 3.83 202.87 
5 2,12 2.30 12.24 2.02 239.79 
6 7.1) 54'4 13M 4,51 456.09 
7 3.43 9.40 15.16 1.567 1160.90 
8 1.2-) 4.61 10.57 6.45 929.59 
9 1.21 IIA6 W06 18.28 2085.49 
01 3.32 gýlj 20.15 27.42 2032.40 
11 
. 
0.87 4.11 RM Tig 257.94 
12 1.56 A (1-0 1,46 76.28 
13 1.08 167 4.81 1.3.71 2463,39 
14 
. 
1,13 7.0 10.68 5.98 168.09 
15 4.11 1111 10.45 29.91 ZURS Ns 
16 1 ý29 4.77 1 11.54 1 370 229.19 197 1 -t-N) 1 11.89 1 5-56 400.08 1 
IA43 1 1-00 1 8-77 1 3.97 237.14 
luo I. 53 1 7.52 1 17.54 1 16 3) 70JI07 
Median and Inter-quartile range values for spring and dashpot constant parameters before 
compression stocking wear. 
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r. Cl k Cl k 
Limb No siDrine constant sDrint! constant DashDot const nT sgring, constant Dashpot constant 
Pha-; e I Phase 11 Phase It Phase III Phase III 
1.23 7.00 37.73 6.85 468.62 
2 1.13 5.31 1406 6.45 803.34 
3 1 
ý48 
6.33 10.57 8.66 639.82 
4 1.16 7 15 2489 6.71 562.19 
1 1.23 506 12.76 6.21 366 25 
61 1.42 7.31 21.49 12.65 825.03 
71 2.12 7.00 16,31 10.97 722.70 
R1 2.62 7.48 22.96 3.62 160.52 
91 4.16 18.13 20.73 19.35 2049.48 
10 1 2.49 802 28.41 9.14 932.29 
11 1 0.75 -)ý89 
. 
43.52 27.42 1444.86 
12 1 1.15 10.28 31.46 2.22 74.91 
13 Its 9.40 4465 4.77 198.83 
14 2.12 8,66 2069 1.63 
15 1-38 7.00 59,78 3.87 177.27 
16 1. ( 
. 
8,44 33.83 W09 . 406.99 
median 1.40 7.23 23.92 
16.58 CICAn 
110 1.16 6.83 19.60 14.54 193.44 
uo 2.1 3.28 M. 80 19.60 808.76 
Median and Inter-quartile range values for spring and dashpot constant parameters after 
compression stocking wear. 
CIRCLIMFERENTIAL LIMB VOLUME MEASUREMENT (m]) 
Disc model meth 
Limb. No Drr-stockine nost-stockine 
1 2621 2610.2 
2 2547 2431.1 
3 28455 2421.9 
4 2798.1 2369.5 
5 2607.7 2116.6 
6 2482,8 2138.2 
7 2373.4 2069.9 
8 2164.5 2213.3 
9 2116.5 2034A 
10 25748 2257.8 
11 2197.1 2132.6 
I-P 222.1 2314.5 
13 ')187 2350.3 
14 2687.1 2478.5 
11 "ITS 2200.6 
1 6 2"', 7.8 2109.8 
Mean value or the circumferential limb volume measurements using a tape measure before 
and after compression stocking wear. 
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Appendix IX 
Studv VIT 
Method orcalculating the Kappa measure of amement between different examiners using the CEAP 
method of clavvirication and scorinje of lower limb chronic venous disease. 
INTER-VARIABILITY OF THE CEAP METHOD OF CLASSIFICATION AND SCORING OF 
LOWER LIMB VENOUS DISEASE 
I I 
- 
I II 
-II CEAP Metho d of classifica CEAP Method of scoring 
No Age I sex Umb Clinical A/S Etiologic I Anatomic Pathophysiologic Clinical Disabilit 
y 
Anatomi 
--c 
Examiner 
1 25 1 F Cn A EI A p 0 0 0 A 
11 21 1 F RI CA A EI A p 0 0 0 B 
- I1 25 1 F RI CA A E A p 0 0 0 C 
11 25 1 F LI Cn A E A p 
il 
0 0 0 A 
f1 25 1 F L C', A E A p 0 0 0 11 
11 25 1 F L Q A E A p 0 0 0 C 
1 32 1 NJ R C', A E A -P 
0 0 0 A 
1 '32 1 NJ R Cn A E A p 0 0 0 
1 12 1 NJ RI Cn A E A p 0 0 0 C 
21 121 KJ Iý I Cn A E A p 0 0 01 A 
_ 71 32 1 N1 LI Ct, A E A p 0 0 0 B 
71 12 1 N1 I- I - Cn A E A p 0 0 0 C 
II "i I sl RI Cn -L -A 
EI A p 0 0 0 A 
55 1 NJ RI Cn A E A p 0 0 0 B 
55 1 to R C. A F A p 0 0 0 C 
55 ýl L Q A F A p 0 0 0 A 
1,5 _ NJ LI Cn 
M 
A p 0 0 0 B 
55 N1 L C11 A A p 0 0 0 C 
4 4) F R Cn A A p 0 0 1 A 
4 42 F R C1 A A p 0 0 1 B 
4 4, ')- F RI Cn A E- A P. 0 0 1 C 
41 _ 42 F LI C, A E A p 0 0 1 A 
41 42 F LI C1 A EI A p 0 0 1 11 
-4 42 F I. I C1 A E A p 0 10 1 C 
5 53 NJ R C, s Ep A%p PR 1 3 A 
53 st- R C, s Fp Aýp PR p 1 3 B 
53 NJ R C, s Ep As P 
p p 1 3 C 
-5 51 1 %1 L C, p I As P p 
p 1 2 A 
53 1 N1 I- I C, I s Fp I Asp PR 1 2 B 
53 1 %J I- I C, _s Fp 
I Aqp PR p 1 1 2 C 
6 72 1F L I C, _s 
Ep I A% PR 
P 
1 1 3 A 
6 72 1F L I C- _s Fp 
I At 
. 
PR I I I B 
6 72 1F L I C, s Fp I As , I1 
1 3 C 
6 72 1F R I -CA 5 Er At PR -1 1 3 A 
6 72 1 F R I CA - S Ep As PR 3 1 3 B 
6 1 72 - 1F R I CA 
_ S Er At R 1 1 3 C 
56 R CA A Fp At PR 1 0 
-A 
7 56 N1 R CA A PR 1 0 -3 B 
7 56 N1 R I C, A Fp M PR 0 0 3 C 
7 56 M L I CA q Fp - At 
PR 2 1 4 A 
7 56 NJ L I CA s Fp I At PR 2 1 14 It 
7 !ý ki L I C, S Ep At R 
1 1 4 C 
_ _ 47 1F R I CA .S 
Ep A% PR 2 1 2 A 
47 1F R I CA , s Ep_ _ 
A- PR 2 1 t 2 B 
m 47 1F R C. S_ Fp A-z PR 1 
pi 
2 C 
9 47 1F I. CA s Fp At PR 2 1 2 A 
8 1 47 1F I. I CA S_ _Fp I 
A,; PR 1 2 B 
8 47 F L C. s F. I ýAjc 
PR 1 1 2 C 
- 9 62 NJ R CA s Fe I Atpn PR 3 12 6 A 
- 9 9 9 f, 2 W. 1 R C. Iq Ft I Aqpn PR -1 2 6 B 
9 
1 
162 1 %1 R CA IS Fý I Agra_ PR 3 2 6 C 
162 1m Iý I C. I -s 
Fq I Atrn PR 3 2 7 A 
9 1 62 1 st I- I C. Is Fi -. 
AS vn PR 1 2 7 B 
tL I- I C. s , Ft __& vn 
R -3 2 17 C _ 67 F R I CA s Ft Atpn P2 4 2 4 A 
67 P R CA S Ft Mpn P2 4 2 4 B 
67 F R CA S Ec As rn PR 4 2 4 C 
0 2 F 1. 1 C. S PR 4 3 A 
10 67 F L CA _r, 
I Fp kt PR 4 2 3 B 
10 1 67 1F L CA rL F" At - 
Pt 4 2 
__2 -2- 
C 
It 1 72 1F IR I CL _ S up A, Pit 7 
A I 
2 E A 
11 1 72 1F IK I CA S Fr A- ps 6 B 
v_ j: K_ j CA A- p 2 2 2 C 
F I I. I C. % t:,. I ý, k q PR __ 
I A 
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1 72 F ci 1 s Ep A ý; PR 7 2 1 
1 72 F L CA s Ep Ag PR 7 2 2 c 
12 75 NI c, s -Z Aýz n PR 12 2 5 A 
12 75 1 NI c6 s -Z Aýz n PR 12 2 5 B 
12 75 NI c6 s 5; Mn PR 10 2 5 c 
12 75 NI Cß s Ep 1 M PR 11 2 2 A 
12 75 NI L CA . s Ep A-z po 2 2 B 
12 75 NI CA S p Ae PR 2 c 
11 63 F C, 8 JL EP Aýz PR 7 2 2 A 
13 63 F R1 CA P M PR 7 2 2 B 
13 63 F R CA Ep Xz PR 7 2 2 c 
11 63 F cý s Ep A ý; PR 7 2 2 A 
11 63 F L Ci . Ae 
PR 7 2 -2 B 
13 1 63 1 F L1 Ci 1 S Ep X; PR 71 2 2 _ c 
14 1 71 1 F L1 Q1 S EP A% PR 81 2 2 A 
4 71 cq S Ep A-z P 8 2 2 B 
4 71 C, EP Ae P 8 2 2 c 
14 7,1 F R Ci EP A-z P 10 2 2 A 
14 71 1 F R1 Ce 1 S EP M 10 2 2 
14 1 71 1 F R1 Ci 1 S1 Ep 1 A% P 8 2 
The kappa measure of a-c"ement 
This method is used in study VIT to assess the agreement between three different observers in assessing 
the ease of use of the application of the CEAP method of classification and scoring of lower limb chronic 
venous discase. 
The method for the kappa measure of agreement is as follows. The observed measure of agreement, I0, 
and the corresponding expected measure, 4. are defined as follows: 
n= total no of 
observations 
Examiner A 
Examiner BIC positive negative 
positive a b 
negative c d 
a+d 
n 
L. (a+c)(a+b)+(b+d)(c+d) 
n' 
Kappa is defined as the difference between observed and expected agreement as a fraction of the 
maximum difference: 
I()- Te 
1-4 
The maximum value of lappa is 1, %%hich represents perfect agreement, and kappa will take the value zero 0 
if there is only chance agreement. 
Fleiss et &I, recommended that Lappa values exceeding 0.75 represents excellent aC-Ireement, values 
between 0.40 and 0.75 represents fair to good agreement and values less than 0.40 represents poor 
agreement. 
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Calculation of the Kappa meavure of agreement 
Clinical classification 
Examiner A 
Examiner B positive negative 
positive 22 1 
negative 0 
Examiner A 
Examiner C positive negative 
positive 10 0 
negative 6 12 
27 . 0.96, 28 
(23)(22) + (6)(51 . 0.68. 784 
k 0.96 - 0.68 . 0.28 . 0.875 1-0.68 0.32 
22 . 0.79, 28 
L. (10)(16)+(12)(18) . 0.48, 784 
k. 0.79 - 0.48 . 0.31 . 0.60 1-0.48 0.52 
Etiological classification 
Examiner A 
Examiner B positive negative 
positive 20 0 
negative 0 8 
Examiner A 
Examiner C positive negative 
positive 20 0 
negative C, 0 8 
28 . 1.00, 28 
(20)(20) + (8)(8) . 0.59, 784 
k 1.00-0.59 . 0.41 . 1.00 1.00 - 0.59 0.41 
1. . 28 . 1.00, 28 
. (20)(20) + (8)(8) . 0.59, 784 
k. 1.00 - 0.59 . 0.41 . 1.00 1.00 - 0.59 0.41 
AIS classification 
Examiner A 
Examiner B positive negative 
positive 19 0 
negative 0 9 
Examiner A 
Examiner C positive negative 
positive 19 0 
negative_ 0 9 
14. L8 . 1.00, 28 
(19)(19) + (9)(9) . 036. 784 
k. 1.00 - 0.56 . OA4 . MW 1.00 - 0.56 0.44 
1,28 . 1.00, 28 
14 . (19)(19) + (9)(9) . 0.56, 784 
k. 1.00 - 0.56 . 0.44 . 1.00 1.00 - 0.56 0.44 
272 
Anatomical classification 
Examiner A 
Examiner B positive negative 
positive 20 0 
negative 0 
28 . 1.00, 28 
(20)(20) + (8)(D . 0.59, 
784 
k. 1.00 - 0.59 . 0.41 . 1.00 
1.00- 039 0.41 
Pathophysiological classification 
Examiner A 
Examiner B positive negative 
positive 20 0 
negative 0 
28 . 1.00, 28 
(20)(20) + (8)(8) . 039, 
784 
k. 1.00 - 0.59 . 0.41 .1 . 00 
1.00 - 0.59 0.41 
Clinical Scoring 
Examiner A 
Examiner B positive negative 
positive 19 0 
negative 1 1 8 
2-7 . 0.96. 28 
(19)(20) + (8)(9) . 038, 784 
k. 0.96 - 0.5 8. Q, 1_8 . 0.90 1.00 - 0.58 0.42 
Examiner A 
Examiner C positive negative 
positive 20 0 
negative 0 8 
28 . 1.00, 28 
(20)(20) + (8)(8) . 0.59, 784 
k. 1.00 - 0.59 . 0.41 . 1.00 1.00 - 0.59 0.41 
Examiner A 
Examiner C positive negative 
positive 20 0 
negative 0 8 
28 . 1.00, 28 
(20)(20) + (8)(8) . 0.59, 784 
k. 1.00 - 0.59 . 0.41 . 1.00 1.00 - 0.59 
E41 
Examiner A 
Examiner C positive negative 
positive 13 0 
negative 7 
1. . 21 . 0.75, 28 
14 . (13)(20) + (8)(LQ . 0.48, 784 
k. 0.75 - 0.48 . 0.27 . 0.52 1.00 - 0.48 0.52 
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Disability Scoring 
Examiner A 
Examiner B positive negative 
positive 20 0 
negative 0 
28.1.00. 
28 
(20)(20) + NY& . 0.59, 
784 
k. 1.00 - 0.59 . 0.41 . 1.00 
1.00 - 0.59 0.41 
Anatomical Scoring 
Exwdner A 
Examiner B positive negative 
positive 22 0 
negative 0 6 
28 . 1.00, 28 
(26)(26) + (6)(6) . 0.66. 
784 
1.00-0- 0.34 . 1.00 
1.0- 0.66 0.34 
Examiner A 
Examiner C positive negative 
positive 20 0 
negative 0 8 
L. 28 . 1.00, 28 
(20)(20) + (8)(8) . 0.59, 784 
k. 1.00 - 0.59 . 0.41 . 1.00 1.00 - 0.59 0.41 
Examiner A 
Examiner C positive negative 
positive 22 0 
negative 0 6 
L. 28 . 1.00, 28 
(26)(26) + (6)(6) . 0.66, 784 
k. 1.00 - 0.66 . 0.34 . 1.00 1.00 - 0.66 0.34 
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